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Increases in air pollution, especially the particulate component, are associated with 
increased cardiovascular mortality, possibly through increases in thrombogenic 
mechanisms. The research presented in this thesis addresses the hypothesis that 
diesel exhaust particulates (DEP) increase thrombogenicity by impairing the release 
of tissue plasminogen activator (t-PA) from vascular endothelial cells, thus inhibiting 
the endogenous fibrinolytic mechanisms that promote thrombus breakdown.  
 
The initial aims of this work were to develop an in vivo model of thrombosis, to 
determine whether exposure to DEP did alter clotting. Initial attempts to develop the 
Folts’ model (which stimulates thrombus formation via arterial stenosis and 
mechanical injury), first in male C57/Bl6 mice and later in male Wistar rats, were 
unsuccessful. An alternative approach, using ferric chloride (FeCl3) to induce 
chemical injury to the rat carotid artery was found to produce reliable and 
reproducible thrombotic occlusion:  this model was used for all subsequent 
experiments. 
 
The effects of DEP on thrombus formation were assessed in vivo by applying the 
FeCl3 model. DEP were administered via intratracheal instillation or tail vein 
injection 2, 6 or 24 hours prior to induction of thrombosis. The effects of DEP were 
compared with vehicle and suitable controls: carbon black (a clean carbon 
nanoparticle); quartz (a large non-carbon particle that causes well-characterised 
pulmonary inflammation). The time to thrombotic occlusion was significantly 
reduced 6h after intra-pulmonary instillation of DEP (0.5ml of a 1mg/ml 
suspension). In contrast, instillation of carbon black or quartz had no significant 
effect on thrombosis, despite causing greater pulmonary (increased neutrophils and 
levels of interleukin-6, tumour necrosis factor-α and C-reactive protein in 
bronchoalveolar lavage fluid) and systemic (C-reactive protein in plasma) 
inflammation than DEP. Direct administration of DEP (0.5mg/kg) to the blood 
stream resulted in an acute (2 hours after injection) increase in time to thrombotic 
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occlusion in the absence of pulmonary inflammation. A similar (but less pronounced) 
effect was observed following administration of carbon black (0.5mg/kg). These data 
suggest that the DEP-mediated increase in thrombosis is independent of pulmonary 
and systemic inflammation. The mechanisms involved were addressed by measuring 
platelet-monocyte interactions (flow cytometry) and markers of the endogenous 
fibrinolytic system (ELISA). Exposure (either instillation of injection) to DEP 
significantly increased platelet-monocyte aggregation. Carbon black and quartz 
produced no such effect (but did increase platelet-platelet aggregation). t-PA antigen 
and activity were reduced, whilst PAI-1 and fibrinogen were increased, following 
either instillation or injection of DEP.  
 
The final aim was to develop a suitable dispersant for use in cell culture to determine 
whether DEP alter the expression (real-time polymerase chain reaction; rtPCR) and 
generation (enzyme-linked immunosorbent assay; ELISA) of t-PA and plasminogen 
activator inhibitor (PAI-1). Cell culture medium containing bovine serum albumin 
(0.5mg/ml; BSA) provided the best combination for DEP dispersal and maintenance 
of small particle size (<200nM), without detrimental effects on human umbilical 
endothelial cells (HUVECs). Exposure (6 and 24 hours) of HUVECs to DEP resulted 
in reduced basal and thrombin stimulated t-PA and PAI-1 expression. This was 
mirrored by reduced detection of t-PA and PAI-1 in culture medium. 
 
In conclusion, these investigations confirm that exposure to DEP is capable of 
increasing the rate of thrombus formation and that this is, in part, mediated by an 
alteration in the endogenous fibrinolytic system. These changes did not appear to be 
secondary to pulmonary or systemic inflammation. Whilst cell culture experiments 
suggested DEP could directly alter endogenous fibrinolytic activity in endothelial 
cells, there was no evidence from these experiments of DEP translocation into the 
systemic circulation. Thus, this work suggests that DEP is capable of increasing 
thrombus formation in vivo via several mechanisms. Similar changes may account 
for the increased thrombus formation in humans exposed to diesel exhaust in air 
pollution. 
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Cardiovascular disease is one of the most significant causes of morbidity and 
mortality in the developed world. Many risk factors are recognised in the 
development of cardiovascular disease, such as age, sex, heredity, smoking, weight, 
physical inactivity, high cholesterol and high blood pressure. A growing body of 
epidemiological evidence now supports the theory that exposure to environmental air 
pollution also increases the risk of cardiovascular events, although it is not clear 
which biological mechanisms, or which components of air pollution, are responsible 
for these effects. The number of premature deaths attributed to air pollution 
worldwide is estimated to be ~2 million per annum (World Health Organisation 
2002, World Health Report, Geneva, http://www.who.int/whr/2002/en). Indeed, the 
significance attributed to the association between air pollution and cardiovascular 
disease is illustrated by the decision, in 2004, of the American Heart Association to 
publish a scientific statement on this subject (Brook et al. 2004). This has recently 
been updated, with the emphasis changed to address the relationship between 
cardiovascular disease and particulate matter air pollution; based on increasing 
evidence that even relatively brief exposures to particulate matter with a diameter 
<2.5μm (PM2.5) can cause increased fatal and non-fatal cardiovascular events (Brook 
et al. 2010). The continuing impact of this problem has recently been emphasised 
(and is increasingly brought to the public’s attention) by stories in national and 
international media; such as the problems of acute smog caused by peat fires and 
unusually high temperatures in Moscow this summer 
(http://articles.latimes.com/2010/jul/29/world/la-fg-moscow-smog-fires-20100729). 
Also of particular significance is the problem that atmospheric pollution is causing 
China (http://news.bbc.co.uk/1/hi/world/asia-pacific/6265098.stm) and her 
neighbours (http://www.timesonline.co.uk/tol/news/world/asia/article7072220.ece). 
The work described in this thesis addresses the hypothesis that exposure to 
particulate matter air pollution (specifically ultrafine, diesel combustion-derived 
particles) increases the risk of cardiovascular events by increasing the chance of 
vascular thrombosis. Finding results to support this theory may provide an 
opportunity to develop new treatments or preventative measures to lessen the effects 
of air pollution on the cardiovascular system. 
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1.1   Atmospheric Pollution 
1.1.1   Historical Evidence for the Adverse Effects of Environmental Pollution 
on Human Health 
 
A growing body of evidence, accumulated over more than 50 years, has shown that 
exposure to air pollution has adverse effects on human health. The growing 
realisation that air pollution could have a significant, and acute, impact on human 
morbidity and mortality received corroboration from a number of dramatic incidents 
in the first half to the 20th century (see Simkhovich et al. 2008). Although preceded 
by disasters such as the Meuse Valley smog (Nemery et al. 2001) and the industrial 
pollution incident at Donora (Pennsylvania, USA; Helfand et al. 2001), the most 
notable occurrence from a British perspective must be the London smog of 
December 1952. This was caused by high levels of particulate air pollution, mostly 
derived from burning coal, combined with a period of cold weather and anticyclone 
(windless) conditions, which prevented particulate matter from being cleared from 
the air (Davis et al. 2002; Dooley et al. 2002; Hunt et al. 2003). In the weeks 
following the London smog, it was estimated that ~4,000 people died as a result, and 
a further 100,000 people became ill with respiratory problems. However, more recent 
work has estimated that the number of deaths resulting from the smog was much 
higher, at around 12,000 (Bell et al. 2001). This cluster of severe incidents (the 
London smog is widely regarded as the worst air pollution incident in the United 
Kingdom) had a great effect on stimulating environmental research and promoting 
public awareness of the relationship between air pollution and health. It also resulted 
in legislation aimed at reducing the extent and toxicity of environmental pollution, 
leading to the introduction of regulations such as the Clean Air Act of 1956 (and the 
Clean Air Act (1963) and the Air Quality Act (1967) in the USA). Introduction of 
these measures has been central to a reduction in UK particulate air pollution; from 
130μg/m3 to around 20μg/m3 50 years later (http://www.airquality.co.uk). Despite 
this improvement, atmospheric pollution remains a considerable Public Health issue 
(Ware. 2000; McCreanor et al. 2007) as emphasised in a recent report from the UK 
Parliamentd(http://www.publications.parliament.uk/pa/cm200910/cmselect/cmenvau
d/229/229i.pdf). Indeed, the association between air pollution and mortality does not 
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seem to have a demonstrable threshold and remains evident below current national 
and international standards for air quality (Ware. 2000). Furthermore, the gravimetric 
measure used to demonstrate the reduction in particulate pollution hides the increase 
in combustion-derived nanoparticles, which has paralleled the increase in road 
vehicles in the UK over the same period. Due to their small size, nanoparticles 
contribute very little to mass-based measures of particulate pollution, but are much 
more likely to have effects on health than larger particles (see Mills et al. 2009). 
 
 
1.1.2   Components of Atmospheric Pollution 
 
Air pollution comprises a complex mixture of gases, liquids and particles (Table 1.1) 
that will vary in different locations, at different times and under different weather 
conditions (Harrison & Yin. 2000; Simkhovich et al. 2008; Brook et al. 2010). These 
components are continually changing and also altering through chemical reactions 
with each other and with natural gases in the atmosphere. Some components are 
essentially harmless (eg sodium chloride) whilst others are not particularly toxic at 
ambient levels. However, certain components can have individual toxic effects and 
can also act in synergy or antagonistically with other constituents of the pollutant 
cocktail. 
 
Atmospheric pollutants arise from the natural environment (eg. Wildfires, such as the 
peat fires that recently caused such problems in Moscow) and from human activities 
(industry, agriculture, traffic, power generation, biomass burning) (Simkhovich et 
al., 2008; Brook et al., 2010). In addition to these primary pollutants, secondary 
pollutants can arise as a consequence of chemical reactions (often involving sunlight 
and water vapour) in the atmosphere. For example, ozone is largely generated as the 
product of chemical reactions occurring when exhaust pollution is exposed to 
sunlight (Joseph. 2007). 
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Table 1.1 - The Major Components of Atmospheric Pollution. 
Dae, aerodynamic diameter. Adapted from Simkhovich et al. 2008 and Brook et al. 2010. 
 
 
Particulate Matter (PM) Coarse (Dae 2.5-10μm) 
 Fine (Dae <2.5μm) 
 Ultrafine (Dae <0.1μm) 
Gases Carbon monoxide (CO) 
 Nitrogen oxides (NO, NO2) 
 Ozone (O3) 
 Sulphur dioxide (SO2) 
 Carbon dioxide (CO2) 
 Carbon monoxide (CO) 
Volatile and Semi-Volatile Organic 
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1.1.2.1   Particulate Matter 
 
Given the complex and dynamic nature of air pollution, it is difficult to attribute its 
effects on health to a single constituent. Over the past decade, however, increasing 
emphasis has been placed on the role of particulate matter, and in particular on the 
fine and ultrafine particles. Even so, it is important to remember that these particles 
only account for ~2% of pollutant mass (with the remaining 98% attributable to 
gases and organic vapour phase compounds; Brook et al. 2010). The National 
Atmospheric Emissions Inventory monitors particulate air pollution at 120 sites 
throughout the UK. As expected, emissions are highest in urban areas and along 
major roads. Average UK levels meet the government standards of 50μg/m3 of 
sampled air (http://www.airquality.co.uk/standards.php). However, standard levels 
are regularly exceeded, with particulate levels in London often reaching 300μg/m3  
(http://www.airquality.co.uk/standards.php). 
 
Particulate matter can be derived from natural (e.g. windblown dust, wildfires) and 
human (eg road and agricultural dust, tyre wear emissions, wood combustion, 
combustion, demolition, mining) activities (Simkhovich et al. 2008; Harrison & Yin. 
2000). These ambient particles can comprise inorganic compounds (sulphates, 
nitrates, chloride, ammonia), trace metals, crystals, biological components (pollens, 
spores, bacteria) and adsorbed volatile/semivolatile organic compounds. 
Environmental particulate air pollution is measured by a global sampling convention 
and categorised based on size (see Table 1.1); coarse particles (PM10) range from 
2.5-10μm in diameter, fine particles (PM2.5) range from 100nm-2.5μm, and ultrafines 
are smaller than 100nm. Coarse particles are able to pass the larynx and reach the 
upper airways, fine particles are able to penetrate the unciliated regions of the lungs, 
but only ultrafine particles (UFPs) are able to travel deep into the lungs, finally 
depositing in the alveoli (Donaldson et al. 2001). It should be noted, however, that, 
whilst most studies that link particulate matter to cardiovascular disease focus on 
particle mass, this may not be the best measure of the activity of these pollutants 
(Simkhovich et al. 2008). Some of the effects of particulates are also undoubtedly 
due to their chemical composition and other characteristics (eg, solubility, charge, 
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surface area, pulmonary deposition, stability in the atmosphere and in biological 
tissue). Evidence now suggests that particle size and surface area are important 
contributors to the adverse effects associated with PM10 exposure, as UFPs cause a 
greater pulmonary inflammatory response than fine particles made of the same 
materials. The toxicity of particulate matter is, therefore, usually considered to be 
related to the particle number, size, chemical composition and surface area. In 
addition to their carbon core, combustion-derived particulates often have associated 
toxic compounds (eg, transition metals, organic compounds, semiquinones, 
endotoxins) adsorbed to their surface (Scheepers & Bos. 1992; Donaldson et al. 
2005). 
 
Given the complexity of atmospheric pollution it has been suggested that 
investigations should focus on the sources of pollutants that are of the greatest 
concern to human health, rather than try to document singly which constituents are 
most toxic (Brook et al. 2010). Of particular concern in recent years has been the 
significance of atmospheric pollutants released from road transport. Many 
individuals, particularly in poor areas, live close enough to roads (within 500m) to be 
consistently exposed to high levels of traffic exhaust fumes. In addition, modern 
lifestyles dictate that a significant number of people spend a considerable proportion 
of their day travelling in motor vehicles (Solomon et al. 2008). Certain occupations 
(eg, traffic wardens, traffic police) are more susceptible to the effects of air pollution, 
due to their increased exposure. The work described in this thesis focuses, therefore, 
on diesel combustion, which contributes a significant component of vehicle 
emissions and produces a complex mixture of potentially toxic gases and particles. 
 
Ultrafine particles make up the majority of all diesel exhaust particles, with up to 
50% by mass of urban PM10 being made up of ultrafine carbon-centred particles 
(Donaldson et al. 2005). These particles are associated with metals (including 
transition metals), ammonium salts of nitrogen, sulphur and chlorine, as well as 
geological dust and organic matter (Donaldson et al. 2005). Organic compounds, 
polycyclic aromatic hydrocarbons and oxidized transition metals carried on the 
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surface of combustion-derived nanoparticulates (Scheepers & Bos. 1992) can 
generate oxidative stress and inflammation (Donaldson et al. 2005).  
 
 
1.1.3   Epidemiological Evidence for the Adverse Health Effects of Atmospheric 
Pollution  
 
There is now considerable evidence in the scientific literature (confirming the 
observations from dramatic pollution episodes in the 20th century) showing 
emphatically that exposure to atmospheric pollution increases morbidity and 
mortality (Pope & Dockery. 2006). Indeed, despite reductions of atmospheric air 
pollution in many locations following the introduction of environmental legislation, 
the World Health Organisation (WHO) currently estimates that ~2 million people die 
each year due to conditions caused by exposure to air pollution. This represents 3.6% 
of the 55 million deaths occurring worldwide each year (WHO Statistics: 
http://www.who.int/mediacentre/factsheets/fs313/en/index.html). These deaths arise 
from both acute and chronic exposures to atmospheric pollution, largely from 
cardiovascular disease, respiratory disorders (chronic obstructive pulmonary disease, 
pneumonia) and cancer (largely lung cancer) (Simkhovich et al. 2008). 
 
Many epidemiological studies have shown an association between increased air 
pollution and increases in cardiopulmonary morbidity and mortality, and these have 
been reviewed extensively (Pope & Dockery. 2006; Simkhovich et al. 2008; Brook 
et al. 2010). Large-scale studies have been conduced in order to address concerns 
about city selection bias; one of the largest was the National Morbidity, Mortality 
and Air Pollution Study (NMMAPS), conducted in the U.S. Several reports have 
been published using this data, including Samet et al. (2000), which assessed the 
effects of PM10 in 20 major U.S. cities over a period of 8 years and reported that 
levels of fine particulate air pollution were associated with increased deaths from 
cardiovascular and respiratory illnesses. Dominici et al. (2003) suggested that a 
10μg/m3 elevation in PM10 results in a 1.87% increase in cardiopulmonary mortality, 
whereas a 10μg/m3 elevation in PM2.5 results in a 6% increase in cardiopulmonary 
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mortality (Pope et al. 2002). This suggests that the fine and ultrafine fractions of 
particulate pollution are most likely to cause acute cardiovascular and pulmonary 
problems although it is possible these differences are due to the source of the 
particulates used in the two studies. Similar studies were also conducted in Europe; 
Air Pollution and Health: A European Approach (APHEA and APHEA-2) examined 
daily PM and related mortality in multiple cities (Katsouyanni. 2003; Analitis et al. 
2006) and found that increases in cardiovascular and respiratory mortality were 
significantly associated with increases in PM air pollution. Similar increases in 
cardiovascular mortality were reported following short-term exposure to PM in 
China (Kan et al. 2003; Qian et al. 2008; Wong et al. 2008a) and Bangkok (Wong et 
al. 2008b). In an attempt to compare data for different continents, the Air Pollution 
and Health: A Combined European and North American Approach (APHENA) study 
analysed data from the APHEA, NMMAPS and Canadian studies (Samoli et al. 
2008). This study found that all-cause mortality increased between 0.2% and 0.6% 
for a 10μg/m3 increase in daily ambient PM10. The greatest effects were observed in 
Canada, with individuals over 75 years of age being at greater risk of cardiovascular 
mortality. Furthermore, worldwide evidence collected in the first AHA statement 
(Brook et al. 2004) confirms that short-term elevations in PM2.5 (10μg/m3) result in a 




1.1.4   Interaction of Pollutants with the Cardiovascular System 
 
It is now apparent that the inability of many people to avoid continued long-term 
exposure to pollution may silently and continuously increase acute cardiovascular 
risk (Pope & Dockery. 2006; Simkhovich et al. 2008; Brook et al. 2010). 
Investigation of atherosclerotic risk factors is difficult in the general population, due 
to the silent progression of the condition and the number of different factors that 
contribute to its development. However, there is now some evidence to suggest that 
chronic exposure to air pollution may accelerate the development of atherosclerosis 
in healthy individuals with no previous signs of cardiovascular disease, but with 
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slightly increased low-density lipoprotein levels (Kunzli et al. 2005b). For example, 
increased PM2.5 has been associated with an increase in carotid artery intima-media 
thickness (Kunzli et al. 2005b). Similarly, coronary artery calcification is increased 
in residents living closest to main roads (Hoffmann et al. 2007). Both these 
observations are consistent with pollution causing progression of atherosclerosis. 
Further evidence (from the Netherlands) shows that people living close to major 
roads have an increased incidence of cardiopulmonary mortality (Hoek et al. 2002), 
and it has been suggested that 6% of all coronary heart disease deaths in the UK 
could be due to traffic-related pollution (Maheswaran et al. 2005). 
 
It is also well established that PM triggers cardiovascular events that occur rapidly 
(within hours or days) following exposure (Simkhovich et al. 2008; Brook et al. 
2010). This is consistent with the demonstration that such acute exposures can 
induce a variety of direct changes on various aspects of the cardiovascular system 
(including, heart rate, heart rate variability, blood pressure, vascular tone, blood 
coagulability and the incidence of cardiovascular arrhythmias). Studies in humans 
have shown that exposure to PM can increase blood pressure (Zanobetti et al. 2004; 
Ibald-Mulli et al. 2001), plasma viscosity (Peters et al. 1997b) and prothrombin time 
(Baccarelli et al. 2007) and can impair vascular reactivity (Brook et al. 2002; Mills et 
al. 2005; O’Neill et al. 2005). Studies from Edinburgh University have also shown 
that exposure to diesel exhaust particulate (DEP) increases ex vivo thrombus 
formation and in vivo platelet activation in healthy human volunteers (Lucking et al. 
2008). Inhaled DEP has also been shown to cause vascular dysfunction and impair 
endogenous fibrinolysis in humans (Mills et al. 2005; Mills et al. 2007). PM 
exposure is also associated with altered heart rate and heart rate variability (Devlin et 
al. 2003; Pope et al. 2004; Gold et al. 2000; Pope et al. 1999a; Pope et al. 1999b); 
although whether these are increased (Pope et al. 1999b) or reduced (Gold et al. 
2000) may be dependent on the type of particles and the nature of the exposure. 
These are likely to be more significant in individuals with underlying risk factors and 
are associated with an increased overall risk of myocardial infarction (Tsuji et al. 
1996). This is consistent, therefore, with the demonstration that exposure to air 
pollution significantly increases hospitalizations due to a number of cardiovascular 
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diseases (Burnett et al. 1999; Schwartz et al. 1999; Hoek et al. 2001; Maheswaran et 
al. 2005). For example, exposure to high levels of air pollution causes a transient 
increase in the risk of acute myocardial infarction, which is greatest 1-2 hours after 
exposure and persists for up to 24 hours (Peters et al. 2004). 
 
It is apparent from short- and long-term (cohort) investigations that risk estimates 
relative to unit exposure are consistently higher for chronic studies The most obvious 
explanation for this is that short-term studies assess the acute effects of exposure 
whereas longer studies assess the cumulative effects of long-term exposure to 
pollution (Pope & Dockery. 2006). Given the considerable evidence that airborne 
particulate pollution has a significant impact on human cardiovascular disease, it is 
important to understand the underlying pathology of atherosclerosis and the 




1.2   Atherothrombosis 
 
Atherosclerosis is the leading cause of heart attack and stroke in the developed 
world, and has a number of well-described modifiable (including high cholesterol, 
high blood pressure and cigarette smoking) and non-modifiable (including heredity, 
sex and age) risk factors. Atherosclerosis is thought to be an inflammatory process; a 
wound healing response that continues after the injury is healed. It is characterised 
by the formation of lipid-rich plaques in medium-sized arteries, such as the carotid 
and coronary arteries. Advanced atherosclerotic plaques consist of a necrotic core of 
lipids and inflammatory cells, surrounded by a fibrous, collagen-rich cap made up of 
smooth muscle cells and extracellular matrix (Figure 1.1. Raines & Ross. 1993; 
Ross. 1993; Ross. 1999). These block the flow of blood to important tissues, leading 
to ischaemia and the development of the conditions associated with this disease, 
including angina pectoris, myocardial infarction, stroke and peripheral vascular 
disease (Badimon et al. 1993; Ross. 1993a; Ross. 1999; Fuster et al. 2005). Until 
relatively recently it was accepted that progressive narrowing of the vessel lumen,  
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Figure 1.1 - Schematic Representation of Atherosclerotic Plaques. 
Atherosclerotic plaques form in large conduit vessels within the vessel wall. They are usually 
eccentric: occupying only one side of the vessel. Thrombi can form upon plaque rupture, which can 
cause complete vessel occlusion leading to myocardial infarction or stroke. Schematic representation 
of plaque rupture and occlusive thrombus formation is shown alongside a pathology photograph of an 
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perhaps combined with vasospasm, was the primary cause of myocardial infarction 
and stroke, with thrombus thought to play only a minor (if any) role (see Weissberg. 
2000). More recently, however, this model has been altered, with improved 
understanding of the role of “vulnerable” plaques, plaque rupture and acute, 
catastrophic occlusive thrombus formation (Fuster et al. 2005; Jackson. 2007). This 
has led to unification of several different hypotheses (relating to the roles of arterial 
inflammation, lipid accumulation, rupture and thrombus formation) under the 
umbrella term “atherothrombosis”. In order to understand the pathogenesis of 
atherothrombosis, it is important to understand the normal structure and function of 
the arterial wall. 
 
 
1.2.1   Normal Vessel Structure 
 
The structure of the vascular wall varies between arteries, veins and capillaries and 
can also vary in arteries from different anatomical locations. In general, arteries 
comprise three distinct layers; the tunica intima, tunica media and tunica adventitia, 
each of which has a distinct structural and functional role. 
 
 
1.2.1.1   The Innermost Layer - The Tunica Intima 
 
The tunica intima comprises a confluent monolayer of endothelial cells lining the 
luminal surface of the artery and anchored to the tunica media by a basement 
membrane. This endothelial cell layer is present in all vessel types and is the only 
cell layer in the capillary wall, allowing passage of substances from the blood into 
the tissue under the regulation of substances such as cytokines (Bucana et al. 1988; 
Horvath et al. 1988) histamine and bradykinin (Majno et al. 1969). The structure of 
the tunica intima can vary in different anatomical locations with regions of intimal 
thickening developing, apparently as a physiological response to mechanical stress, 
caused by variations in flow and/or wall tension (Ku et al. 1985; Stary. 1987; Stary 
et al. 1994). Intimal thickening can be described as eccentric or diffuse, although 
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distinction on this basis can be difficult (Stary et al. 1992). Eccentric intimal 
thickening is an abrupt and focal increase in intimal thickness, often associated with 
arterial bifurcations. It has been observed from the first weeks of life and shows a 
high degree of variation. In contrast, diffuse intimal thickening describes a less focal, 
often circumferential pattern around the vessel. Whilst these formations are normal, 
and considered to be a disease free process, they occur at locations associated with 
the development of advanced atherosclerotic lesions, in particular in the coronary 
artery (Stary. 1989). 
 
The endothelium contributes to control of vascular tone (Furchgott & Zawadzki. 
1980) by producing vasorelaxing (eg. nitric oxide (Palmer et al. 1987), prostacyclin, 
endothelium-derived hyperpolarising factor (Nagao & Vanhoutte. 1992)) and 
vasocontracting (eg. thromboxane (Ingerman-Wojenski et al. 1981), endothelin-1 
(Yanagisawa et al. 1988)) factors. A healthy endothelium also acts as an anti-
coagulant barrier, producing a number of anti-thrombotic factors, including heparin-
like anti-coagulant proteoglycans (Marcum, 1986), and enzymes that degrade pro-
aggregants (Cooper, 1979) or activate plasminogen (Kester, 1969). It can also restrict 
platelet activation by production of nitric oxide and prostacyclin (Radomski et al. 
1987a; Radomski et al. 1987b). 
 
 
1.2.1.2   The Middle Layer - The Tunica Media 
 
The middle layer of the vessel wall is composed of sympathetically-innervated 
vascular smooth muscle cells interspersed with collagen, elastic fibres and the elastic 
laminae, which form its borders. The tunica media is absent from capillaries and 
most veins, but is a substantial component of arteries. The composition of the tunica 
media can vary greatly depending on the position of the artery; in the aorta it is rich 
in elastic fibres and relatively poor in smooth muscle, making the aorta capable of 
accommodating pulsed blood flow. Smaller ‘resistance’ vessels have a tunica media 
rich in vascular smooth muscle cells, which provides greater regulation of blood flow 
and pressure (Berne, 1985). 
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The main role of the tunica media is to regulate blood flow via control of vessel 
diameter, which is regulated by changes in smooth muscle tone. Vasoconstriction is 
mediated predominantly by changes in intracellular calcium levels in smooth muscle 
cells, often following direct stimulation of appropriate cell surface receptors (such as 
the α1 adrenoceptor; Heusch et al. 1984). However, some arteries contract in 
response to intra-luminal pressure (myogenic tone; Bund. 2000; Brekke et al. 2002; 
Matchkov et al. 2002) and contraction can be induced by compounds (eg Endothelin-
1) released from the endothelium (Ihling et al. 2001). Similarly, vasodilatation is 
generally caused by a reduction in intracellular calcium, often as a result of 
stimulation of guanylate and/or adenylate cyclases (Gruetter et al. 1979) or changes 
in cell polarisation. These can be induced by a variety of stimuli, such as shear stress 
(Snow et al. 2001) or vasoactive compounds; some acting directly on the smooth 
muscle cell (eg. isoprenaline (Itoh et al. 1985; Oriowo. 1998)) and some (eg, 
acetylcholine, bradykinin (Chand & Altura. 1981; Kato et al. 1997)) by stimulating 
the release of vasodilators (nitric oxide (NO), prostacyclin, endothelium-derived 
hyperpolarising factor) from the endothelium (Siegel et al. 1989; Harada et al. 2000; 
Gwozdz et al. 2007). 
 
 
1.2.1.3   The Outermost Layer - The Tunica Adventitia 
 
The tunica adventitia is a layer of extracellular matrix components; consisting 
mostly of collagen, although sympathetic nerve terminals, vascular smooth muscle 
cells, fibroblasts and macrophages may also be present. It lies outside the external 
elastic lamina, in arteries and in veins, and its main roles are to provide mechanical 
strength and stability to the vessel whilst anchoring it to surrounding tissue. In large 
vessels, the tunica adventitia contains microvessels (vasa vasorum; Clarke et al. 
1965; McGeachie et al. 1982), which deliver oxygen to cells that lie beyond the 
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1.2.2   Atherogenesis 
 
In order to understand the clinical significance of pollution-mediated increases in 
thrombus formation, a general appreciation of the pathogenesis of atherosclerosis is 
required. However, since the work described in this thesis does not address formation 
of atherosclerosis directly, a detailed review of atherogenesis would be inappropriate, 
particularly since many excellent reviews are available in the literature (including 
Badimon et al. 1993; Ross. 1993a; Ross. 1993b; Ross. 1999; Weissberg. 2000; 
Fuster et al. 2005; Rudd et al. 2005). 
 
Since the pioneering work of von Rokitansky and Virchov in the 19th century (see 
Fuster et al. 2005), models for the pathogensis of atherosclerosis have been 
repeatedly revised and refined (Ross & Glomsett. 1976a; (Ross & Glomsett. 1976b), 
leading to Ross’s “Response-to-Injury” hypothesis (Ross et al. 1977; Ross. 1987; 
Newby. 2000) which itself has gone through several revisions (Ross. 1993a; Ross. 
1993b; Ross. 1999). It is now generally accepted that atherosclerosis is a disorder of 
lipid handling and inflammation in the arterial wall, leading to its description as an 
inappropriate ‘wound healing’ response (Hansson. 2005) or a “defence mechanism 
gone awry” (Ross. 1993c). 
 
Atherosclerotic lesions can be broadly sub-divided into three main types; fatty 
streaks, fibrous plaques and complicated lesions (Ross & Glomsett. 1976a; Ross & 
Glomsett. 1976b), although this is a considerable over-simplification. Based on a 
number of clinical and histological criteria the American Heart Association 
Committee on Vascular Lesions provided a basis for a more detailed lesion 
classification (Stary et al. 1994). This has been updated relatively recently (Stary et 
al. 2000) but can still be criticised for failing to identify plaque erosion or vulnerable, 
thin-capped fibroatheromas (Fuster et al. 2005). Consequently, an alternative 
classification has been proposed that takes account of these categories (Virmani et al. 
2000). For simplicity, and a level of detail appropriate for this thesis, lesion 
development and its clinical consequences are probably best summarised in a figure 
(Figure 1.2). 
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Figure 1.2 - Classification of Atherosclerotic Lesion Development and its 
Clinical Consequences. 
Phase 1 lesions (Types I-III) are common and often found in young people.  Phase 2 (Type IV and 
Va) lesions do not necessarily cause stenosis but may be prone to rupture due to increased 
inflammation, their high lipid content and thin fibrous cap. These lesions can develop into those 
associated with acute Phases 3 and 4. In Phase 3, acute, complicated Type VI lesions develop from 
ruptured or eroded Type IV and Va lesions. This leads to the (often asymptomatic) development of 
mural (non-occluding) thrombus and can occasionally cause angina. In Phase 5, clinical symptoms 
(eg. acute coronary syndrome) become evident as fixed or repeated occlusive thrombus forms on 
complicated Type VI lesions. Calcification or fibrosis produces type Vb and Vc (Phase 5), which may 
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1.2.2.1   Early Atherosclerotic Lesion Development 
 
The lesions associated with the early stages (Phase 1) of atherosclerosis can be 
divided into 3 types: types Ι, ΙΙ and ΙΙΙ. Types Ι and ΙΙ are found predominantly in 
children, although they can be identified in adults at sites in the vasculature not 
normally prone to the development of advanced lesions. Type I lesions consist of the 
first detectable deposits of lipid in the tunica intima and contain foam cells 
(macrophages containing phagocytosed lipid droplets (Stary. 1987)). Type ΙΙ lesions 
are characterised by the formation of visible yellow fatty streaks/patches that can 
also be identified by staining neutral lipid (for example with Oil Red O or Sudan ΙV 
(Uemura et al. 1964)). They comprise foam cells formed into organised layers (Stary 
et al. 1994) with small amounts of extracellular lipid (mainly cholesterol esters, 
cholesterol and phospholipids (Katz et al. 1976)). Type ΙΙ lesions can develop in 
arterial locations predisposed to develop intimal thickening (Type ΙΙa; which are 
more likely to progress into atherosclerotic lesions) or in areas where the intima is 
thin and contains few smooth muscle cells (Type ΙΙb; which are resistant to 
progression and only develop into advanced lesions in individuals with high 
circulating levels of atherogenic lipoproteins (Stary et al. 1994)). Type ΙΙΙ lesions 
form a morphological and chemical bridge between type ΙΙ and Type IV (atheroma) 
lesions. Type ΙΙΙ lesions contain extracellular lipid droplets that form pools that lie 
below the layer of macrophages and foam cells and above the smooth muscle cell 
layer, disrupting smooth muscle cell structure (Stary et al. 1994). They contain much 
more free cholesterol, fatty acids and triglycerides than type ΙΙ lesions. 
 
 
1.2.2.2   Development of Advanced Atherosclerotic Lesions 
 
Late atherosclerotic lesion development can be divided into a further 4 phases 
(Figure 1.2) incorporating type ΙV, V and VΙ lesions. Phase 2 involves development 
of type ΙV and type Va lesions (atheroma) which comprise large accumulations of 
extracellular lipid (the lipid core), inside an extensive but well-defined intimal area. 
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Type Va lesions (fibroatheroma) are those in which fibrous tissue grows over a pre-
existing lipid core. Lipid cores thicken the artery wall and are generally visible to the 
naked eye but these lesions do not always cause narrowing of the vascular lumen, as 
they can be offset by outward remodelling of the affected artery (Glagov et al. 1987). 
Type ΙV lesions have great potential clinical significance as the characteristic lesion 
of advancing atherosclerosis, even though they generally remain asymptomatic. In 
Phase 3, acute, complicated type VI lesions develop following rupture or erosion of 
existing (type IV or Va) plaques. This causes the development of mural (non-
obstructive) thrombosis, which, while usually clinically-silent, can cause angina. 
Alternatively, type IV and Va lesions can rupture causing fixed or repetitive 
occlusive thrombosis (Phase 4). This produces type VΙ, or complex, lesions. These 
are defined as type ΙV or V lesions with one or more of the following superimposed 
features: haematoma (type VΙa), haemorrhage (type VΙb) and thrombosis (type VΙc). 
Lesions that exhibit all three of these features are classified as type VΙabc (Stary et 
al. 1994). These processes produce clear clinical symptoms in the form of acute 
coronary syndrome (although they can also be asymptomatic), with morbidity and 
mortality from atherosclerosis largely due to rupture of type ΙV and V lesions. 
Finally, calcification or fibrosis of advanced lesions (Phase 5) can produce type Vb 
and Vc lesions, respectively, which may obstruct blood flow and cause angina (Stary 
et al. 1994). 
 
Lesion rupture can vary greatly in extent and severity. Small ulcerations, often 
consisting of a loss of the endothelial cell layer from the surface of the lesion and 
only visible on microscopic examination, may occur. Alternatively, deep fissures can 
expose and release the highly thrombogenic lipid core, causing thrombus formation 
and complete arterial occlusion. As described (above), Type ΙV and Va lesions are 
particularly prone to fissuring and subsequent thrombus formation (Davies & 
Thomas. 1985). Many factors may contribute to the vulnerability of these lesions, 
including the presence of inflammatory cells in the lesions (Tracy et al. 1985), the 
release of enzymes and cytotoxic substances by macrophages within the lesions 
leading to breakdown of the fibrous cap (Steinberg & Witztum. 1990; Henney et al. 
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1991), coronary spasm (Nobuyoshi et al. 1991), shear stress (Ku et al. 1985) and 
structural weaknesses due to lesion composition (Richardson et al. 1989). There is 
evidence to suggest that fissures are more likely to occur in “shoulder regions” of 
lesions, which have accumulations of foam cells and relatively thin fibrous caps 
(Davies et al. 1993). Fissures may also be able to reseal, incorporating thrombi into 




1.2.2.3   Initiation of Lesion Formation 
 
The processes leading to the formation of type Ι lesions remain unclear. The 
‘Response-to-Injury’ hypothesis suggests that damage (often non-denuding damage) 
to the endothelium causes intimal thickening by stimulating smooth muscle cells to 
migrate from the tunica media to the tunica intima, where they then proliferate (Ross 
& Glomset. 1976). The nature of the initial insult remains controversial but there is 
certainly evidence to suggest that plasma-derived lipoproteins accumulate in the 
arterial intima, causing specific cellular responses essential to the initiation of lesion 
development (Getz. 1990). Another theory suggests that platelets and/or fibrin 
deposits on the intimal surface could be the initial event in atherosclerosis (More et 
al. 1957; McMillan. 1965; Spurlock & Chandler. 1987). Many in vivo studies have 
been conducted in order to study the processes involved, such as artificial endothelial 
cell denudation (Stemerman & Ross. 1976), heat shock (Berberian et al. 1990), viral 
infections (Hajjar et al. 1986) and electrical stimulation (Betz & Schlote. 1979). 
However, none of these models successfully reproduced the development of human 
atherosclerotic lesions. 
 
Endothelial cell dysfunction describes the imbalance between endothelium-
dependent vasodilatation and endothelium-dependent contraction (Mahmoudi et al. 
2007). Healthy endothelial cells respond to stimuli such as shear stress, thrombin and 
aggregating platelets by releasing compounds (eg. NO and prostacyclin) which cause 
relaxation of underlying vascular smooth muscle, and inhibit platelet aggregation 
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(Lloyd-Jones & Bloch. 1996; Bos et al. 2004; Feletou et al. 2008). NO also reduces 
endothelial cell expression of adhesion molecules (thus reducing macrophage 
adhesion), which prevents vascular smooth muscle cell proliferation and limits the 
formation of oxidised low-density lipoprotein (oxLDL). When the endothelium is 
damaged, production and release of NO is reduced, which facilitates the 
inflammatory response and accelerates formation of atherosclerotic plaques (Lloyd-
Jones & Bloch. 1996; Vanhoutte. 2009). Endothelial dysfunction also results in a 
build up of reactive oxygen and nitrogen species (Ross. 1993; Freeman et al. 1995; 
Harrison. 1997). Excessive production of reactive oxygen species can result in 
mitochondrial damage in endothelial cells, which then results in whole cell damage 
as mitochondrial antioxidant enzymes protect healthy cells from damage (Cohen & 
Kesler. 1999). Mitochondrial damage may provide a link between risk factors, 




1.2.3   Thrombosis 
 
As described, the formation of blood clots at sites of atherosclerotic plaque erosion 
and rupture is central to the acute life-threatening complications associated with this 
condition. Therefore, it is important to understand the processes that lead to clot 
formation. 
 
Prevention of blood loss, while maintaining fluidity of blood within the intact 
circulation, is essential for maintaining the integrity of the circulatory system. Arrest 
of blood flow from damaged blood vessels is achieved through a mechanism termed 
haemostasis. In this process, vessel damage causes vasoconstriction, which reduces 
blood flow, followed by platelet activation and aggregation. This leads to formation 
of a haemostatic plug, which is reinforced by fibrin and, in many instances, is 
sufficient to stop bleeding (Macfarlane. 1940). Thrombosis, by contrast, is the 
pathological formation of a haemostatic plug within the vasculature, without 
bleeding or traumatic vessel damage and has been described as “haemostasis in the 
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wrong place” (Macfarlane. 1977; Gailani & Renne. 2007). Thrombus formation can, 
in some cases, completely block blood flow to the heart or brain, causing myocardial 
infarction or stroke. Three major factors (Virchow’s triad), identified over a hundred 
years ago, influence thrombus formation, size and stability. These are; injury to the 
vessel wall (generation of a thrombogenic surface), altered blood flow, and abnormal 
blood coagulability (Fuster et al. 2005). Thrombi formed in veins and arteries have 
very different properties; venous thrombi, which are similar in composition to blood 
clots that form in static blood in vitro, are rich in fibrin and erythrocytes but contain 
few platelets (see Gailani & Renne. 2007), whereas arterial thrombi consist of 
platelets and leukocytes in a fibrin mesh, and are usually associated with 
atherosclerosis (see Gailani & Renne. 2007). Thrombus formation in the vasculature 
is controlled by activation (and aggregation) of platelets (Gailani & Renne. 2007) 
and initiation of a cascade of proteolytic reactions leading to the generation of 
thrombin and formation of a fibrin clot (Macfarlane. 1964; Davie & Ratnoff. 1964). 
These processes do not occur independently, and there is much ‘cross-talk’ between 
the two systems to modulate the formation of a stable thrombus (Gailani & Renne. 
2007). In healthy individuals, haemostasis is regulated by a complex balance 
between pro-thrombotic and anti-thrombotic mechanisms (Rosenberg & Aird. 1999). 
However, coagulant pathways are activated upon rupture of atherosclerotic plaques 
(as described, Chapter 1.2.3), often leading to the formation of fully occlusive 
thrombi, which can result in myocardial infarction or stroke. A comprehensive 
review of the complexities of haemostasis is beyond the scope of this chapter, which 
will be restricted to consideration of key processes of direct relevance to the 
experimental investigations. Figures 1.3 and 1.4 outline the key processes of platelet 
function and the coagulation cascade, while figure 1.5 shows how these processes 
interact with each other in terms of thrombus formation. 
 
 
1.2.3.1   Platelet Function 
 
Platelets are small (2-4μm in diameter) disc-shaped cells, containing organelles but 
no nucleus (Berger. 1970). Platelets are an important factor in haemostasis and 
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vascular thrombosis, due to their ability to become rapidly activated at sites of 
vascular injury. A healthy endothelium produces and secretes NO and 
prostaglandins, which inhibit platelet activation and aggregation (as discussed in 
Chapter 1.2.1.1. Radomski et al. 1987a; Radomski et al. 1987b), allowing the 
continuation of blood flow in undamaged vessels. Upon damage to the vascular wall, 
platelets interact with subendothelial extracellular matrix, which contains adhesive 
molecules such as collagen, von Willebrand Factor and integrins (Andre et al. 2000; 
Ruggeri. 2002; Jackson et al. 2003; Nieswandt & Watson. 2003; Ruggeri. 2003). 
Platelet interactions with these molecules cause adhesion to the vessel wall, resulting 
in the formation of a platelet monolayer (Offermanns. 2006). The recruitment of 
additional platelets, to form a platelet plug, is mediated via locally-accumulating 
mediators, such as ADP/ATP and thromboxane A2, which are released from 
activated platelets (Offermanns. 2006. Figure 1.3). These mediators act through G 
protein-coupled receptors on the platelet surface, resulting in a positive feedback 
loop, which allows platelet coverage of damaged vessels (Offermanns. 2006).  
 
Atherosclerosis is widely considered to be an inflammatory process, with lipids in 
the vessel wall becoming abnormally oxidised, associated with the local infiltration 
of leukocytes (Lusis. 2000). In this state, endothelial cell dysfunction, and thus 
reduced generation of factors inhibiting platelet activation (NO and prostaglandin), 
contribute to platelet activation that has a role in the initiation of atherosclerosis (see 
Ruggeri. 2002; Schafer & Bauersachs. 2008). Upon plaque rupture, the highly 
thrombogenic plaque core is exposed to circulating blood, resulting in a high degree 
of platelet activation and aggregation, and subsequent activation of the coagulation 
cascade through exposure of acidic phospholipids (Rosenberg & Aird. 1999. See 
Figure 1.5), resulting in the generation of thrombin and fibrin (Chapter 1.2.3.2). This 
is combined with the synthesis and secretion of mediators such as ADP, which 
creates a positive feedback loop causing further platelet activation (Offermanns. 
2006). These processes are activated abnormally in this situation, and cause 
thrombus formation in the damaged vessel, which can lead to complete vessel 
occlusion. 
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Figure 1.3 - Mechanism of Haemostatic Plug Formation. 
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1.2.3.2   The Coagulation Cascade 
 
Injury to the vessel wall is a major stimulus for coagulation. Injury results in the 
release of P-selectin and von Willebrand factor to the surface of endothelial cells 
(McEver et al. 1989; Andre et al. 2000). P selectin binds to its receptor, P-selectin 
glycoprotein ligand-1, on the surface of neutrophils and monocytes (Wagner. 2005), 
which promotes rolling of leukocytes on the surface of activated endothelial cells, 
concentrating these cells at the area of thrombus formation (Polgar et al. 2005). Von 
Willebrand factor binds to platelet membrane glycoprotein Ιbα and to exposed vessel 
connective tissue, helping to secure adhesion of platelets to the site of injury (Andre 
et al. 2000). The adhesion of platelet-leukocyte aggregates to injured endothelium 
results in the activation of tissue factor. Tissue factor, along with calcium ions and 
acidic phospholipids released from activated platelets, is required for the activation 
of the extrinsic coagulation pathway (Rosenberg & Aird. 1999. Figure 1.4). This 
involves the activation of a series of serine protease enzymes, producing a “cascade” 
in which each enzyme activates increasing amounts of the next. This process has the 
ability to convert a small initiating event into a large fibrin clot. The first enzyme to 
be activated is factor X, to produce factor Xa. Factor Xa, along with factor Va, then 
converts factor ΙΙ (prothrombin) into factor ΙΙa (thrombin). Thrombin then converts 
inactive fibrinogen into fibrin, which stabilises the ‘platelet plug’, and activates 
factor XΙΙΙa, which stabilises the fibrin mesh. Several other factors are also involved 
in coagulation, namely factor XΙΙa, which activates factor XΙ, which activates factor 
ΙX. Factor ΙXa is also capable of activating factor X through a separate mechanism to 
tissue factor (Green. 2006). This mechanism is known as the intrinsic pathway, it 
was thought to be activated only when blood comes into contact with an artificial 
surface such as glass; however recent studies have provided evidence that 
components of the intrinsic pathway also contribute to regulation of arterial 
thrombosis (Gailani & Renne. 2007). The extrinsic pathway, also known as the in 
vivo pathway, is directly responsible for controlling blood coagulation and thrombus 
formation in response to stimuli within the vasculature.  
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Figure 1.4 - The Coagulation Cascade. 
Schematic representation of the coagulation cascade, showing the factors activated in the intrinsic 
pathway via thrombus formation (tissue activation) and the extrinsic pathway via surface interaction 
of blood ex vivo. Adapted from Pharmacology. 5th Edition. Rang et al. 
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Figure 1.5 - Common Pathways Involved in Activation of Platelets and the 
Coagulation Cascade. 
Interactions between the platelet activation pathway and the coagulation cascade. Red arrows show 
pathways common to both systems. Acidic phospholipids released from activated platelets cause 
activation of the extrinsic pathway, increased conversion of factor X to factor Xa (in both the extrinsic 
and intrinsic pathways) and increased conversion of factor ΙΙ to thrombin via action on factor Xa. 
Both thrombin and fibrinogen act on platelets to increase platelet aggregation. Adapted from 





Rupture of Atherosclerotic 

































Platelet Reactions Coagulation 
Fibrinogen                                           Fibrin
Thrombin                                                   ΙΙ







Chapter 1 - Introduction 
 
 28
As described, platelet activation and the coagulation cascade occur simultaneously, 
with many common activation pathways involved. Figure 1.5 shows the crossover 
points between these two systems. 
 
 
1.2.3.3   The Fibrinolytic System 
 
The role of the endogenous fibrinolytic system is to prevent abnormal thrombus 
formation (Figure 1.6). Upon thrombus formation, the pro-enzyme plasminogen is 
converted to the functional enzyme plasmin, which breaks down fibrin to soluble 
fibrin degradation products and D Dimer, allowing the thrombus to be dissolved 
(Lijnen. 2001). Two distinct enzymes have been found which convert plasminogen 
to plasmin: urokinase plasminogen activator (u-PA) and tissue plasminogen activator 
(t-PA) (Thorsen & Philips. 1984; Lijnen. 2001). Only t-PA, however, is involved in 
the dissolution of thrombi in the circulation (Thorsen & Philips. 1984; Lijnen. 2001). 
t-PA is a single-chain serine proteinase (Pennica et al. 1983). The actions of t-PA are 
regulated by a second enzyme, plasminogen activator inhibitor (PAI-1), which is a 
single-chain glycoprotein and a member of the serpin family (Kruithof et al. 1984; 
Ny et al. 1986; Pannekoek et al. 1986). PAI-1 appears to be the major regulator of   
t-PA action, as naturally occurring complexes form between t-PA and PAI-1, 
inhibiting the action of t-PA (Rijken et al. 1983; Thorsen & Philips. 1984). Most 
circulating t-PA is inactive and complexed with PAI-1, as circulating PAI-1 levels 
are significantly greater than t-PA levels; this allows prevention of systemic bleeding 
while permitting necessary local clot lysis (Voetsch & Loscalzo. 2004). The vascular 
endothelium plays a significant role in regulation of the fibrinolytic system; 
endothelial cells synthesise and release fibrinolytic proteins (Levin & Loskutoff. 
1982; Cerveny et al. 1984), and endothelial surface proteins are now thought to 
modulate the function of fibrinolytic proteins (Hajjar et al. 1986; Laiho et al. 1986). 
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Figure 1.6 - Schematic Representation of the Endogenous Fibrinolytic System. 
Interactions between factors of the endogenous fibrinolytic system in response to thrombus formation 
within the vasculature. Tissue plasminogen activator (t-PA) is released from endothelial cells in 
response to thrombus formation; t-PA converts inactive plasminogen to active plasmin, plasmin in 
turn causes the breakdown of fibrin (which is involved in thrombus stabilisation) to fibrin degradation 
products and D dimer, allowing dissolution of the thrombus. t-PA action is inhibited by the production 
and release of plasminogen activator inhibitor 1 (PAI-1); the balance of t-PA and PAI-1 synthesis and 
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1.2.3.4  Pre-Clinical Investigation of Thrombus formation - Animal Models of 
Arterial Thrombosis 
 
A number of in vitro and ex vivo assays are available for investigating blood 
coagulation and platelet activation. Indeed such assays have been central in 
clarifying the mechanisms that contribute to thrombus formation and some have 
important roles in the clinic. However, improving understanding of the processes that 
regulate thrombus formation in vivo has necessitated the development of suitable 
assays in experimental animals (Day et al. 2004; Furie & Furie. 2005). Although 
animal models have been developed to assess both venous and arterial thrombus 
formation, it is the latter that is most relevant to the work described in this thesis (as 
atherothrombosis is an arterial disease). The principle behind most of the models 
available is simple: induction of a discrete focal injury to the arterial wall causes a 
thrombotic response that can be assessed in several ways (often by measuring blood 
flow/arterial occlusion (Day et al. 2004; Furie & Furie. 2005)). The main variation 
tends to be the approach used to cause arterial damage. These techniques have been 
applied to a variety of animals; use of mice has made it possible to exploit gene 
targeting of a number of genes encoding proteins involved in development of 
thrombosis (see Day et al. 2004). It should be noted, however, that many (although 
not all; Xian et al. 2009) studies use animals without pre-existing cardiovascular 
disease, whereas pathological thrombosis in humans is associated with diseased 
vessels. 
 
Direct application of ferric chloride to the adventitial surface of an artery induces the 
formation of a platelet-rich thrombus, which typically leads to complete vessel 
occlusion (Kurz et al. 1990). Alternatively, damage to the vascular endothelium can 
be induced using oxidative stress. This is achieved by intravenous administration of a 
photo-reactive substance (Rose Bengal) which is then activated by illumination 
(green light; 540 nm) of an exposed section of a target artery to produce reactive 
oxygen species (Watson et al. 1985). Both these methods induce thrombus formation 
through endothelial damage and produce reliable, reproducible generation of 
thrombi. They do not, however, involve arterial stenosis, which is an important factor 
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in the development of thrombi associated with acute cardiovascular events. In 
contrast, the Folts model uses both endothelial damage and stenosis to promote 
arterial thrombus formation and is widely regarded as the pharmaceutical industry 
‘gold standard’ (Day et al. 2004). It was first developed using dog coronary arteries 
(Folts et al. 1982), and has since been adapted for use in small animals such as mice 
(Sturgeon et al. 2006), rats (Daykin et al. 2006; Sturgeon et al. 2006) and rabbits 
(Marret et al. 2004; Daykin et al. 2006; Sturgeon et al. 2006). All small animal 
models use the carotid, rather than coronary, artery. This is necessary due to the size 
and accessibility of the coronary artery in small animals, but it also produces more 
reliable and reproducible results by avoiding the haemostatic disturbance associated 
with open-chest surgery. The adapted Folts models apply 50% (Daykin et al. 2006; 
Sturgeon et al. 2006) or 60% (Marret et al. 2004) stenosis to the carotid artery which 
is then subjected to repeated mechanical injury. This causes de-endothelialisation 
and exposure of the thrombogenic intimal surface. Blood flow in the carotid artery is 
monitored until it stops, indicating that an occlusive thrombus has formed at the site 
of stenosis. The thrombus is then embolised to restore blood flow and allow 
formation of a new thrombus. This causes repeated changes in blood flow (cyclic 
flow reductions (CFRs; (Folts 1991)) which are counted over a set period of time to 
give a quantitative measure of thrombogenicity. The results of the modified Folts 
model have shown consistency, both within and between experimental groups with 
CFRs comparable in rats (7.0±0.3 CFRs/ 30 min (Daykin et al. 2006; 7.9±0.4 CFRs/ 
30 min (Sturgeon et al. 2006)), mice (8.7±1.1 CFRs/ 15 min (Sturgeon et al. 2006)) 
and rabbits (4.6±0.2 CRFs/30 min; (Sturgeon et al. 2006)). Histological analysis 
confirms that the thrombi formed using this technique are comparable to human 
thrombi that form following vessel damage or atherosclerotic plaque rupture. 
 
 
1.2.4   Atherothrombosis 
 
As described, the fibrinolytic system regulates formation and dissolution of thrombus 
and, thus, can modulate the thrombotic response to plaque rupture. It seems logical, 
therefore, that thrombus formation would be more severe following plaque rupture in 
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individuals with a dysfunctional endogenous fibrinolytic system. This is important, 
as some cardiovascular risk factors (such as changes in lipid metabolism, cigarette 
smoking, hyperglycemia, haemostasis) are associated with increased blood 
thrombogenicity and impaired fibrinolysis (Kullo et al. 2000; Edelberg et al. 2001; 
Edgington. 2001; Rauch et al. 2001; Salomaa et al. 2002). A number of 
epidemiological studies have also shown a clear association between increased 
circulating fibrinogen levels and increased incidence of ischemic heart disease 
(Meade et al. 1980; Wilhelmsen et al. 1984; Stone et al. 1985; Meade et al. 1986; 
Kannel et al. 1987a; Kannel et al. 1987b; Welin et al. 1987; Moller & Kristensen. 
1991; Ernst. 1993; Voetsch & Loscalzo. 2004), indicating that increased fibrinogen 
level is an independent cardiovascular risk factor. Another cardiovascular risk factor 
linked with altered clotting pathways is dyslipidaemia. For example, high levels of 
low density lipoproteins, such as are found within atherosclerotic plaques, can 
increase platelet activity (Aviram & Brook. 1987); patients presenting with primary 
hypercholesterolemia show increased platelet activation, aggregation and secretion 
(Brook & Aviram. 1988). In addition, high levels of lipoprotein A (which are 
associated with increased risk for coronary heart disease) may inhibit fibrinolysis: 
lipoprotein A is structurally similar to plasminogen and may bind fibrin or inhibit the 
formation of fibrinolytic proteins (Loscalzo. 1990; Scanu. 1991). 
 
One of the clearest associations between a cardiovascular risk factor and the 
fibrinolytic system is provided by cigarette smokers (a group of particular relevance 
when considering the effect of inhaled pollutants). Smokers have higher levels of 
fibrinogen (Miller. 1992) and lower levels of t-PA (Newby et al. 1999; Newby et al. 
2001) than non-smokers, plus a considerably increased risk of myocardial infarction. 
Interestingly, due to their low circulating t-PA levels, smokers are more likely to 
respond to thrombolytic treatment with t-PA post-myocardial infarction (Newby et 
al. 1999; Newby et al. 2001). Whether an equivalent of this “smoker’s paradox” 
exists in individuals exposed to high levels of air pollution for extended periods has 
not been shown. Thus atherothrombosis, which is one of the most significant causes 
of death and disability in the developed (and increasingly in the developing) world, is 
exacerbated by factors that promote coagulation. This is consistent with the 
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suggestion that the increased incidence of cardiovascular events in individuals 
following acute exposure to particulate atmospheric pollution is caused by an 
increased propensity to thrombosis at sites of atherosclerotic plaque erosion/rupture. 
 
 
1.3   Nanoparticulates and Thrombosis 
 
Thus far it has been shown that exposure to atmospheric pollution, in particular to 
combustion-derived fine particulate matter, can increase cardiovascular morbidity 
and mortality. This can be attributed to the chronic effects of exposure, which 
accelerate atherogenesis, and/or short-term effects, which cause acute cardiovascular 
events (including myocardial infarction). The role of thrombosis in the development 
of myocardial infarction and stroke, combined with increasing evidence that airborne 
combustion-derived particulate matter increases blood coagulability, suggests that 
enhanced thrombosis may contribute to the effects of acute exposure. However, 
despite an increasing number of investigations over the past 10 years, the nature of 
the interaction between pollution particulate and the thrombotic system has not been 
established. In order to investigate this relationship, a number of practical issues need 
to be addressed. 
 
 
1.3.1   Choice of Particulate for Investigating the Effects of Combustion-Derived 
Pollutants on Thrombosis 
 
Many different nanoparticles have been investigated for their effects on thrombosis. 
As discussed earlier (Chapter 1.1.2.1) particles occurring in air pollution include 
diesel exhaust particulates (DEP) and concentrated ambient particles (CAPs). Both 
have been studied for their effects on thrombosis (Vincent et al. 2001; Nemmar et al. 
2002c; Nemmar et al. 2003b; Nemmar et al. 2003c; Mills et al. 2005; Carlsten et al. 
2007; Mills et al. 2007; Lucking et al. 2008; Mills et al. 2008) but these 
investigations are limited, as the mechanism responsible for the effects of DEP have 
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still to be fully established. In addition to these pollution-derived particles, many 
studies have also used nanocarbon black (CB), often as a control particle (Vincent et 
al. 2001; Donaldson et al. 2005; Yamawaki et al. 2006). CB is a clean carbon 
nanoparticle, which, although not occurring naturally, can be used to distinguish 
effects of the carbon core from those of the metals and organic compounds 
associated with the surface of DEP. An alternative approach has been to use 
nanoparticles that have been artificially charged (either positively using carboxylates 
or negatively using amines) in order to investigate the effects of charged particles on 
the vascular system (Nemmar et al. 2002a; Nemmar et al. 2003b), due to the fact that 
a large proportion of ambient particles are charged (Cohen et al. 1998), and that the 
acidic nature appears to play an important role in particle toxicity (Chen et al. 1992; 
Dockery et al. 1992). Finally, medical nanoparticles, such as quantum dots, have also 
been investigated for their potential to promote thrombus formation (Geys et al. 
2008). Quantum dots are nanoparticle crystal semiconductors that emit visible light 
upon excitation. They can be bio-engineered to specifically target molecules in order 
to track generation or breakdown in vivo and, consequently, have many exciting 
potential medical applications. Although quantum dots are not yet being used to 
study disease in humans, it is important to ensure that they do not have effects on 
thrombus formation similar to those reported with other nanoparticles. 
 
 
1.3.2   Particle Administration 
 
Many approaches have been used for exposing both humans and animals to various 
particles. In clinical trials the most appropriate method of exposure is inhalation, as it 
most accurately recreates the effects of real life particulate exposure. In many of the 
acute clinical trails described below (Chapter 1.3.4.1), exposure was achieved using 
a specially designed diesel exposure chamber (Mills et al. 2005; Mills et al. 2006; 
Mills et al. 2007; Lucking et al. 2008; Mills et al. 2008; Tornqvist et al. 2008). In 
contrast, exposure by inhalation is often difficult in pre-clinical studies, as animals 
pose problems not encountered when using human volunteers. Rodents, for example, 
have a more complex nasal passage than humans, meaning that nasal hairs and cilia 
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filter out a considerable quantity of particulate pollution before entering the lungs 
(Morgan & Monticello. 1990). Also, if whole body exposures are being used, a 
substantial proportion of the particulate matter may become trapped in the animals’ 
fur, thus reducing the amount inhaled (Morgan & Monticello. 1990). Consequently, 
and in contrast to controlled human exposures, the amount of particulate reaching the 
lungs cannot be easily calculated. Intratracheal instillation was developed to avoid 
these problems and thereby allow delivery of a known quantity of particulate to the 
lungs. Using this method, the animal is temporarily anaesthetised and the trachea 
briefly cannulated to allow administration of a suspension of the relevant particulate 
(Nemmar et al. 2002a; Nemmar et al. 2003a; Nemmar et al. 2003b; Nemmar et al. 
2003c; Nemmar et al. 2004a; Nemmar et al. 2004b; Nemmar et al. 2005; Geys et al. 
2008). This method has proved to be very reliable, ensuring minimum discomfort to 
the animals, which are allowed to recover from the anaesthetic before the start of 
experiments. Another technique used with experimental animals is the direct 
injection of particle suspensions into the bloodstream (Nemmar et al. 2002a; 
Nemmar et al. 2009). This approach allows examination of the direct effects of 
particles on the cardiovascular system. This can be used, therefore, to model the 
potential action of particles that translocate from the lungs into the bloodstream (if 
this occurs; see Chapter 1.3.5.3). Using both mechanisms of animal exposure it 
should be possible to distinguish those effects mediated by pulmonary exposure to 
particulate matter from those caused by direct effects of particles that may 
translocate into the bloodstream. 
 
 
1.3.3   Chronic Particulate Exposure  
 
Few chronic exposure studies investigating the cardiovascular effects of particles are 
available in the literature. Clinical studies appear to be limited to the epidemiological 
(cohort) approaches described earlier (Chapter 1.1.3). Indeed, given the evidence 
available from these, chronic human exposure to particulate matter would be 
ethically unacceptable. Pre-clinical studies in this area are also limited. Stinn et al. 
(2005) exposed rats to tobacco smoke and diesel engine exhaust via inhalation for 6 
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hours a day, 7 days a week, for 2 years. After this extended period it was shown that 
exposure to diesel engine exhaust caused pulmonary inflammation, which was not 
unexpected. However, no investigations were made into thrombogenicity in these 
animals. Sun et al. (2005) showed that a 6 month regimen of PM2.5 exposure using 
apolipoprotein E-/- mice accelerated the progression of atherosclerosis, as well as 
altering vasomotor tone and inducing vascular inflammation. A similar study 
conducted in C57BL/6 mice (Sun et al. 2009) showed that PM2.5 inhalation increases 
systemic inflammation. However, no chronic pre-clinical studies have fully 




1.3.4   Acute Particulate Exposure 
 
Acute exposures of subjects to pollutant particles are obviously more straightforward 
and cheaper (and, for humans, more ethically acceptable) than chronic exposures. It 
is unsurprising, therefore, that a greater number of investigations (both clinical and 
pre-clinical) into the cardiovascular impact of acute exposures to particulates are 
available in the published literature. 
 
 
1.3.4.1   Clinical Studies 
 
Following on from epidemiological studies, clinical trials have become a useful tool 
for clarifying the mechanisms by which human subjects react to DEP exposure at 
environmental levels. A number of clinical studies have investigated the effects of 
inhaled particles both on healthy human volunteers and on those with stable coronary 
disease (outlined in Table 1.2). Many of these studies have been conducted by the 
clinical research department at the University of Edinburgh and associated 
institutions. The first in this series of studies was conducted by Mills et al. (2005). In 
this study, 30 healthy males were exposed to inhalation of DEP (300mg/m3) and 
filtered air in a randomised double-blind trial for 1 hour with intermittent exercise. 
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This study showed that endothelium-dependent (bradykinin, acetylcholine) and             
-independent (sodium nitroprusside and verapamil) vasodilatation were impaired in 
the forearm 2 and 6 hours after exposure. These results were reinforced by a 
subsequent investigation, using 20 healthy male volunteers, which demonstrated 
impaired endothelial function in the forearm 24 hours after inhalation of DEP 
(300mg/m3 for 1 hour; Tornquist et al., 2007). Mills et al. (2005) also showed that 
infusion of bradykinin into the forearm caused a dose-dependent increase in plasma 
t-PA, which was suppressed 6 hours after exposure to DEP, indicating dysregulation 
of the fibrinolytic system; these results were remarkably similar to those observed by 
Newby et al. (1999) when studying the effects of cigarette smoking on the 
endogenous fibrinolytic system, indicating that similar mechanisms may be at work 
during both exposures. The ability of DEP to influence coagulation pathways was 
also demonstrated in a study that exposed 20 healthy human volunteers to inhalation 
of DEP (350mg/m3) or filtered air for 1 or 2 hours, with moderate exercise, in a 
randomised double-blind trial (Lucking et al., 2008). DEP was shown to increase 
thrombus formation ex vivo (in the Badimon chamber), apparently as a result of 
increased platelet-neutrophil and platelet-monocyte aggregation (measured using 
flow cytometry). Since the acute cardiovascular effects of pollution-derived 
particulate matter are more likely to be evident in patients with pre-existing 
cardiovascular disease, some studies have been performed using volunteers from this 
patient population. Mills et al. (2007) examined the responses of 20 males with prior 
myocardial infarction when exposed to inhalation of DEP (300mg/m3) or filtered air 
for 1 hour, with intermittent exercise, in a randomised double-blind trial. DEP 
promoted myocardial ischemia and inhibited the endogenous fibrinolytic system by 
reducing acute release of t-PA from endothelial cells. A later study showed that 
inhaled concentrated ambient particles (190±37mg/m3; 2 hours) did not alter 
vasomotor or fibrinolytic function in 12 healthy males or in 12 male patients with 
stable coronary heart disease (Mills et al, 2008). It should be noted, however, that the 
concentrated ambient particles (collected from Edinburgh) were shown to comprise 
mainly sea salt, which would not be expected to influence cardiovascular function. 
 
 






Table 1.2 - Overview of Clinical Studies Investigating the Acute Effects of Particulate Exposure. 
 
 
Subjects Route of 
Administration 
Timing Particle Dose Effects Reference 
30 healthy males Inhalation 1 hour with 
intermittent 
exercise 
DEP and filtered air 300mg/m3 DEP impaired regulation of vascular 
tone and endogenous fibrinolysis 
Mills et al. 2005 
20 healthy 
volunteers 
Inhalation 1 and 2 hours 
with moderate 
exercise 
DEP and filtered air 350mg/m3 DEP increased ex vivo thrombus 
formation and caused in vivo platelet 
activation 
Lucking et al. 2008 
15 healthy males Inhalation 1 hour exposure, 
studies continue 
for 24 hours 
DEP and filtered air 300mg/m3 DEP impaired endothelium-
dependent vasodilatation and mild 
systemic inflammation 24 hours after 
exposure 
Tornqvist et al. 2007 
20 males with prior 
myocardial 
infarction 
Inhalation 1 hour with 
intermittent 
exercise 
DEP and filtered air 300mg/m3 DEP promoted myocardial ischemia 
and inhibited endogenous fibrinolysis 
Mills et al. 2007 
12 healthy males; 
12 males with 
stable coronary 
heart disease  
Inhalation 2 hours Concentrated ambient 
fine and ultrafine 
particles and filtered 
air 
190±37mg/m3 Concentrated ambient particles did 
not affect vasomotor of fibrinolytic 
function in healthy volunteers or 
patients with coronary heart disease 
Mills et al. 2008 
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These studies support the hypothesis that exposure to DEP, at levels that could be 
found in cities and built-up areas, causes changes in the cardiovascular system. These 
include alterations of the endogenous fibrinolytic system and increased platelet 
activation as well as direct evidence of increased thrombus formation. This is 
consistent with the contention that exposure to particulate pollution increases 
myocardial infarction by increasing the risk of acute thrombosis.  
 
 
1.3.4.2   Pre-Clinical Studies 
 
Several pre-clinical studies have investigated the acute effects of particle exposure on 
thrombus formation (summarised in Table 1.3). A number of these studies were 
performed by Nemmar and colleagues, who assessed the effects of intratracheal DEP 
instillation on acute thrombus formation. In 2003, they reported that instillation of 
DEP (5-500μg/animal) caused pulmonary inflammation and rapid platelet activation 
(measured by platelet aggregometry) in hamsters 30 minutes and 1 hour after 
exposure (Nemmar et al. 20003b). In a later study, a similar exposure regiment 
increased photochemical (Rose Bengal) thrombus formation in vivo 1 hour after 
exposure. As in the earlier study, increased thrombus formation appeared to be caused 
by platelet activation. Further investigations have suggested that increased thrombus 
formation in response to DEP instillation (50μg/animal) remained evident up to 24 
hours after exposure (Nemmar et al. 2003c; Nemmar et al. 2004b) and was associated 
with pulmonary inflammation and histamine release from mast cells. Initially, these 
studies indicated that pulmonary inflammation and thrombus formation may be 
partially linked. However, whilst the earlier study (Nemmar et al. 2003c) showed that 
both fine and ultrafine particles caused pulmonary inflammation, only ultrafine 
particles increased thrombus formation. Finally, administration of DEP (0.01 and 
0.02mg/kg; 24 hours) by tail vein injection (to bypass the lungs) caused cardiac 
changes, which appeared to be associated with systemic and pulmonary inflammation, 
even though DEP was never in direct contact with the lungs (Nemmar et al. 2009). 







Table 1.3 - Overview of Pre-Clinical Studies Investigating the Acute Effects of Particulate Exposure. 
 
 
Animal Model Route of 
Administration 
Timing Particle Dose Effects Reference 
Hamster Platelet 
aggregometry 
Intratracheal instillation 30 min ,  
1 hr 
DEP 5-500μg/animal Lung inflammation and rapid 
platelet activation 
Nemmar et al. 2003b 
Hamster Rose Bengal Intratracheal instillation 1, 6 and 
24 hours 
DEP 50μg/animal Increased thrombosis not 
associated with pulmonary 
inflammation 
Nemmar et al. 2003c 
Hamster Rose Bengal Intratracheal instillation 1 hour DEP 5-500μg/animal Enhanced platelet activation 
and thrombus formation. 
Nemmar et al. 2004a 
Hamster Rose Bengal Intratracheal instillation 24 hours DEP 50μg/animal Thrombosis caused by DEP can 
be prevented by inhibiting 
histamine release from mast 
cells 




and heart rate 
Tail vein injection 24 hours DEP 0.01, 0.02mg/kg Cardiac and systemic changes 
with pulmonary inflammation 
Nemmar et al. 2009 






10 min Negatively charged carboxylate 
modified, positively charged amine 
modified and unmodified polystyrene 
UFPs 
5-500mg/kg Platelet activation resulting in 
increased thrombogenicity with 
positively charged particles 
Nemmar et al. 2002a 
Hamster Rose Bengal Intratracheal instillation 1 hour Negatively charged carboxylate 
modified, positively charged amine 
modified  and unmodified polystyrene 
UFPs 
5-500μg/animal Positive UFPs cause pulmonary 
inflammation and enhance 
thrombus formation 
Nemmar et al. 2003a 
Hamster Rose Bengal Intratracheal instillation 24 hours Silica particles 2-200μg/animal Platelet activation via systemic 
release of neutrophil elastase 
Nemmar et al. 2005 




Not Stated in Paper Not 
Stated in 
Paper 
Multiplewall and singlewall carbon 
nanoparticles, carbon nanoparticles 
Not Stated in 
Paper 
Carbon nanoparticles activate 
platelets and enhance vascular 
thrombosis 
Radomski et al. 2005 
Mouse Platelet 
aggregometry 
Intravenous injection 1, 4 and 
24 hours 
Amine and carboxylated Quantum Dots 1.44-
3,600pmol/animal 
Pulmonary vascular thrombosis 
possibly via activation of the 
coagulation cascade 
Geys et al. 2008 
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In addition to these experiments using DEP, Nemmar and colleagues have also 
investigated the effects of charged particles on platelet activation and thrombus 
formation, using negatively-charged carboxylate-modified, positively-charged amine-
modified and unmodified polystyrene ultrafine particles (Nemmar et al. 2002a; 
Nemmar et al. 2003a). These studies showed that, while instillation of uncharged and 
negatively-charged particles had no effect, positively-charged particles caused platelet 
activation, pulmonary inflammation and increased thrombogenicity. Ultrafine silica 
particles were also found to cause platelet activation 24 hours after instillation, which 
was thought to be caused by systemic release of neutrophil elastase (Nemmar et al. 
2005). Other studies have also found that carbon nanoparticles (Radomski et al. 2005) 
and quantum dots (Geys et al. 2008) have the ability to enhance vascular thrombosis 
via activation of platelets and the coagulation cascade. These studies indicate, 
therefore, that several different types of nanoparticulate have the ability to increase 
thrombus formation although the mechanisms involved remain unclear. 
 
 
1.3.5   How Does Particulate Air Pollution Alter Cardiovascular Function? 
 
As described, there is increasing evidence that exposure to particulate matter can alter 
the function of the cardiovascular system and, in particular, can increase thrombus 
formation by the blood. However, whilst it appears that air pollution causes an 
increase in plasma viscosity (Peters et al. 1997), perhaps due to increased plasma 
concentrations of fibrinogen (Ghio et al. 2000, 2003; Ulrich et al. 2002), the precise 
mechanisms involved remain the subject of debate. Some effects of exposure to 
particulates, such as the PM-induced changes in heart rate (Pope et al. 1999b), 
indicate that pollution induces dysregulation of the autonomic nervous system 
(Simkhovich et al. 2008). In a recent review, however, Mills & colleagues distilled 
current understanding into two main pathways that might underpin particulate-
mediated changes in vascular function: the “classical” pathway in which 
cardiovascular abnormalities are induced via inflammatory mediators, and an 
“alternative” pathway, in which particulates translocate into the circulation and 
interact directly with components of the cardiovascular system (Mills et al. 2009). 
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1.3.5.1   Particulate-Induced Inflammation   
 
Pulmonary inflammation is a well-known effect of pulmonary exposure to ultrafine 
particles, including DEP. Inhalation of CAPs in human subjects causes mild 
inflammation in the lower respiratory tract (Ghio et al. 2000). Similarly, intratracheal 
instillation of DEP increases pulmonary expression of a number of inflammatory 
factors, including cytokine-induced neutrophil chemoattractant-1 (CINC-1), tumour 
necrosis factor-alpha (TNFα), macrophage inflammatory protein-2 (MIP-2. Singh et 
al. 2004; Yokota et al. 2005; Yokota et al. 2008), cyclooxygenase-2 (COX-2) and 
prostaglandin E2 (Cao et al. 2007; Ahn et al. 2008). Significant increases in 
pulmonary neutrophils, lymphocytes and total lavage protein have also been observed 
following particulate instillation (Clarke et al. 1999; Yokota et al. 2008). It has been 
proposed that pulmonary inflammation due to DEP is mediated through the 
production of peroxynitrite, initiated via DEP-mediated up-regulation of inducible 
nitric oxide synthase (Ito et al. 2000). Instilled silica particles also produce pulmonary 
macrophage-neutrophil cross talk, causing the release of neutrophil elastase into the 
bloodstream. Elastase acts to trigger the activation of circulating platelets, potentially 
providing a link between pulmonary inflammation and the initiation of thrombotic 
events (Nemmar et al. 2005). 
 
Systemically administered particles, including DEP, have been shown to cause 
systemic inflammation with increased expression and activity of inflammatory factors 
such as superoxide dismutase, IL-6 (Nemmar et al. 2009; Nemmar et al. 2010), 
tumour necrosis factor (TNFα) and leukotriene B4 (Nemmar et al. 2009). Systemic 
administration of particulates also increases the number of circulating monocytes and 
granulocytes (Nemmar et al. 2008). However, these direct affects on systemic 
inflammation may not apply when subjects are exposed to DEP via inhalation or 
instillation. Seaton et al. (1995) suggested that deposition of ultrafine particles in the 
alveoli causes local inflammation leading to a systemic inflammatory response, which 
can exacerbate cardiovascular conditions in susceptible individuals (Seaton et al. 
2005). In this model, inhalation of ultrafine particles causes an increase in 
inflammatory cells in the lungs, which release proinflammatory cytokines and 
chemokines, including IL-8, TGF-β1 and C-reactive protein, into the circulation. 
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These then trigger a cascade of inflammatory reactions throughout the body leading to 
accelerated atherogenesis and altered cardiac function (Salvi, et al. 1999; Abe et al. 
2000; Donaldson et al. 2001; van Eeden et al. 2001; Fujii et al. 2002; Goto et al. 
2004; Pope et al. 2004). Exposure to ultrafine particles has also been shown to 
increase reactive oxygen species, promoting an oxidative stress response, which may 
promote the progression of atherosclerosis and increase the severity of acute 
cardiovascular responses such as hypertension and myocardial infarction (Delfino et 
al. 2005). Instilled DEP has also been shown promote systemic inflammation via 
increased levels of CINC-1, causing an increase in systemic neutrophils and 
oxyradical production (Yokota et al. 2005). These studies suggest that systemic 
inflammation may be a secondary reaction to pulmonary inflammation caused by 
particulate exposure, and may provide an insight into the mechanisms responsible for 
the increased incidence of cardiovascular events following human exposure to 
airborne particulate pollution. 
 
 
1.3.5.2   Translocation of Ultrafine Particles   
 
The second theory is that UFPs are able to translocate from the alveoli into the blood 
to affect the heart and vasculature directly. Extrapulmonary translocation of 
radiolabelled ultrafine polystyrene particles has been shown in rats by measuring the 
amount of radioactivity collected in the blood and organs following instillation (Chen 
et al. 2006). This study also showed that pre-treatment with lipopolysaccharide 
induced pulmonary inflammation and markedly increased the rate of translocation, 
suggesting that inhaled UFPs reach the alveoli and cause inflammation, which makes 
the alveoli more permeable and allows particles to enter the bloodstream (Chen et al. 
2006). Similar results have also been shown in healthy human volunteers; 
radiolabelled ultrafine carbon particles (Technegas) could be detected in the blood of 
the volunteers 1 minute after inhalation (Nemmar et al. 2002). However, a study by 
our group suggested that extrapulmonary translocation of this particular particle does 
not occur, and instead the radiolabel leeched off the ultrafine particles before entering 
the bloodstream (Mills et al. 2006). Whether ultrafine diesel particles can pass into 
the blood still remains unclear.  
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1.4   Summary 
 
This introduction outlines the potential link between exposure to air pollution, in 
particular nanoparticulate pollution, and increased morbidity and mortality due to 
cardiovascular incidents. Many epidemiological studies have shown that exposure to 
airborne pollution (a significant component of which comes from combustion of 
fossil fuels) results in an increased risk of myocardial infarction. However until 
recently the mechanism at work could only be speculated. Practical constraints have 
ensured that there are few clinical or pre-clinical studies into the cardiovascular 
effects of chronic exposure to particulate pollutants. Considerably more 
investigations have addressed the cardiovascular consequences of acute exposure to 
particulates. These suggest that DEP can increase thrombus formation by causing 
platelet activation and inhibiting the endogenous fibrinolytic system. Whether 
pulmonary and systemic inflammation are necessary mediators of these changes 
remains unclear, as does the role of particle translocation from the lungs to the 
systemic circulation. Particle-induced increase in thrombus formation could 
predispose at-risk individuals to thrombosis at sites of atherosclerotic plaque rupture. 
This would explain the increased cardiovascular events observed in patients 
following acute exposure to atmospheric pollution. The work described in this thesis 
was designed to clarify the mechanisms through which exposure to DEP increases 
the likelihood of thrombus formation. 
 
 
1.5   Hypothesis and Aims 
 
The work described in this thesis addressed the hypothesis: 
Exposure to diesel exhaust particulate increases thrombosis, by activating platelets 
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The specific aims were to: 
 
• Develop a suitable in vivo model for assessing the effects of DEP exposure 
on thrombus formation. 
• Use this model to investigate the effects of DEP (and suitable control 
particles) on thrombus formation and pulmonary and systemic inflammation. 
• Clarify the importance of platelet activation and inhibition of the endogenous 
fibrinolytic system to the DEP-mediated increase in thrombus formation. 
• Determine whether exposure to DEP inhibits the activity of the endogenous 
fibrinolytic system in cultured endothelial cells. 












Materials & Methods 
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2.1   In Vivo Models of Thrombus Formation 
2.1.1   Animals 
 
Male Wistar rats (150-200g) were obtained from Charles River Laboratories 
(Wilmington, MA, USA). All animals were housed for at least one week, with 
constant access to food and water and a 12 hour light/dark cycle, before use in the 
following experiments. All animal experiments were licensed and followed the 
Home Office Procedures Act. 
 
 
2.1.2   Preparation and Administration of Particulate Suspensions 
2.1.2.1   Preparation of Particulate Suspensions 
 
Diesel exhaust particulates (DEP) collected from industrial forklift engine exhausts 
(SRM 2975) were obtained from the National Institute of Standards and Technology 
(NIST; Gaithersburg, MD, USA). Carbon black particles (CB; Degussa, Germany) 
and quartz particles (DQ12; IUF, Germany; Robock. 1973) had previously been 
baked at 290°C for 8 hours to ensure the particles were free of contaminants, 
especially lipopolysaccharide (LPS). DEP could not be baked, as this would remove 
volatile chemical compounds from the particle surface. Instead DEP was regularly 
tested for LPS via Limulus Amebocyte Lysate assay (QCL-1000 Endotoxin Assay; 
Cambrex, NJ, USA) according to the manufacturers instructions. Dr Catherine Shaw 
also recently tested CB and DEP particles, and were both found to be completely 
LPS free. Solutions of DEP (1mg/ml), CB (1mg/ml) and DQ12 (0.25mg/ml) were 
prepared in sterile 0.9% saline by sonication (Status Homogenisers. Probe from 
Philip Harris Scientific, US70; Lichfield, UK) at 70% power for 5 minutes. All 
particle suspensions were prepared immediately prior to use. The comparison of CB 
with DEP would allow observations of the effects of the carbon core versus the 
associated compounds on the DEP surface, as CB is a clean carbon particle. DQ12 is 
a large particle that induces pulmonary inflammation; its concentration in the 
following experiments was chosen to induce a similar level of pulmonary 
inflammation as the corresponding DEP and CB doses, based on previous work (Dr. 
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Rodger Duffin, Centre for Inflammation Research, University of Edinburgh; Duffin 
et al. 2001). 
 
 
2.1.2.2   Pulmonary Instillation 
 
Animals were anaesthetised using isoflurane (Merial; Essex, UK) and suspensions 
(0.5ml) containing the relevant amount of particulate (DEP, CB, DQ12) or vehicle 
(0.9% sterile saline) were applied directly into the lungs by intratracheal instillation 
(Duffin et al. 2001). Briefly, animals were temporarily anaesthetised by isoflurane 
inhalation, cannulated with a paediatric laryngoscope to expose the trachea, and 
0.5ml of saline or suspensions containing the experimental particles were instilled 
into the lungs before the animal regained consciousness. Animals were allowed to 
recover from the anaesthetic and maintained for 2, 6 or 24 hours under normal 
housing conditions before being assessed for thrombus formation and markers of 
inflammation (see below, Chapter 2.1.3). Instillations were performed by Dr Rodger 
Duffin (Centre for Inflammation Research, University of Edinburgh). 
 
 
2.1.2.3   Intravenous Administration 
 
Intravenous administration of experimental solutions and saline was carried out by 
tail vein injections. Animals were weighed and received a bolus (0.5ml) of DEP or 
CB suspensions (0.5mg/kg) while conscious and restrained. Control animals received 
a comparable volume of vehicle (saline). Animals were allowed to recover from the 
procedure for 2, 6 or 24 hours before being anaesthetised and assessed for thrombus 
formation and markers of inflammation (see below; Chapter 2.1.3). Injections were 
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2.1.3   Models of Thrombosis 
2.1.3.1   Ferric Chloride-Mediated Induction of Thrombosis 
 
Induction of arterial thrombus by direct application of ferric chloride was developed 
in male Wistar rats (Body weight 175g and 275g) by adaptation of the method 
described by Kurz et al. (1990). Rats were anaesthetised and maintained via 
inhalation of isoflurane, and prepared for surgery by shaving the anterior surface of 
the neck. The left carotid artery was exposed by blunt dissection and carotid artery 
flow measured by emplacement of an ultrasonic flow probe (Transonic Systems Inc; 
Maastricht, Netherlands). Ferric chloride was applied topically to the carotid artery; 
this was achieved using a cylinder of plastic tubing (2mm internal diameter) 
approximately 3mm in length. The tubing was cut open and a strip of Whatman filter 
paper (No 5) was placed inside and folded to create a double layer. The tubing and 
filter paper were then dipped in 20% ferric chloride solution (BDH; Poole, UK) and 
placed around the carotid artery. Care was taken to ensure full contact between the 
filter paper and the artery wall. The ferric chloride solution was left in contact with 
the artery for 10 minutes before being carefully removed. Blood flow through the 
artery was recorded, timing was started when ferric chloride was applied to the artery 
and was stopped when blood flow reached 0ml/min. 
 
 
2.1.3.2   Time to Arrest of Bleeding 
 
In all animals, the time to arrest of tail tip bleeding (Tanaka et al. 1998) was assessed 
once total occlusion of the carotid artery had been achieved. The tail tip (~5mm) was 
removed using a scalpel and cleaned every 10 seconds using a swab (Medical Wire 
and Equipment Company; Wiltshire, UK). Arrest of bleeding was considered to be 
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2.2   Histological Analysis of Thrombus Formation and Particle 
Translocation 
 
Following surgery, aorta, carotid artery, kidney, liver and lung sections were 
removed and fixed in neutral buffered formalin (24 hours) before being processed 
and embedded in paraffin wax for histological analysis. Serial sections (4μm) were 
cut using a microtome and the sections were stained using the haemotoxilin and 
eosin method to look at organ/vessel structure and thrombus (Lillie et al. 1976). 
Sections mounted on glass microscope slides (Superfrost Plus, 75mm x 25mm. VWR 
International Ltd; Leicestershire, UK) were rehydrated through a series of alcohol 
steps at reducing concentrations, then rinsed in distilled water. Nuclei were then 
stained using haemotoxilin and the samples were differentiated using 0.3% acid 
alcohol. Sections were again rinsed in distilled water, then stained with eosin and 
rinsed again. Following staining, sections were dehydrated through a series of 
alcohols of increasing concentration. Samples were then cover-slipped using DPX 
solution (Sigma Aldrich; Dorset, UK) and photographed at 100x and 400x 
magnification, and compared with lung sections, taken 2 hours after DEP instillation, 
for identification of DEP. 
 
 
2.3   The Impact of Particulate Administration on Pulmonary 
Inflammation 
 
Intratracheal administration of particulate solutions was expected to induce 
pulmonary inflammation, whereas intravenous administration was not. A number of 
complementary methods were used to assess the nature of pulmonary inflammation 
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2.3.1   Collection and Processing of Plasma and Bronchoalveolar Lavage Fluid 
 
Anaesthetised rats, exposed to particulate solutions or vehicle, were killed by 
exanguination; blood was removed into a syringe, via the abdominal aorta, and 
mixed with 3.8% sodium citrate solution (dilution factor 10:1). Whole blood was 
centrifuged (1500g, 5 minutes, room temperature) to obtain plasma, which was 
separated into aliquots (0.5ml) and stored at -80°C until further analysis. The lungs 
were then cannulated and lavaged with (1 × 8ml) sterile saline. This first lavage was 
retained in a 15ml falcon tube for cellular analysis of the bronchoalveolar lavage 
(BAL) fluid profile. The lungs were then lavaged a further 3 times with sterile saline 
(8ml) and the BAL fluid from these lavages was combined in a 50ml falcon tube 
(Duffin et al. 2001; Duffin et al. 2007). All samples were centrifuged (180g, 5 
minutes, 4°C). The supernatant from the first lavage was separated into 1ml aliquots 
and stored at -80°C for further analysis. The supernatant from the 50ml falcon tube 
was removed and discarded, and the cell pellet was resuspended in 1ml sterile saline 
and added to the cell pellet from the first lavage. 
 
 
2.3.2   Cell content of Bronchoalveolar Lavage fluid 
 
Cell pellets obtained from BAL fluid (see above; Chapter 2.3.1) were re-suspended 
(in 1ml sterile saline) and analysed using an automatic cell counter using standard 
settings (ChemoMetec A/S; Denmark). Briefly, 50μl of the cell suspension was 
added to 50μl lysis reagent A-100 and 50μl stabilizing reagent B (ChemoMetec A/S; 
Denmark). The solution was then loaded into a Nucleocassette (ChemoMetec A/S; 
Denmark) for the cell count. For solutions in which the initial cell count was too high 
to give an accurate reading, the cell suspension was diluted 1:10 using sterile saline 








2.3.3   Pulmonary Cell Differential Counts Following Particle Administration 
 
Cytocentrifuge smears were prepared by adding 1 × 106 cells from the cell 
suspensions described above (Chapter 2.3.2) to 300μl saline containing 0.1% bovine 
serum albumen (BSA). Samples were centrifuged (300g, 3 min, room temperature) 
onto a microscope slide (Superfrost Plus, 75mm x 25mm. VWR International Ltd; 
Leicestershire, UK), and stained with Diff-Quick (Raymond A Lamb. London, UK) 
for differential cell counts to be assessed. 300 cells per slide were counted and the 
results expressed as total number of each cell type in the lung lavage by referring 
back to the original cell count (Duffin et al. 2001; Duffin et al. 2007). Macrophages 
were identified as large, circular cells with single-lobed nuclei, neutrophils were 
identified as smaller cells with multi-lobed nuclei (Figure 2.1). 
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Figure 2.1 - Differential Analysis of Pulmonary Inflammatory Cells. 
Microscope image showing macrophages (large, circular, single lobed nuclei) and neutrophils 
(smaller, multi-lobed nuclei) after Diff-Quick staining. Image taken 6 hours after instillation of DEP, 
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2.3.4   Measurement of Cell Death and/or Pulmonary Inflammation 
 
Lactate dehydrogenase (LDH) is an enzyme released after cell death and lysis. It is 
also found in lung exudate, and is a marker of pulmonary inflammation. LDH levels 
taken from the BAL fluid were assessed using a cytotoxicity detection kit (LDH. 
Roche Diagnostics Ltd; Burgess Hill, UK), according to manufacturer’s instructions. 
Cell pellet suspensions were stored briefly at 4°C before performing lactate 
dehydrogenase assays; assays were always performed on the same day as surgery.  
Briefly, 100μl of the resuspended cell pellet obtained from BAL fluid were added to 
working solution (100μl) in a 96-well plate. Positive control wells also received 5μl 
lysis solution, while negative control wells received deionised water instead of the 
cell suspension. The plate was read at 490nm with a 630nm reference filter (MRX 
plate reader. Dynex Technologies; Berlin, Germany), and LDH level was calculated 
as a percentage from positive and negative control values (Duffin et al. 2007). 
 
 
2.3.5   Quantification of Protein Content in Bronchoalveolar Lavage Fluid 
 
Protein content of BAL fluid provides another measure of pulmonary inflammation, 
as inflamed lungs allow the exudate influx, which increases protein levels. The total 
protein content of the resuspended cell pellet obtained from BAL fluid samples was 
measured using a bicinchoninic acid (BCA) protein assay (Thermo Scientific; 
Northumberland, UK), according to manufacturer’s instructions. Resuspended cell 
pellet were stored briefly at 4°C before performing protein assays; assays were 
always performed on the same day as surgery. Briefly, BAL fluid (10μl) and BSA 
standards (10μl; 0.025 to 2mg/ml) were added to a 96-well plate. A 1:50 solution of 
copper (ΙΙ) sulphate and BCA was prepared and added (190μl) to each well. The 
plate was incubated (37°C, 30 minutes), and then read at 570nm using a plate reader 
(MRX plate reader. Dynex Technologies; Berlin, Germany). The known standard 
concentrations were used to generate a standard curve from which sample protein 
concentrations were interpolated. 
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2.3.6   Measurement of Pro-Inflammatory Cytokines in Bronchoalveolar Lavage 
Fluid 
 
BAL fluid was collected and stored at -80°C (as described in Chapter 2.1.3.1) for 
ELISA analysis for markers of inflammation including interleukin 6 (IL-6. DuoSet 
ELISA Rat IL-6 kit; R&D Systems; Abingdon, UK), C reactive protein (CRP. 
DuoSet ELISA Rat CRP kit; R&D Systems; Abingdon, UK) and tumour necrosis 
factor alpha (TNFα. DuoSet ELISA Rat TNFα kit; R&D Systems; Abingdon, UK). 
The standard protocol was the same for each ELISA; briefly, optically clear 96-well 
plates (R&D Systems; Abingdon, UK) were incubated at room temperature 
overnight with 100μl capture antibody at the required concentration for each assay. 
The plates were then washed 3 times with 400μl wash buffer (R&D Systems; 
Abingdon, UK) per well, before being blocked by adding 300μl reagent diluent 
(R&D Systems; Abingdon, UK) to each well, and incubating at room temperature (1 
hour). The wash step was then repeated, and 100μl of samples or standards were 
added to each well in duplicate. The plate was covered and incubated at room 
temperature (2 hours). The wash step was then repeated, and 100μl detection 
antibody at the required concentration was added to each well. Once again the plate 
was covered and incubated at room temperature (2 hours). The wash step was 
repeated and 100μl of the working solution (Streptavidin-HRP) was added to each 
well. The plate was incubated in the dark at room temperature for 20 minutes before 
the final wash step. 100μl of substrate solution (1:1 mixture of H2O2 and 
Tetramethylbenzidine. R&D Systems; Abingdon, UK) was added to each well and 
the plate was incubated in the dark at room temperature (20 minutes) to allow for 
colour development. Stop solution (50μl; 2N H2SO4. R&D Systems; Abingdon, UK) 
was then added to each well and the plate was read at 450nm with the reference 
wavelength set at 550nm using a Triturus ELISA analyser (Grifols; Barcelona, 
Spain) and corresponding software. An example of a standard curve conducted for 
the CRP ELISA is shown (Figure 2.2). 
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Figure 2.2 - Standard Curve for C Reactive Protein ELISA. 
Standard curve for CRP ELISA with a non-linear second order polynomial curve. Graph shows 
linearity up to 4000pg/ml and is very close to complete transection of both axes at zero. All sample 
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2.4   The Impact of Particulate Administration on Systemic 
Inflammation 
 
Plasma samples collected from animal exposures were assessed for levels of IL-6, 
CRP and TNFα. Samples were stored and analysed using the same method used to 
analyse BAL fluid samples (Chapter 2.1.3.6). 
 
 
2.5   The Impact of Particulate Administration on Endogenous 
Fibrinolytic and Clotting Pathways 
 
The effect of particulate exposures on clotting systems was determined using flow 
cytometry to assess platelet-monocyte interactions and ELISAs to measure 
circulating concentrations of endogenous thrombolytic factors. Blood was collected 
from the rat abdominal aorta by syringe, and mixed with 3.8% sodium citrate 
solution (dilution factor 10:1). Fresh whole blood was used immediately for flow 
cytometry. Whole blood was centrifuged (1500g, 5 minutes, room temperature) to 
obtain plasma for ELISAs, which was separated into aliquots (0.5ml) and stored at    
-80°C until further analysis. 
 
 
2.5.1   Impact of Particulate Administration on Platelet-Monocyte and Platelet-
Platelet Interactions 
 
In order to characterise platelet-monocyte and platelet-platelet aggregation following 
exposure to particulates, flow cytometric analysis was carried out to measure the 
percentage of cells positive for platelet and monocyte cell surface markers. Flow 
cytometry is a method of characterising cells based on how they fluoresce and scatter 
light as they are passed in suspension through a laser beam. Forward scatter (FS) of 
the laser can be used to provide information on the relative size of the cell, while side 
scatter (SS) of the laser provides information about the relative granularity (Ibrahim 
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& Van Den Engh. 2007). This method has been previously used to study platelet-
monocyte aggregation (Tarnow et al. 2008). Fluorescent-conjugated antibodies can 
be used to detect specific cell surface markers; fluorescein isothiocyanate (FITC)-
labelled anti-rat CD42d antibody was used to label platelets (detected in the FL1 
channel; Sato et al. 2000), phycoerythrin (PE)-labeled hamster anti-rat CD61 was 
used to label monocytes (detected in the FL2 channel; Wiwanitkit. 2005). The FL1 
and FL2 channels are photomultipliers and filters, used to detect light emitted from 
the fluorophores FITC (green light) and PE (orange light). These channels are able to 
detect light and also convert the strength of the light signal into a quantitative 
measure of labeled cells. PE-labelled hamster IgG1κ was used as a negative isotype 
control in order to check for non-specific staining (All antibodies from BD 
Biosciences; Oxford, UK). Platelet-monocyte aggregates are defined as double 
positive for CD42d and CD61, platelet-platelet aggregates are defined as CD42d 
positive with a further shift in the FL1 channel away from the main group of single 
platelets. Blood was collected into 3.8% sodium citrate solution (dilution factor 10:1) 
from the abdominal aortae of rats exposed to particulates. Whole blood (30μl) was 
added to 30μl of diluted antibody (CD42d - 1/100 dilution in PBS, CD61 and isotype 
control 1/50 dilution in PBS), or 15μl of each antibody when double stains were 
performed. Samples were incubated at room temperature in the dark (20 min) before 
the addition of 500μl 1x FACS lysing solution (BD Biosciences; Oxford, UK), 
which causes lysis of red blood cells only. Samples were then incubated for a further 
10 minutes before being analysed using flow cytometry (BD FACscan flow 
cytometer using CellQuest software and FlowJo software for analysis). A graph of 
the initial set-up showing forward scatter and side scatter can be seen below (Figure 
2.3). Examples of FL1/FL2 scatter plots showing platelet-monocyte and platelet-










Figure 2.3 - Initial Set-Up and Gating of Whole Cell Population Via Flow 
Cytometry. 
Forward scatter (FSC-H) vs. side scatter (SSC-H) plot taken from set up of flow cytometry 
experiments. Plot shows dead cells located with low forward scatter. A gate was set up (black square) 
to eliminate dead cells from further analysis, only cells located inside the gate were analysed for 
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Figure 2.4 - Flow Cytometry Scatter Plots Showing Platelet-Monocyte and 
Platelet-Platelet Aggregation. 
a) FL1/FL2 plot showing unstained control cells taken following instillation of saline. All cells are 
found in the double negative region of the plot. b) FL1/FL2 plot showing cells stained with 
fluorescein isothiocyanate (FITC)-labelled CD42d antibody following instillation of saline. Plot 
shows a large proportion of cells labelled with the CD42d antibody in the FL1 positive section, these 
cells are identified as platelets. Plot also shows a smaller subgroup further along the FL1 axis, which 
represents platelet-platelet aggregates. c) FL1-FL2 plot showing cells stained with both FITC-labelled 
CD42d antibody and phycoerythrin (PE)-labelled CD61 antibody following instillation of saline. Plot 
shows a large proportion of cells in the FL1 positive FL2 positive section. These cells are identified as 
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2.5.2   Measurement of Markers of the Endogenous Thrombolytic System 
 
In order to determine whether administration of particulate solutions altered 
endogenous fibrinolysis, plasma samples were assessed for levels of tissue 
plasminogen activator (t-PA), plasminogen activator inhibitor (PAI-1), fibrinogen 
and D dimer. Upon thrombus formation, fibrinogen is cleaved to form fibrin, which 
stabilises the clot. t-PA enzyme is released from endothelial cells in response to 
thrombus formation. t-PA breaks down inactive plasminogen to active plasmin, 
which in turn breaks down fibrin into fibrin degradation products and D-dimer. PAI-
1 enzyme is also released from endothelial cells to inactivate t-PA and control the 
fibrinolytic process. Rat t-PA antigen, rat PAI-1 antigen and rat fibrinogen antigen 
ELISAs were obtained from Patricell Ltd. (Nottingham, UK). The standard protocol 
was the same for each ELISA; briefly, 100μl of samples and standards were added to 
duplicate wells on the plate provided in the kit. The plate was incubated at room 
temperature for 30 minutes agitated on a Belly Dancer (Stovall Life Sciences; 
Greensboro, NC, USA) at maximum speed. After incubation, the plate was washed 3 
times with 300μl wash buffer (provided in the kits), and 100μl of reconstituted 
primary antibody was added to each well. The plate was incubated (30 min; room 
temperature on the Belly Dancer) before the wash step was repeated. Reconstituted 
secondary antibody (100μl) was then added to each well, the plate was incubated and 
washed again in the same manner. Substrate solution (100μl) was then added to each 
well and the plate was incubated (up to 15 min) to allow colour development. The 
reaction was then quenched by the addition of 50μl of stop solution (1N H2SO4), and 
absorbance of each sample was measured at 450nm (MRX plate reader. Dynex; 
Technologies, Berlin, Germany). D dimer ELISAs were performed by Pamela 
Dawson (Department of Haematology, Royal Infirmary of Edinburgh) using 
HemosIL D dimer HS reagents assessed using an ACL TOPS analyser (both from 
Beckman Coulter Ltd; Buckinghamshire, UK). Sample concentrations were 
calculated from the standard curves conducted with every assay.  
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2.6  Preparation of DEP Suspensions 
 
Suspensions (1mg/ml) of DEP (SRM-2975; National Institute of Standards and 
Technology) were made up in endothelial cell culture medium (EGM-2 BulletKit 
Lonza Walkersville; Maryland, USA) without serum, containing 0.5mg/ml bovine 
serum albumen (BSA) and prepared using a probe sonicator (Status Homogenisers. 
Philip Harris Scientific; US70, Lichfield, UK) at 70% power for 5 minutes, to ensure 




2.6.1   Analysis of Particle Size in DEP Suspensions 
 
To determine particle sizes 1:50 dilutions of the DEP suspensions were measured 
using a particle size analyser (90 Plus particle size analyser. Brookhaven Instruments 
Corporation; NY, USA), which uses laser-scatter to calculate mean particle diameter 
(O’Brien et al. 2006). The settings for these experiments were as follows; each run 
lasted 1 minute with a total of 10 runs per sample, laser angle for light scatter was 
fixed at 90°, laser wavelength was 659nm, the refractive index was set at 1.5 and the 
dust cut-off filter was set at 30μm (the machine is accurate between 3nm and 3μm). 
 
 
2.6.2   Absorbance Spectra of DEP Suspensions (Indirect Measure of Suspension 
Concentrations) 
 
In order to provide an estimate of particle concentration remaining in suspension 
during the initial testing phase, DEP suspensions were diluted to a 1:50 concentration 
with dH2O and analysed in a spectrophotometer (SmartSpec 3000. Bio-Rad; 
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2.6.3   Final Analysis of DEP Suspension Concentrations 
 
The exact concentration of DEP in this dispersant after centrifugation was 
investigated by spinning 1ml samples of the DEP suspension in a heated vacuum 
centrifuge overnight, along with 1ml samples of serum free medium + 0.5mg/ml 
BSA. The dry weights of the serum free medium + BSA samples were subtracted 
from the dry weights of the DEP samples to give the mass of DEP in a 1ml  




2.7   Endothelial Cell Culture 
 
Human umbilical vein endothelial cells (HUVECs; Promocell; Heidelberg, 
Germany) were cultured at 37°C in 75cm3 flasks using endothelial cell culture 
medium (EGM-2 BulletKit - basal medium containing human epidermal growth 
factor, hydrocortisone, gentamicin, ampheroteracin B, fetal bovine serum, vascular 
endothelial growth factor, human fibroblast growth factor B, insulin-like growth 
factor 1, ascorbic acid and  heparin - Lonza Walkersville; Maryland, USA). When 
cells had grown to confluence they were passaged by first removing the culture 
medium and then washing the cells twice with 3ml HEPES-buffered saline solution 
(Reagent Pack Subculture Kit - Lonza Walkersville; Maryland, USA). Cells were 
then incubated with 3ml trypsin/EDTA solution (Reagent Pack Subculture Kit - 
Lonza Walkersville; Maryland, USA) at 37°C for 5 minutes, and the sides of the 
flask were gently tapped to lift cells from the culture surface. 5ml trypsin neutralising 
solution (Reagent Pack Subculture Kit - Lonza Walkersville; Maryland, USA) was 
then added to the cells to prevent cell lysis. The cell suspension was then split 
equally between four new flasks, 15ml culture medium was added and the flasks 
were incubated at 37°C. Cells up to passage 6 (P6) were used for further 
experiments. 
 




2.7.1   Exposure of Human Umbilical Vein Endothelial Cells (HUVECs) to DEP 
Suspensions 
 
HUVECs were exposed to DEP in 2 separate experiments. The first was designed to 
investigate the effects of DEP on constitutive release of fibrinolytic factors, by 
exposing HUVECs to DEP only. HUVECs were washed twice with HEPES-buffered 
saline solution, and full growth medium was replaced with serum free medium 
containing DEP (10, 20, 50, 100 or 150μg/ml) in serum free medium plus BSA 
(0.5mg/ml). Controls were exposed to serum free medium alone. Cells were 
incubated under these conditions for 2, 6, 16 or 24 hours. The second experiment 
was designed to investigate the effects of DEP on stimulated release of fibrinolytic 
factors. In these experiments, HUVECs were first incubated with either 100μg/ml 
DEP (made up in serum free culture medium + 0.5mg/ml BSA, added to 15mls 
serum free culture medium for exposure) or serum free medium alone for 16 hours. 
Cells were then washed and exposed to a range of thrombin concentrations (0.1, 0.5 
and 1U/ml in serum free culture medium with serum free culture medium used as a 
second control) for 24 hours. Following incubation, cell supernatants and cellular 
RNA were isolated and stored at -80°C for later analysis. 
 
 
2.7.2   Assessment of Cell Viability 
 




2.7.2.1   Trypan Blue Exclusion 
 
HUVECS (200,000 cells/well in 2ml growth medium) were plated onto 6 well plates 
and incubated (2 hours, 37°C) to allow adhesion to the well surface. These were then 
incubated (under standard culture conditions) with DEP solutions (20 and 60μg/ml; 
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15ml final volume in serum free cell culture medium) for up to 24 hours. Control 
wells contained dispersant in culture medium without DEP. After the appropriate 
exposure time, HUVECs were photographed and assessed for viability using Trypan 
Blue exclusion (Cook and Michell, 1989). Briefly, the HUVECs were washed and 
trypsinised and an aliquot (10μl) of the cell suspension was mixed with 90μl trypan 
blue (Sigma Aldrich; Dorset, UK). Live cells actively exclude the stain and appear 
white when examined microscopically. Dead cells cannot exclude the stain and, 
therefore, appear dark blue. Live and dead cells were counted using a 




2.7.2.2   Lactate Dehydrogenase Release 
 
In cultured cells the LDH assay is only a marker of cell death and cytotoxicity, as 
opposed to experiments using BAL fluid where LDH can also detect pulmonary 
inflammation. To measure lactate dehydrogenase (LDH) release HUVECs (50,000 
cells/well in 100μl cell culture medium) were seeded on 96 well plates and incubated 
(2 hours, 37°C) to allow adhesion to the well surface. Cells were incubated (under 
standard conditions for up to 24 hours), with positive cytotoxic controls, hydrogen 
peroxide (1μM - 1mM) and Tween 20 (0.1% - 50%), to provide high control levels 
of cell death. Test exposures were achieved by incubating cells (at 37oC for 2, 6, 16 
and 24 hours) with DEP (at 10, 20, 40, 60 and 80μg/ml in serum free medium 
containing 0.5mg/ml BSA) or vehicle. LDH release was determined using a 
colorimetric assay (cytotoxicity detection, LDH assay kit; Roche Diagnostics). 
Briefly, cells were incubated with DEP, hydrogen peroxide, Tween 20 or serum free 
medium for the required exposure times in 96 well plates. Microplates were 
centrifuged at 250g for 10 minutes and supernatant (100μl) was carefully transferred 
from each well into corresponding wells on a second optically clear, flat-bottomed 
96 well microplate. Reaction solution was a mixture of catalyst solution 
(diaphorase/NAD+ mixture) and dye solution (iodotetrazolium chloride and sodium 
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lactate); 100μl of reaction solution was added to each well and the plate was 
incubated at room temperature(30 minutes) in the dark. The plate was assessed by 
measuring absorbance at 490nm (MRX plate reader. Dynatech Laboratories; VA, 
USA). Cytotoxicity was calculated as a percentage of maximum, as determined from 
control wells containing no cells (to measure background absorbance at each of the 
DEP concentrations) and positive control wells (containing cells treated with 50% 
detergent to rupture cell membranes resulting in total cell lysis). 
 
 
2.7.3   Measurement of t-PA and PAI-1 Released by HUVECs 
 
The influence of experimental manipulations on the endogenous fibrinolytic system 
in HUVECs was assessed by measuring release of key components of this system 
into the culture medium. The effect of DEP on stimulated t-PA and PAI-1 release 
was assessed by incubating HUVECs in serum free medium with DEP (100μg/ml for 
16 hours) or vehicle. DEP was then removed by washing with HEPES buffer, and 
replaced with serum free medium containing thrombin (0.1, 0.5 or 1 U/ml: 24 hour 
exposure). Following both incubations, cell supernatants and cellular RNA were 
isolated and stored at -80°C for subsequent analysis using t-PA ELISA and RT-PCR 
(as described in Chapter 2.7.3.1), respectively. In order to stimulate t-PA and PAI-1 
release HUVECs were incubated with 0, 0.1, 0.5 or 1 U/ml thrombin (Sigma 
Aldrich; Dorset, UK) for 6 or 24 hours.  
 
 
2.7.3.1   t-PA ELISA 
 
Activity and antigen concentrations of t-PA were measured in cell supernatants using 
a commercially available ELISA (t-PA Combi Actibind ELISA kit. Technoclone 
Ltd; Surrey, UK.), according to manufacturer’s instructions. Briefly, sample 
supernatants were diluted 1:4 with incubation buffer and 100μl of each sample and 
standards were added in triplicate to separate wells of the test microplate for 
overnight incubation at 4°C. The plate was then washed 3 times and 200μl of 
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detection mixture was added to each well; the plate was incubated (37°C, 1 hour) and 
absorbance was measured using a plate reader (MRX plate reader. Dynatech 
Laboratories; VA, USA) at 405nm to assess t-PA activity (0.125-10U/ml). The plate 
was then washed 3 times before diluted horseradish peroxidase (POX) conjugated 
monoclonal anti-t-PA (100μl) antibody was added to each well, the plate was then 
incubated for 1 hour at 37°C. The plate was washed a further 3 times, 100μl of TMB 
substrate was added to all wells and the plate was incubated at room temperature for 
10 minutes before the addition of 100μl of stop solution. Absorbance was then 
assessed using a plate-reader at 450nm to assess t-PA antigen levels in reference to 
readings from the standards (0.125-30ng/ml).  
 
 
2.7.3.2   PAI-1 ELISA 
 
Supernatants taken from HUVECs exposed to DEP solutions or vehicle were 
assessed for PAI-1 activity using a commercially-available ELISA (TECHNOZYM® 
PAI-1 Actibind® ELISA Kit. Technoclone Ltd; Surrey, UK), according to 
manufacturer’s instructions. Briefly, 25μl of controls and sample plasma were added 
in triplicate to separate wells of the test microplate along with 75μl of diluted POX 
conjugated monoclonal anti-PAI-1 antibody working solution. The plate was 
incubated at 37°C for 45 minutes. It was then washed 3 times before adding substrate 
solution (100μl) to each well; the plate was then incubated (15 min, room 
temperature) before adding stop solution (100μl). Absorbance was then assessed 
using a plate reader (MRX plate reader. Dynatech Laboratories; VA, USA) at 450nm 
to assess PAI-1 activity in reference to readings from the standards (0.3-61.1U/ml). 
 
 
2.7.4   Molecular Analysis of HUVECs 
 
Qualitative molecular analysis of HUVECs was performed using RT-PCR to confirm 
the presence of markers of endothelial cell phenotype. Quantitation of expression of 
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2.7.4.1   Reverse Transcription Polymerase Chain Reaction for Effects of DEP 
Exposure on the Thrombolytic System 
2.7.4.1.1   RNA Extraction 
 
Cultured cells were trypsinised and centrifuged (1000rpm, 5 min) and the 
supernatant removed and discarded. RNA extraction was achieved using the TRIzol 
extraction method. Briefly, cells were incubated (room temperature, 5 minutes) in 
TRIzol (1ml, Invitrogen), then mixed with chloroform (0.2ml, Fisher Scientific; 
Loughborough, UK) and incubated (room temperature) for a further 3 minutes. 
Samples were centrifuged (12,000g, 15 minutes, 4°C) to separate the solid and 
aqueous phases. The aqueous phase was transferred to a fresh Eppendorf tube and 
isopropanol (0.5ml, Fisher Scientific; Loughborough, UK), added to precipitate the 
RNA. Samples were incubated (room temperature, 10 min) and centrifuged 
(12,000g, 10 minutes, 4°C), the supernatant was removed and discarded, and the 
RNA pellet was washed with cold (4°C) 75% ethanol (1ml, Fisher Scientific; 
Loughborough, UK). Samples were vortexed and centrifuged (7,500g, 5 minutes, 
4°C), the supernatant discarded and the RNA pellets allowed to air dry (room 
temperature, 5 minutes). Pellets were then resuspended in autoclaved 0.1% 




2.7.4.1.2   RNA Integrity 
 
RNA concentration was determined using a GeneQuant spectrophotometer reading at 
320nm. The integrity of the extracted RNA was verified by denaturing agarose gel 
electrophoresis. A small (50ml) gel tray and comb were cleaned and treated with 
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‘RNase Zap’ (Ambion International; Cambridgeshire, UK). The 1.2% agarose gel 
was prepared by adding 0.6 g agarose (Cambrex; NJ, USA) to 44 ml DEPC water 
and boiling in a microwave (30 seconds). The mixture was left to cool slightly, then 
formaldehyde (1ml, Sigma-Aldrich; Dorset, UK), 5 ml autoclaved 10x 4-
morpholinepropanesulfonic acid (MOPS) solution (0.4 M MOPS, 0.1 M Sodium 
acetate, 10 mM EDTA; pH 7; Sigma Aldrich; Dorset, UK) and 4μl dilution of 
ethidium bromide (Sigma-Aldrich; Dorset, UK) were added and mixed in a fume 
hood. The mixture was poured into the tray and left to set. RNA samples (2μl) were 
denatured by mixing with 2.5μl formaldehyde, 2.5μl 10x MOPS, 10μl deionised 
formamide (Sigma-Aldrich; Dorset, UK) and 8μl DEPC water and incubating at 
65°C for 15 minutes. Loading buffer (2μl) was added to each of the samples and 
10μl of each sample mixture was then loaded into separate wells of the agarose gel 
and run in 1x MOPS for 40 minutes at 150v. RNA was then visualised on a UV 
trans-illuminator at 254nm and photographed using a Mitsubishi P93 video printer. 
 
 
2.7.4.1.3   Reverse Transcription Polymerase Chain Reaction (RT-PCR) 
 
Reverse Transcription PCR was conducted to show RNA expression in HUVECs. 
RT-PCR was conducted using primers for Tie2 (an endothelial cell marker) to show 
that HUVECs were still of endothelial lineage up to P6 (Partanen et al. 1992). 
Reverse transcription of extracted RNA was performed using a Promega A3500 RT 
system (Promega Corporation; Hampshire, UK). RNA (1μg/ml) was added to the 
Promega Mastermix (containing 10x Buffer, MgCl2, Oligo nucleotides, dNTPs and 
RNase inhibitor at a ratio of 2:4:1:2:1). Reverse transcriptase enzyme was added and 
samples were incubated at 42°C for 30 minutes, 99°C for 5 min and 4°C for 10 
minutes in an Eppendorf 5331 thermal cycler. At this time two negative controls 
were added; one containing no reverse transcriptase enzyme, and a second containing 
no RNA. PCR was performed using a Promega M5661 Taq Bead Hot Start 
Polymerase kit. cDNA samples were added to the Promega Mastermix (containing 
10x Buffer, MgCl2, dNTPs, forward primer, reverse primer and nuclease free H2O at 
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a ratio of 5:3:1:2:2:32). Samples were run in an Eppendorf 5331 thermal cycler at 
95°C for 45 seconds, then 35 cycles of 90°C for 45 seconds, 60°C for 30 seconds, 
72°C for 90 seconds, 72°C for 5 minutes and finally 4°C for 10 minutes. Samples 
were run on a 1.2% agarose gel along with a 100bp DNA ladder (Promega 
Corporation; Hampshire, UK) and visualised using a UV trans-illuminator at 254nm. 
Expression of t-PA, PAI-1 and GAPDH were assessed via RT-PCR following the 
RNA extraction  method discussed above, following incubation with DEP. RT-PCR 
was conducted using primers for t-PA, PAI-1 and GAPDH; primer sequences are 
shown (Table 2.1). 
 
 
2.7.4.2   Quantitative Real-Time Polymerase Chain Reaction  
 
RNA was extracted from HUVECs exposed to DEP as described previously (Chapter 
2.7.3.1.1), reverse transcribed to cDNA and stored at -80°C until real-time PCR was 
performed. Real time primers (shown in Table 5.2, Invitrogen; Paisley, UK) were 
diluted to 200pM using TE (Tris EDTA buffer solution. pH 8.0. Fluka BioChemika; 
Switzerland). Each primer (0.1μl) was added to 0.1μl of the corresponding 
fluorescent probe, 2.7μl RNase free H2O and 5μl Roche probe master (both from 
LightCycler 480 probes master kit; Roche; Burgess Hill, UK), providing an 8μl 
Mastermix that was added to each well. 2μl of cDNA (previously diluted 1:40 using 
RNase free H2O) was then added to each corresponding test well. Probes were 
obtained from the Roche Universal Probe Library, and primers were designed using 
the Roche UPL Design Centre (Roche; Burgess Hill, UK) using the species-specific 
gene and nucleotide sequence. Standard curves were conducted for each gene tested, 
starting at a 1:8 cDNA dilution with 7 further 1:2 dilutions. RNase free H2O was also 
tested as a negative control. Samples were analysed using a Roche LightCycler 480 
and corresponding software, and by comparing the unknown samples with standard 
curves for each set of primers. Results from housekeeping genes (GAPDH, β-actin) 
were used to normalise the data and show changes in the test genes (t-PA, PAI-1). 
 




Table 2.1 - Reverse Transcription Polymerase Chain Reaction Primers.  
RT-PCR primer sequences and band sizes for endothelial tyrosine kinase receptor (Tie2), tissue 
plasminogen activator (t-PA), plasminogen activator inhibitor (PAI-1) and Glyceraldehyde 3-
phosphate dehydrogenase (GAPDH). 
 
 Forward Primer  Reverse Primer  Band Size 
Tie2 TCA CTC CAG TAT 
CAG CTC AAG GG 
CAG CTG GTT CTT 
CCC TCA CGT T 
300bp 
t-PA ATC TTT GCC AAG 
CAC AGG AGG TCG 
CTT CAG CCG CTC 
CGA ATA GAA AGG 
410bp 
PAI-1 AGC ACG GTC AAG 
CAA GTG GAC T 
GGC AGT TCC AGG 
ATG TCG TAG TAA 
325bp 
GAPDH CCA CCC ATG GCA 
AAT TCC ATG GCA 
TCT AGA CGG CAG 






Table 2.2 - Real Time Polymerase Chain Reaction Primers. 
Real-time PCR primer sequences for tissue plasminogen activator (t-PA), plasminogen activator 
inhibitor (PAI-1), Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and β Actin. 
 
 
 Forward Primer  Reverse Primer  
t-PA CGG GTG GAA TAT TGC 
TGC T 
CTT GGC TGG CTG CAA 
CTT 
PAI-1 CTC CTG GTT CTG CCC 
AAG T 
CAG GTT CTC TAG GGG 
CTT CC 
GAPDH GCT AGG GAC GGC CTG 
AAG 
GCC CAA TAC GCC AAA 
TCC 
β Actin CCA ACC GCG AGA AGA 
TGA 










2.8   Statistics 
 
Data are expressed as mean ± SEM. Results were analysed using GraphPad Prism 
software. Comparison of 2 groups was performed using an unpaired two-tailed t-test. 
Comparison of 3 or more groups was performed using a one-way ANOVA followed 
by a Tukey’s multiple comparison post-test. Comparison of 2 groups at 3 different 
time-points was achieved using a two-way ANOVA with a Bonferroni post-test. 
Significance was assumed when P<0.05. Non-statistically significant data trends 
were discussed when P<0.1 to allow consideration of experimental power. 
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3.1   Introduction 
 
Animal models are useful tools for improving our understanding of the regulation of 
arterial thrombosis in vivo. In order to assess the effects of diesel exhaust particulates 
(DEP) on thrombus formation in vivo, a suitable experimental model was required. 
None of the currently used experimental models were established in the department, 
so the introduction of a suitable model required method development. The model 
required for the following experiments would ideally replicate components of the 
clotting response in human atherothrombosis; for example, endothelial 
dysfunction/removal, arterial occlusion and arterial damage leading to the formation 
of a platelet-rich thrombus (Watson et al. 1985; Kurz et al. 1990; Denis et al. 1998; 
Farrehi et al. 1998; Furie & Furie. 2005). As discussed previously (see Chapter 
1.2.3.4), several models of arterial thrombosis have been developed. These are 
commonly based on the induction of injury to the artery wall followed by either 
measurement of blood flow or of thrombus development. The main differences 
between models are in the target blood vessel and in the techniques used to cause the 
initial injury and to measure clot formation. 
 
The Folts model of arterial thrombosis, which induces both endothelial damage and 
arterial stenosis in order to promote thrombus formation, is widely regarded as the 
pharmaceutical industry ‘gold standard’ technique. It was first developed in 
anaesthetised dogs, and has since been adapted for use in small animals such as mice 
(Sturgeon et al. 2006), rats (Daykin et al. 2006; Sturgeon et al. 2006) and rabbits 
(Marret et al. 2004; Sturgeon et al. 2006). The adapted Folts models induce 50% or 
60% stenosis of the carotid artery and this stenosed section is then injured 
mechanically (by repeated pinching with a pair of forceps). This injury causes de-
endothelialisation leading to occlusive thrombus formation. Embolisation of the 
thrombus re-opens the vessel and re-starts the clotting procedure (Sturgeon et al. 
2006; Daykin et al. 2006), and when repeated produces cyclic flow reductions 
(CFRs); the number of CFRs over a set period of time give a quantitative measure of 
thrombogenicity. 
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An alternative approach is to injure the endothelium by application of ferric chloride 
(FeCl3) to the adventitial surface of an artery damages (Kurz et al. 1990). This 
typically leads to complete vessel occlusion. Quantification is achieved by timing the 
period from application of FeCl3 to complete cessation of blood flow in the target 
artery. This model has also been widely used in small rodents and has the advantage 
of being relatively straightforward and reproducible. The third most commonly used 
technique for inducing thrombosis in rodent arteries induces injury by illumination of 
a photo-reactive substance (such as Rose Bengal) resulting in the local production of 
damaging reactive oxygen species. Formation of thrombus is then measured by 
reduction of blood flow as measured via flow probe. However, whilst the use of 
FeCl3 or photosensitive dyes induces thrombus formation through endothelial 
damage, they do not produce arterial stenosis. Whilst this could appear to be a 
shortcoming it should be noted that outward remodelling often occurs in 
atherosclerosis, preventing lumen narrowing (Jackson et al. 2007). 
 
In addition to induction of arterial thrombosis, alterations in thrombosis in rats and 
mice can be assessed by measuring tail tip bleeding time (Elg et al. 1998; Sato et al. 
1998; Tanaka et al. 1998; Wang & Xu. 2004; Daykin et al. 2006). Use of this model 
would help to distinguish the effects of DEP on haemostasis from the effects on 
platelet activation and aggregation, activation of the coagulation cascade and fibrin 
deposition. It is also a relatively straightforward model that could be performed in 
animals used for induction of arterial thrombosis. 
 
Experimental thrombosis has been induced both in arteries and in veins in rodents 
(Nemmar et al. 2002; Nemmar et al. 2003; Day et al. 2004; Rumbaut et al. 2005; 
Daykin et al. 2006) and DEP has been shown to increase thrombosis in both types of 
vessels (Nemmar et al. 2003). For the purposes of this thesis, however, arteries were 
studied, as the disease of interest, atherothrombosis, affects predominantly medium-
sized muscular arteries (Soldatos & Cooper. 2006). Studies in larger mammals (eg 
dogs) often target the coronary arteries (Folts et al. 1982), but those in small animals 
generally use the carotid artery. This is necessary due to the small size and difficult 
accessibility of the coronary artery in small animals, but it also produces more 
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reliable and reproducible results by avoiding the haemostatic disturbance associated 
with open-chest surgery. 
 
Finally, the choice of animal used in these experiments was taken into consideration. 
Both rats and mice have been used previously to study the effects of pollution 
(Yoshino et al. 1999; Ito et al. 2000; Hirano et al. 2003; Wold et al. 2006; Arimoto 
et al. 2007; Yokota et al. 2008; Nemmar et al. 2008; Jaspers et al. 2009; Nemmar et 
al. 2009). These animals can be easily exposed to DEP in a variety of ways, for 
example, intratracheal instillation, inhalation or intravenous injection (Nemmar et al 
2002: Nemmar et al. 2003; Nemmar et al. 2004; Yokota et al. 2005; Wold et al. 
2006; Nemmar et al. 2008). Mice are desirable because of the possible use of 
transgenics to clarify the mechanisms at work. However, their small size does 
present a problem for some of the previously described models, such as the FeCl3 
model (Kurz et al. 1990); in such cases rats are a useful alternative and have been 
used extensively to study the effects of pollution. 
 
 
3.1.1   Hypothesis 
 
The work described in this chapter addressed the hypothesis that it was possible to 
introduce a reproducible model of in vivo thrombus development in experimental 
animals, in order to study the effects of DEP. 
 
 
3.1.2   Aims 
 
The aims of the work described in this chapter were: 
i.  to introduce a suitable in vivo model of reproducible thrombosis 
ii.  to perform a pilot study to confirm that this model was suitable for testing the 
effects of diesel exhaust particulate on thrombus formation. 
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3.2   Methods 
3.2.1   Animals 
 
Male C57 Black 6 mice (aged 70-77 days) and male Wistar rats (100-125g) were 
obtained from Charles River Laboratories (Wilmington, MA, USA). All animals 
were housed for at least one week, with constant access to food and water and a 12 
hour light/dark cycle, before use in the following experiments. 
 
 
3.2.2   Development of Models of In Vivo Thrombosis 
3.2.2.1   The Folts Model of Arterial Thrombosis 
 
The Folts model of arterial thrombosis (Folts et al. 1982; Sturgeon et al. 2006) was 
attempted first in mice, and, subsequently, in rats. Animals were anaesthetised by 
inhalation of isoflurane (Merial. Essex, UK), body temperature was maintained at 
37°C using a heat blanket, and hair was shaved from the anterior surface of the neck 
prior to surgery. The left carotid artery was then isolated by blunt dissection and 
blood flow through the carotid artery was measured by placement of an ultrasonic 
flow probe (Transonic Systems Inc. Maastricht, Netherlands). Waxed 6-0 Dysilk 
thread (Dynek Pty Ltd. South Australia) was then tied around the carotid artery in 2 
places, roughly 5mm apart, distal to the flow probe. These ligatures were tightened to 
create a 50% reduction in blood flow (as measured by the flow probe). The area 
between the ligatures was then crushed with forceps to damage the endothelial layer. 
Crushing was carried out in sets of five pinches of the artery, with this protocol 
repeated up to five times, as required. When effective, this procedure should produce 
a blood clot in the affected area, which reduces blood flow to zero. After 20 seconds 
in mice, and 30 seconds in rats, the clot is embolised by pinching the vessel with 
forceps. This restores blood flow until a new clot begins to form. The repeated 
reductions in blood flow as new clots form are known as cyclic flow reductions 
(CFRs). The number of CFRs in a 30 minute period are then recorded. 
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3.2.2.2   Ferric Chloride-Mediated Induction of Thrombosis 
 
Induction of arterial thrombus by direct application of FeCl3 (Kurz et al. 1990) was 
attempted using male Wistar rats (body weight 175-275g). Rats were anaesthetised, 
the left carotid artery exposed and carotid artery flow measured by emplacement of a 
flow probe, as described for the Folts Model (Chapter 3.2.2.1). FeCl3 was applied 
topically to the carotid artery; this was achieved using a piece of plastic tubing (2mm 
internal diameter) approximately 3mm in length. The tubing was cut open and a strip 
of Whatman filter paper (No 5) was placed inside and folded to create a double layer. 
The tubing and filter paper were then dipped in FeCl3 solution (concentration range 
5-40%. BDH. Poole, UK) and placed around the carotid artery. Care was taken to 
ensure full contact between the filter paper and the artery wall. The FeCl3 solution 
was left in contact with the artery for 10 minutes before being carefully removed. 
Blood flow through the artery was recorded and timing was stopped when blood 
flow reached 0ml/min. Preliminary experiments were performed to determine the 
optimum concentration of FeCl3 for induction of thrombosis. All subsequent 
experiments were preformed using this concentration (20% w/v). 
 
 
3.2.2.3   Time to Arrest of Bleeding 
 
In all animals, the time to arrest of tail tip bleeding (Tanaka et al. 1998) was assessed 
once total occlusion of the carotid artery had been achieved. The tail tip (5mm) was 
removed using a scalpel and cleaned every 10 seconds using a swab (Medical Wire 
and Equipment Company). Arrest of bleeding was considered to be the time when no 
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3.2.3   Pilot Investigation into Effects of DEP on Thrombus Formation 
 
DEP solutions (1mg/ml) were prepared in sterile 0.9% saline and sonicated (Status 
Homogenisers. Probe from Philip Harris Scientific, US70; Lichfield, UK) at 70% 
power for 5 minutes. DEP working solutions were then prepared to a final volume of 
0.1ml with sterile 0.9% saline.  
 
Male Wistar rats (body weight 175-275g) were prepared for surgery as described 
above (Chapter 3.2.2.2) and the left carotid artery exposed. The left jugular vein was 
isolated by blunt dissection and cannulated to allow bolus injection of DEP solutions 
(0.1ml) or vehicle (0.1ml; 0.9% saline). The rat was maintained under anaesthesia for 
2 hours after injection. At the end of this period, FeCl3 (20%) was applied to the left 
carotid artery, as described (Chapter 3.2.2.2), to induce clot development, and time to 
occlusion was recorded. Once the carotid artery had occluded, time to arrest of 
bleeding was measured using the tail tip technique (Chapter 3.2.2.3). Initial 
investigations used a dose of 500μg/kg DEP (Nemmar at al, 2003). However, during 
these preliminary experiments the animals developed breathing difficulties and died 
approximately 1 hour after injection. The dose was then reduced to 250μg/kg DEP; 
animals receiving this dose survived the 2 hour exposure time before induction of 
thrombosis, and so this concentration was used for all further infusion experiments. 
 
 
3.2.4   Histology 
 
Carotid arteries were taken from experimental animals after induction of thrombosis 
using either the Folts model or FeCl3 application. Arteries were fixed in formalin for 
24 hours, before being dehydrated in ethanol, processed and embedded in paraffin 
blocks. Blocks were later sectioned (4mm) and stained using the standard 
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3.2.5   Statistics 
 
All data are expressed as mean ± SEM. The impact of exposure to DEP on FeCl3-
induced thrombosis and time to arrest of tail tip bleeding was assessed by comparing 
data from DEP- and vehicle-treated groups using an unpaired two-tailed t-test. 
 
 
3.3   Results 
3.3.1   Development of the Folts Model of Arterial Thrombosis 
 
Initial experiments encountered methodological difficulties in applying the Folts 
model to mice. Blood flow through the artery could be successfully measured, but 
the small size of the carotid arteries in mice meant that it was not possible to 
accurately reduce blood flow by 50% and crush injury did not produce an occlusive 
thrombus (animals used and experimental outcome outlined in Table 3.1). 
 
As a consequence of the problems experienced applying the Folts model to mice, rats 
were used in all subsequent experiments. Using rats, blood flow data logs taken 
during development of the Folts model confirmed that it was possible to reduce 
blood flow by approximately 50% by tightening the silk ligatures (Figure 3.1a). 
However, despite repeated attempts, mechanical damage to the exposed artery did 
not produce a completely occlusive thrombus that could then be embolised by 
agitating the artery (Figure 3.1b).  Sections of carotid arteries were taken from rats 
after the Folts model had been applied and stained with haematoxylin and eosin. 
Typically no thrombus would form during this experiment (Figure 3.2a). On only 
one occasion a completely occlusive thrombus did form (Figure 3.2b), but it was not 
possible to embolise this thrombus by agitating the artery. 
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Table 3.1 - Experimental Outcomes of Folts Model Experiments. 





Mouse 1 Sutures tightened (slip knot), blood flow reduced 
Mouse 2 Sutures tightened (slip knot), blood flow initially reduced but 
sutures worked loose, no thrombus formation 
Mouse 3 Sutures tightened (half hitch), 50% stenosis achieved, artery 
damaged by pinching, no thrombus formation. 
Rat 1 Sutures tightened (half hitch) and secured in place using bulldog 
clips, artery damaged by pinching, no thrombus formation. 
Rat 2 Sutures tightened (half hitch) and secured in place using bulldog 
clips, artery damaged by pinching, no thrombus formation. 
Rat 3 Sutures tightened (half hitch) and secured in place using bulldog 
clips, artery damaged by pinching, occlusive thrombus formation 
but thrombus could not be fully embolised. 
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Figure 3.1 - Blood Flow Traces from Folts Model Experiments. 
a) Blood flow trace showing successful reduction in blood flow (by 50%) in a rat carotid artery. b) 
Blood flow trace of a partially successful Folts model experiment in a rat; the beginning of the trace 
shows low blood flow due to pinching the artery to destroy the endothelium. Flow is then restored 
until an occlusive thrombus begins to form, reducing blood flow to almost zero. The artery was then 
agitated to embolise the thrombus. However blood flow was not restored to its original rate, despite 
repeated attempts. In both traces, time 0 indicated the beginning of the test and included initial set-up. 
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Figure 3.2 - H&E Staining of Carotid Arteries Following Application of the 
Folts Model. 
a) Uninjured section of rat carotid artery. b) Unsuccessful attempt at thrombus formation; vessel wall 
is damaged due to stenosis and repeated pinching. c) Fully occlusive thrombus that could not be 






    
a) 
 b)   c) 
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3.3.2   Development of the Ferric Chloride Model of Arterial Thrombosis 
 
Initial experiments were designed to determine the correct concentration of FeCl3 to 
use in future experiments. Previous studies had used concentrations ranging from 10-
70% (Denis et al. 1998; Kurz et al. 1990; Radomski et al. 2005; Wang & Xu; 2005). 
Initially a 40% solution of FeCl3 was used, but this caused complete vessel occlusion 
in approximately 2.5 minutes. It was felt that this was too short a time to accurately 
detect changes between experimental groups, so a 20% solution was tried (Figure 
3.3). This concentration typically produced complete vessel occlusion in 
approximately 15 minutes with a high degree of consistency (coefficient of variation 
= 0.167). It was decided that this concentration of ferric chloride would be used for 
all future experiments. 10% and 5% FeCl3 solutions were also examined, but these 
solutions failed to produce complete vessel occlusion within 1 hour (Results of 
preliminary experiments into FeCl3 concentration are shown in Table 3.2). Sections 
of carotid arteries exposed to FeCl3 were stained with haematoxylin and eosin 
(Figure 3.4). In these pictures the occlusive thrombus is clearly visible, along with a 
dark ring around the inside of the artery where the FeCl3 solution has collected and 
destroyed the endothelium. 
 
 
3.3.3   Pilot Investigation into Effects of DEP on Thrombus Formation 
 
The results of the pilot experiment showed that intravenous infusion of DEP 
(250μg/kg) significantly reduced the time to vessel occlusion following 
administration of 20% FeCl3 solution from 17.89±0.67mins (saline) to 
15.66±0.70mins (DEP. P=0.044; n=6. Figure 3.5a). This result was mirrored by a 
similar reduction in tail tip bleeding time following DEP administration from 
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Table 3.2 - Experimental Outcomes of Preliminary Experiments Investigating 
FeCl3 Concentration. 
Effects of FeCl3 concentration on thrombus formation. Where thrombus formation occurred, time to 
occlusion is plotted below in Figure 3.3. In experiments where thrombus formation did not occur, time 




FeCl3 Conc Clot Formation Time to Occlusion (min:sec) 
5% No - 
10% No - 
20% No - 
20% Yes 12:22 
20% Yes 10:40 
20% Yes 15:12 
20% Yes 17:02 
20% Yes 15:43 
20% Yes 16:55 
20% Yes 14:13 
20% Yes 14:41 
20% Yes 17:24 
20% Yes 10:31 
20% Yes 14.07 







Figure 3.3 - Time to Occlusion After Administration of 40% or 20% FeCl3 to 
Rat Carotid Arteries. 
Total vessel occlusion occurred in ~2.5min following administration of 40% FeCl3 (n=1). 
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Figure 3.4 - Thrombus Formation in Carotid Arteries Following Treatment 
with FeCl3. 
Carotid artery sections from adult male Wistar rats stained with haematoxylin and eosin. a) Uninjured 
section of carotid artery. b) Carotid artery exposed to 5% FeCl3 shows little sign of injury or thrombus 
formation. c) Carotid artery exposed to 20% FeCl3 shows a dark ring around the inside of the vessel 
wall where FeCl3 accumulates and destroys the endothelium, causing a fully occlusive thrombus to 
form within the vessel. d) Carotid artery exposed to 40% FeCl3 shows a fully occlusive thrombus and 
extensive damage to the endothelium. Magnification x100. 
 
 
    
 







 a) b) 
c) d) 
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Figure 3.5 - Pilot Investigation of the Effect of DEP Administration on 
Thrombus Formation. 
Intravenous administration of DEP (250μg/kg) to anaesthetised male Wistar rats 2 hours before 
application of FeCl3 (20%) significantly reduced a) time to occlusion in response to administration 
and b) time to arrest of tail tip bleeding. All experiments were conducted 2 hours after DEP exposure. 
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3.4   Discussion 
 
The aims of the work described in this chapter were: (1) to develop suitable in vivo 
models of thrombosis; and (2) to perform a pilot study to determine whether these 
models were suitable for assessing the effects of diesel exhaust particulate (DEP) on 
thrombus formation. Initial investigations failed to produce reproducible, occlusive 
thrombosis using the Folts model in rats or mice. In contrast, application of 20% 
ferric chloride (FeCl3) to the adventitial surface of the rat carotid artery consistently 
produced occlusive thrombus formation. Measurement of tail tip bleeding time 
provided a convenient and reproducible complementary measurement of clot 
formation in the same animals. Using these models, pilot investigations demonstrated 
that intravenous administration of DEP accelerated thrombosis; reducing both time to 
carotid artery occlusion and tail-tip bleeding time. These results indicate, therefore, 
that these methods are suitable for investigating the mechanisms underlying DEP-
induced changes in endogenous thrombotic pathways. 
 
Initial attempts to introduce an in vivo model of thrombosis focussed on the Folts 
model, as its combination of arterial stenosis and damage to the endothelium is 
considered a good representation of the processes contributing to coronary events in 
human atherothrombosis (Folts et al. 1982; Sturgeon et al. 2006). This model has 
been applied successfully to a variety of animals including: baboons (Wu et al. 
2002), dogs (Folts et al. 1991; Hasa et al. 2001), pigs (Folts et al. 1991), rabbits 
(Dellamonica et al. 2008; Charbonneau et al. 2007; Sturgeon et al. 2006) and, more 
recently, to rats (Sturgeon et al. 2006) and mice (Sturgeon et al. 2006). Therefore, 
introduction of the technique to our labs was considered a realistic undertaking. The 
original intention was to induce thrombus formation in mice, as this would allow 
subsequent studies to use relevant transgenic animals (for example, PAI-1 knockout 
mice: Liu et al. 2009) and models of disease (such as the atherosclerotic 
apolipoprotein E deficient mouse; Schafer et al. 2003). However, although carotid 
artery blood flow measurements were successfully obtained in these animals, 
consistent reduction of blood flow by 50% proved very difficult (due to the small 
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size of the vessels). It may be for this reason that physical injury to the mouse carotid 
artery did not cause the generation of occlusive thrombus. Previous reports suggested 
that mice may be more resistant than rats or rabbits to induction of thrombosis using 
the Folts method (Sturgeon et al., 2006). Therefore, application of this technique was 
switched to the rat, in the hope that this would prove more reliable and reproducible 
and, given the size difference, technically less demanding. In rats it was possible to 
reduce blood flow by 50% through arterial stenosis, but when the artery was pinched 
to damage the endothelial layer the ligature had a tendency to loosen and allow 
normal blood flow to resume. Even in rats, formation of an occlusive thrombus was 
infrequent (occurring on only one occasion), and in this case the thrombus produced 
was so dense that it could not be fully embolised by agitating the artery. 
Communication with the Sturgeon group in Australia prompted the use of several 
methodological variations in an attempt to induce consistent thrombus formation. 
These included the use of Dysilk thread from South Australia as it was suggested that 
this would produce a more stable knot than standard suture silk. Despite these 
changes, no improvement in the development of thrombus was seen and further 
discussions with groups experienced with the Folts model led us to conclude that an 
alternative, more practical and reliable model of arterial thrombosis should be 
considered. 
 
The application of FeCl3 to the adventitial surface of the artery seemed an ideal 
alternative model. This approach is among the most common methods of inducing 
thrombus formation and has been applied to both large and small vessels (Denis et 
al. 1998; Farrehi et al. 1998). Following the earlier problems encountered applying 
the Folts model to mice, it was decided that rats would be used in these experiments. 
This model induces the formation of reactive oxygen species that cause local 
endothelial denudation, resulting in the formation of a platelet-rich thrombus, which 
is relevant to human atherosclerosis (Farrehi et al. 1998; Kurz et al. 1990; Denis & 
Wagner. 2007). Preliminary work showed that, as expected, exposure of the rat 
carotid artery to FeCl3 produced occlusive thrombus formation that was 
concentration dependent and very reliable. Previous studies have used this model, 
with FeCl3 concentrations ranging from 10-70% (Denis et al. 1998; Kurz et al. 1990; 
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Radomski et al. 2005; Wang & Xu. 2005), and so preliminary experiments were 
designed to find a suitable concentration; 20% FeCl3 was used for subsequent 
experiments as it produced complete vessel occlusion in approximately 15 minutes 
with a high degree of consistency. Use of this concentration is not consistent with 
previous studies; two of which used mice as the experimental animal (Denis et al. 
1998; Wang & Xu. 2005), which need a lower FeCl3 concentration to produce 
occlusive thrombus formation than rats. The studies that used rats as the 
experimental animal used much higher FeCl3 concentrations, such as 35% and 70% 
w/v (Kurz et al. 1990; Radomski et al. 2005). However the animals used in these 
studies were much older and larger (up to 450g) than the animals used in this thesis. 
In the study by Kurz et al. (1990), the application of 35% FeCl3 appeared to cause 
total vessel occlusion in roughly the same time period with similar data consistency 
experienced with 20% FeCl3 in this thesis. The result of 20% FeCl3 application in 
this chapter showed that time to vessel occlusion was very consistent and reliable 
(coefficient of variation = 0.167). To summarise, the FeCl3 model is a simple, 
inexpensive and reliable method of inducing thrombus formation. The only 
disadvantages to be considered are the so-called ‘outside-inside’ nature of the 
vascular injury, and the fact that the precise mechanism by which FeCl3 triggers 
thrombosis is not well defined, or fully explained by simple endothelial denudation 
(Day et al. 2004). However, in this case the advantages of the model far outweigh the 
disadvantages. 
 
The FeCl3 technique is a model of platelet rich thrombus formation (as is the Folts 
model). It has been used previously to assess the effects of anti-platelet agents (Elg et 
al. 1999; Wang & Xu. 2004; Radomski et al. 2005) and bleeding disorders (Denis et 
al. 1998). Denis et al. (1998) showed that genetically-altered mice lacking von 
Willebrand factor rarely developed complete vessel occlusion following exposure to 
FeCl3. These animals showed defects in platelet accumulation and significant 
impairment of platelet-vessel wall interaction, which lead to defective thrombus 
formation. The fibrinolytic system, particularly fibrinogen, also appears to play a role 
in this model. Ni et al. (2000) used fibrinogen-null mice to show that, while platelet 
deposition and onset of thrombus formation were the same as that of wild type mice, 
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the thrombi formed were unstable and generally embolised before complete vessel 
occlusion occurred. This suggests that both platelet function and the fibrinolytic 
system are essential for thrombus formation using this model, and therefore may 
provide a mechanism by which DEP accelerates thrombus formation. This 
mechanism requires further investigation, which will be discussed in the next 
chapter. 
 
The tail tip method was also investigated in this chapter to be used alongside the 
FeCl3 method. It is a straightforward technique that is easy to apply to animals 
undergoing the FeCl3 technique. When used in these preliminary studies, this 
technique mirrored the results found following FeCl3 application. However, previous 
studies investigating the effects of anti-coagulant and anti-platelet drugs have 
suggested that the tail tip technique shows different results than those found with the 
FeCl3 technique (Elg et al. 1998; Wang & Xu. 2004). This suggests that the tail tip 
method may provide a different insight into the effects of DEP than the FeCl3 
method. This would help to differentiate the effects of DEP on haemostasis from the 
effects on platelet activation and aggregation, activation of the coagulation cascade 
and fibrin deposition. 
 
Having established reliable, reproducible models of thrombus formation in vivo, it 
was important to determine whether they were able to detect the effects of DEP on 
this process. Consequently, a pilot study was performed based on previous work 
performed in a model of thrombus formation in the hamster (Nemmar et al. 2002; 
Nemmar et al. 2003). Initially, 500μg/kg DEP were administered intravenously to 
rats, based on the work of Nemmar and colleagues (Nemmar et al. 2002; Nemmar et 
al. 2003). A high DEP dose was chosen deliberately to ensure a maximal effect on 
thrombus formation. The finding that rats exposed to this dose only survived ~1 hour 
(before dying of apparent respiratory failure) was unexpected as the previous study 
had reported no such complications. Reduction of the DEP dose to 250μg/kg ensured 
that all rats survived the 2 hour experimental time point with no signs of respiratory 
distress. The method of administration, jugular vein injection, was also based on 
previous work (Nemmar et al. 2002). It appeared to be a suitable method, as the 
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experimental animal could be maintained under anaesthesia throughout the 
experiment, although using this method it would be very difficult to examine later 
timepoints in future experiments. Examinations of thrombogenesis 2 hours after 
administration of DEP was based on both previous studies (Vincent et al. 2001; 
Khandoga et al. 2004; Mills et al 2005), and work from our own group, and should 
allow differences in thrombus formation to be detected without significant effects on 
inflammation. Furthermore, this short exposure also had practical benefits, as it 
would not have been desirable to maintain the animals under anaesthesia for a longer 
period. 
 
The results obtained with these pilot experiments showed that intravenous 
administration of DEP significantly reduced time to vessel occlusion. This is 
consistent with previous work investigating the effects of injected polystyrene 
nanoparticles on thrombus formation (Nemmar et al. 2002). This route of 
administration has not been previously conducted with combustion-derived particles 
to investigate thrombus formation, although it has been used to show that DEP can 
cause systemic inflammation and both pulmonary and cardiac morphological 
alterations in rats at later time points (Nemmar et al. 2007). Carbon nanotubes 
(Bihari et al. 2009; Radomski et al. 2005), nanoparticulate titanium dioxide (Chen et 
al. 2009) and engineered quantum dots (Geys et al. 2008) have been shown to 
activate platelets and accelerate thrombus formation via intraperitoneal injection. 
Measurement of tail tip bleeding time produced results broadly consistent with those 
obtained from the application of FeCl3 with a significant reduction in bleeding time 
following DEP injection. A similar reduction in bleeding time has been reported 
previously using the same method of DEP administration (Nemmar et al. 2007), 
which suggests that this is a useful additional technique in the investigation of the 
effects of DEP on thrombus formation. 
 
Thus, in conclusion, the work reported in this chapter has led to the successful 
introduction of two reliable and reproducible models of thrombus formation in vivo. 
Both models were found to be sensitive to the administration of DEP, indicating that 
they were suitable for investigating the mechanisms responsible for enhanced 
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thrombogenesis following exposure to combustion derived diesel particles. This 
work, therefore, paved the way for more detailed mechanistic investigations, detailed 
in chapter 4, aimed at determining the importance of direct interaction with the 
vascular wall and (systemic and pulmonary) inflammation in mediating the pro-
thrombotic effects of DEP. 












Effects of Diesel Exhaust Particulate on Thrombus 
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4.1   Introduction 
 
Method development and pilot investigations (Chapter 3) confirmed the ferric 
chloride (FeCl3) and tail tip models could be used to successfully detect changes in 
thrombus formation following exposure to diesel exhaust particulate (DEP). The 
work described in this chapter was designed to clarify the mechanisms through 
which DEP enhance thrombus formation. 
 
Previous studies have also shown that DEP have an effect on increasing thrombus 
formation, by affecting expression of factors that enhance, or inhibit the breakdown 
of thrombi; this has been shown in both pre-clinical and clinical studies (Nemmar et 
al. 2002; Nemmar et al. 2003; Mills et al. 2007; Lucking et al. 2008). The exact 
mechanism behind this effect, however, remains unclear. The effects of DEP may be 
due to direct interaction with the cardiovascular system, following translocation from 
the lungs (Nemmar et al. 2004), or secondary to pulmonary (Ito et al. 2000; Nemmar 
et al. 2003; Singh et al. 2004; Ahn et al. 2008; Yokota et al. 2008) and/or systemic 
(Salvi et al. 1999; Yokota et al. 2005; Tornqvist et al. 2007; Mills et al. 2008; 
Nemmar et al. 2008; Nemmar et al. 2009) inflammation caused by a spill-over of 
inflammatory mediators from the lung into the circulation. The pathways via which 
DEP has already been shown to cause changes in thrombus formation are alterations 
in platelet activity (Lucking et al. 2008) and impairment of the endogenous 
fibrinolytic system (Mills et al. 2005; Mills et al. 2007), although changes in 
fibrinogen and coagulation factors are also possible. 
 
In order to address these questions it was necessary to administer DEP both via the 
lungs and directly into the bloodstream. Administration to the lungs is the most 
relevant exposure route to air pollution experienced by humans. In practice 
pulmonary administration can be achieved either by inhalation of a DEP aerosol or 
by intrapulmonary instillation of a particulate suspension. Superficially, inhalation 
appears to be the best method to adopt and, indeed, it has been used many times in 
the study of DEP on the cardiovascular system (Vallyathan et al. 1986; Lewis et al. 
1986; Vincent et al. 2001; Campen et al. 2003; Furuyama et al. 2006; Wold et al. 
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2006; Simkhovich et al. 2007; Cherng et al. 2009). There is some concern, however, 
that this may be problematic in rodents. A previous study using rats indicated that 
only a small percentage of inhaled DEP actually reached the lungs (Chan et al. 1981; 
Duffin et al. Unpublished observations). This is most likely due to the complex nasal 
structure in these animals, which can filter out a large component of the particulate 
before it reaches the lungs. Animals exposed to whole cage exposure to aerosols can 
also experience particle deposition on their coats, or ingestion, rather than inhalation, 
of particles, making the exact exposure difficult to calculate. In contrast, 
intrapulmonary instillation has the advantage of ensuring administration of a well-
defined particulate dose directly into the lungs (Nemmar et al. 2002; Nemmar et al. 
2003; Nemmar et al. 2004; McQueen et al. 2007), as well as allowing delivery of 
different particle types that are practically difficult to deliver by inhalation. By 
comparison with intrapulmonary exposure, direct administration of particulate 
solutions to the bloodstream is relatively straightforward. Particle suspensions have 
been administered directly by intravenous injection in a number of previous animal 
studies (Nemmar et al. 2002a; Radomski et al. 2005; Geys et al. 2008; Nemmar et 
al. 2009). These studies show that injection of nanoparticles can cause systemic and 
pulmonary inflammation, increased thrombogenicity via platelet activation and 
possible involvement of the coagulation cascade. However, only the study by 
Nemmar et al. (2009) investigated the effects of DEP, and in this study 
spontaneously hypertensive rats were used instead of healthy animals. This study 
will significantly enhance the field by investigating multiple effects of DEP, and 
control particles, on healthy animals. Comparing the responses to intravenous and 
intratracheal administration should also clarify the contributions of direct interaction 
with the cardiovascular system and pulmonary activation to DEP-mediated increases 
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4.1.1   Hypothesis 
 
Exposure of rats to diesel exhaust particulate (DEP) will increase thrombogenesis, 
independent of pulmonary or systemic inflammation, possibly through changes in 
platelet function and/or the endogenous fibrinolytic system. 
 
 
4.1.2   Aims 
 
The aims of the work described in this chapter were to determine whether: 
i. exposure to DEP increases thrombus formation in complementary 
experimental models. 
ii. the ability of DEP to enhance thrombogenicity is influenced by the route of 
exposure. 
iii. enhanced thrombogenesis in response to DEP administration is secondary to 
systemic or pulmonary inflammation. 
iv. enhanced thrombogenesis in response to DEP administration is due to 
changes in platelet activity or in the endogenous fibrinolytic system. 
v. the effects of DEP on inflammation and thrombogenicity are mirrored by the 
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4.2   Methods 
4.2.1   Animals 
 
Adult male Wistar rats (100-125g) were obtained from Charles River Laboratories 
(Wilmington, MA, USA). All animals were housed for at least one week, with 




4.2.2   Preparation and Administration of Particulate Suspensions 
4.2.2.1   Preparation of Particulate Suspensions 
 
DEP and carbon black (CB) solutions (1mg/ml) and quartz (DQ12) solution 
(0.25mg/ml) were prepared in sterile 0.9% saline solution by sonication (Status 
Homogenisers; Probe from Philip Harris Scientific, US70; Lichfield, UK) at 70% 
power for 5 minutes.  
 
 
4.2.2.2   Pulmonary Instillation of Particulates 
 
Intratracheal instillation was performed by Dr Rodger Duffin, as described 
previously (McQueen et al. 2007). Rats were anaesthetised briefly using isoflurane 
(Merial, Essex, UK) and an equivalent volume of DEP (0.5ml of a 1mg/ml 
suspension) or 0.9% sterile saline (0.5ml) was applied directly into the trachea. 
Animals were allowed to recover from the anaesthetic and housed for 2, 6 or 24 
hours before being assessed for thrombus formation and markers of inflammation. 
This range of timepoints allows examination of immediate and longer-lasting effects. 
CB (0.5ml of a 1mg/ml solution) was administered to examine the results of clean 
carbon nanoparticles in order to determine the DEP specific effects that may be a 
result of the volatiles, metals and organic compounds associated with the surface of 
DEP. DQ12 solutions (0.5ml of a 0.25mg/ml solution) were administered to examine 
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the results of large non-carbon particles that cannot translocate into the systemic 
circulation. These control particles were examined 6 hours after administration. 
 
 
4.2.2.3   Intravenous Administration of Particulates 
 
Intravenous administration of experimental solutions and saline was achieved by tail 
vein injection in rats briefly anaesthetised with inhaled isoflurane. Rats were 
weighed and received either DEP (0.5mg/kg in 0.2ml saline) or sterile saline (0.2ml). 
This concentration was chosen based on previous injection experiments in mice 
(Yoshino et al. 1999). Animals were allowed to recover from the procedure for 2, 6 
or 24 hours before being anaesthetised and assessed for thrombus formation and 
markers of inflammation. CB (0.5mg/kg in 0.2ml saline) was administered and the 
effects examined 2 hours after tail vein injection. DQ12 was not examined in the tail 
vein injection experiments, as this large particle would not be able to translocate 
from the lungs into the bloodstream. 
 
 
4.2.3   Assessment of Clotting Time 
4.2.3.1   Ferric Chloride-Mediated Induction of Thrombosis 
 
Induction of arterial thrombus by direct application of ferric chloride was performed 
as described (Chapter 2.3.3.1). Briefly, 20% FeCl3 was applied topically to the 
carotid artery for 10 minutes before being carefully removed. Blood flow through the 
artery was recorded, with timing started from the application of FeCl3 and stopped 
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4.2.3.2   Time to Arrest of Bleeding 
 
In all animals, the time to arrest of tail tip bleeding (Tanaka et al. 1998) was assessed 
by removing the tail tip (5mm) with a scalpel and cleaning the wound every 10 
seconds until no blood was transferred from the tail to the swab (Chapter 2.3.3.2).  
 
 
4.2.3   Impact of Particulate Administration on Pulmonary Inflammation 
4.2.3.1   Collection and Processing of Bronchoalveolar Lavage Fluid 
 
After rats had been killed by exanguination, the lungs were cannulated and lavaged 
with 1 × 8ml of sterile saline. This first lavage was retained for cellular analysis of 
the bronchoalveolar lavage (BAL) fluid profile. The lungs were then lavaged a 
further 3 times with 8ml sterile saline and the BAL fluid from these lavages was 
combined. All samples were centrifuged at 180g for 5 mins at 4°C. The supernatant 
from the first lavage was separated into 1ml aliquots and stored at -80°C for further 
analysis. The supernatant from the 2nd-4th lavages was removed and discarded, and 
the cell pellet was resuspended in 1ml sterile saline and added to the cell pellet from 
the first lavage. 
 
 
4.2.3.2   Pulmonary Cell Count Following Particulate Administration 
 
The resuspended cell pellets were analysed using an automatic cell counter 
(ChemoMetec A/S. Denmark). Briefly, 50μl of the cell suspension was added to 50μl 
lysis reagent A-100 and 50μl stabilizing reagent B (ChemoMetec A/S. Denmark). 
The solution was then loaded into a Nucleocassette (ChemoMetec A/S. Denmark) for 
the cell count. Where the initial cell count was too high to give an accurate reading, 
the cell suspension was diluted 1 in 10 using sterile saline and analysed again. The 
number of cells counted using the automatic cell counter was then multiplied by the 
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dilution factor to give the total number of cells recovered from the bronchoalveolar 
lavage. 
4.2.3.3   Differential Cell Counts Following Particulate Administration 
 
Cytocentrifuge smears were prepared by adding 1 × 106 cells from the previous cell 
suspension to 300μl saline + 0.1% bovine serum albumen (BSA). Samples were 
centrifuged (300g, 3 mins, room temperature) onto a microscope slide (Superfrost 
Plus, 75mm x 25mm. VWR International Ltd. Leicestershire, UK), and stained with 
Diff-Quick (Raymond A Lamb. London, UK). 300 cells per slide were counted at 
random and the results expressed as total numbers of each cell type in the lung 
lavage by referring back to the original cell count. 
 
 
4.2.3.4   Effects of Particulates on Pulmonary Cytotoxicity 
 
The cytotoxic effects of DEP, CB and DQ12 on cytotoxicity and pulmonary exudate 
were assessed using a cytotoxicity detection kit (LDH. Roche Diagnostics Ltd, 
Burgess Hill, UK) on BAL fluid samples. Briefly, 100μl of BAL fluid sample was 
added to 100μl working solution in a 96-well plate. Positive control wells also 
received 5μl lysis solution, while negative control well received deionised water 
instead of the cell suspension. The plate was read at 490nm with a 630nm reference 
filter, and LDH levels were calculated as a percentage value of the difference 
between the maximum and minimum control. 
 
 
4.2.3.5   Effects of Particulates on Pulmonary Protein Levels 
 
Total protein content in BAL fluid was measured using a bicinchoninic acid (BCA) 
protein assay (Thermo Scientific. Northumberland, UK). Briefly, 10μl of sample 
BAL fluid and BSA standards from 0.025 to 2mg/ml were added to a 96-well plate. 
A 1:50 solution of copper (ΙΙ) sulphate and bicinchoninic acid was made and 190μl 
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of the working solution was added to each well. The plate was incubated (37°C, 30 
mins), then read using a plate reader at 570nm. The known standard concentrations 
(0.125-2mg/ml) were used to calculate sample protein concentrations. 
 
 
4.2.4   Impact of Particulate Administration on Platelet-Monocyte Interactions 
4.2.4.1   Collection of Blood and Plasma 
 
Blood was collected from the abdominal aorta and mixed (10:1) with 3.8% sodium 
citrate solution. Fresh whole blood was used immediately for flow cytometry 
experiments. Whole blood was centrifuged at 1500g for 5 mins to obtain plasma, 
which was separated into 0.5ml aliquots and stored at -80°C until further analysis. 
 
 
4.2.4.2   Flow Cytometry 
 
In order to characterise platelet-monocyte and platelet-platelet aggregation following 
exposure to particulates, flow cytometric analysis of whole blood was carried out to 
measure the percentage of cells positive for platelet and monocyte cell surface 
markers. Fluorescent-conjugated antibodies (BD Biosciences; Oxford, UK) can be 
used to detect specific cell surface markers; fluorescein isothiocyanate (FITC)-
labelled anti-rat CD42d antibody was used to label platelets, phycoerythrin (PE)-
labeled hamster anti-mouse CD61 was used to label monocytes and PE-labeled 
hamster IgG1κ was used as a negative isotype control. Whole blood (30μl) was 
added to 30μl of diluted antibody (CD42d - 1/100 dilution in PBS, CD61 and isotype 
control 1/50 dilution in PBS. Dilutions were based on antibody concentrations and 
preliminary experiments), or 15μl of each antibody when double labelling was 
performed. Samples were incubated at room temperature in the dark for 20 minutes 
before the addition of 500μl 1x FACS lysing solution (BD Biosciences; Oxford, 
UK). They were then incubated for a further 10 minutes before being analysed via 
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flow cytometry (BD FACscan flow cytometer using CellQuest software and FlowJo 
software for analysis). 
 
4.2.5   Analysis of Inflammatory Markers by ELISA 
 
In order to determine whether administration of particulate solutions caused systemic 
or pulmonary inflammation, plasma (collected as described in Chapter 4.2.4.1) and 
BAL (collected as described in Chapter 4.2.3.1) fluid samples were assessed for 
levels of interleukin 6 (IL-6. DuoSet ELISA Rat IL-6 kit), C reactive protein (CRP. 
DuoSet ELISA Rat CRP kit) and tumour necrosis factor alpha (TNFα. DuoSet 
ELISA Rat TNFα kit). Due to problems with these assays in rat plasma, both DuoSet 
and Quantikine ELISA kits were examined for IL-6 and TNFα levels in plasma (all 
kits from R&D Systems. Abingdon, UK). However, these kits were also 
unsuccessful; only CRP could be reliably measured in plasma (See Results and 
Chapter 2.5 and 2.6 for full details).  
  
 
4.2.6   Analysis of the Thrombolytic System by ELISA 
 
In order to determine whether administration of particulate solutions altered 
endogenous fibrinolysis, plasma samples were assessed for levels of tissue 
plasminogen activator (t-PA), plasminogen activator inhibitor (PAI-1), fibrinogen 
and D dimer. Rat t-PA antigen, rat PAI-1 antigen and rat fibrinogen antigen ELISAs 
were obtained from Patricell Ltd. (Nottingham, UK. See Chapter 2.5.2). D dimer 
ELISAs were performed by Pamela Dawson (Haematology department; Royal 
Infirmary of Edinburgh). 
 
 
4.2.7   Histological Assessment of Thrombus and Particle Translocation 
 
Following surgery, both carotid arteries, a section of aorta, one whole kidney and a 
section of liver were removed and fixed in neutral buffered formalin for 24 hours 
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before being processed and embedded in paraffin wax for histological analysis. 
Serial sections (4μm) were cut using a microtome and the sections were stained 
using the haemotoxilin and eosin method. Samples were then cover slipped and 
photographed at 1000x magnification, and compared with lung sections taken 2 
hours after DEP instillation for visualisation of DEP. 
 
 
4.2.8   Statistics 
 
Data are expressed as mean ± SEM. Results were analysed using GraphPad Prism 
software. Comparison of 2 groups was performed using an unpaired two-tailed t-test. 
Comparison of 3 or more groups was performed using a one-way ANOVA followed 
by a Tukey’s multiple comparison post-test. Comparison of 2 groups at 3 different 
time-points was achieved using a two-way ANOVA with a Bonferroni post-test. 
Significance was assumed when P<0.05. 
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4.3   Results 
4.3.1   DEP Administration Accelerates Thrombosis 
4.3.1.1   Effects of Particulate Instillation on Thrombus Formation 
 
In rats exposed to intratracheal instillation of vehicle (saline), the time to complete 
thrombotic occlusion of the carotid artery (Figure 4.1) was slightly faster (~13mins) 
than vehicle-treated (~17mins) rats tested during the pilot investigations (Chapter 
3.3.3). However, the response of vehicle-treated animals appeared to be relatively 
consistent at the different timepoints examined in this study. Instillation of DEP 
produced an apparent reduction in the time to occlusion 2, 6 and 24 hours after 
administration (Figure 4.1a). This effect only achieved significance, however, 6 
hours after administration (P<0.05). Both CB and DQ12 also produce an apparent 
reduction in time to occlusion 6 hours after administration, but this did not achieve 
statistical significance (Figure 4.1c). 
 
Time to arrest of tail tip bleeding (~13min) in vehicle-treated rats (Figure 4.1b & 
4.1d) was also slightly faster than that observed for controls (~15min) during the 
model development (Chapter 3.3.3), with the exception of the vehicle-treated group 
24 hours after instillation (~16min). In contrast to the changes seen in carotid artery 
thrombosis, intratracheal instillation of DEP had no effect on time to arrest of 
bleeding at any of the time-points studied (Figure 4.1b). Similarly, exposure to CB or 
DQ12 did not alter time to arrest of bleeding when studied 6 hours after 





Chapter 4 - Effects of Diesel Exhaust Particulate on Thrombus Formation In Vivo 
 
 106
Figure 4.1 - Effects of Particle Instillation on Thrombus Formation In Vivo. 
a) Time to carotid artery occlusion following ferric chloride (FeCl3) application 2, 6 and 24 hours after 
instillation of saline (Blue columns) or diesel exhaust particulate (DEP - 0.5mg: Red columns). 
Results suggest a reduction in time to occlusion following DEP instillation at all 3 timepoints, 
however, significance was only achieved at the 6hr timepoint (P<0.05). b) Time to carotid artery 
occlusion following FeCl3 application 6 hours after instillation of saline, carbon black (CB - 0.5mg: 
Green columns) or quartz (DQ12 - 0.125mg: Purple columns). c) Time to arrest of bleeding following 
tail tip removal. Results show no significant differences between saline and DEP (0.5mg) at any of the 
3 timepoints. d) Time to arrest of bleeding following tail tip removal. Results show no significant 
differences between saline, CB (0.5mg) and DQ12 (0.125mg) at the 6 hour timepoint. Columns 
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4.3.1.2   Effects of Particulate Tail Vein Injection on Thrombus Formation 
 
In rats exposed to intravenous injection of vehicle (saline), the time to complete 
thrombotic occlusion of the carotid artery (Figure 4.1) was slightly faster (~14mins) 
than vehicle-treated (~17mins) rats tested during the pilot investigations (Chapter 
3.3.3). However, the response of vehicle-treated animals appeared to be relatively 
consistent at the different timepoints examined in this study. Intravenous injection of 
DEP significantly reduced time to occlusion 2 hours after administration (Figure 
4.2a). This effect was not observed 6 and 24 hours after administration. CB also 
significantly reduced time to occlusion 2 hours after administration when compared 
with saline (P=0.0293; Figure 4.2c). 
 
Time to arrest of tail tip bleeding (~13min) in vehicle-treated rats (Figure 4.2b & 
4.1d) was also slightly faster than that observed for controls (~15min) during the 
model development (Chapter 3.3.3). In contrast to the changes seen in carotid artery 
thrombosis, intravenous injection of DEP had no effect on time to arrest of bleeding 
at any of the time-points studied (Figure 4.1b). Similarly, exposure to CB 2 hours 
after injection did not alter time to arrest of bleeding (Figure 4.2d). 
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Figure 4.2 - Effects of Particle Injection on Thrombus Formation In Vivo. 
a) Time to carotid artery occlusion 2, 6 and 24hrs following ferric chloride (FeCl3) application after 
tail vein injection of saline (Blue columns) or diesel exhaust particulate (DEP - 0.5mg/kg: Red 
columns). Results show a significant reduction in time to occlusion following DEP injection at the 2 
hour timepoint (P<0.001). b) Time to carotid artery occlusion following FeCl3 application 2 hours 
after tail vein injection of saline or carbon black (CB - 0.5mg/kg: Green columns). Results show a 
significant reduction in time to occlusion following CB injection (P=0.0293). c) Time to arrest of 
bleeding following tail tip removal. Results show no significant differences between saline and DEP 
at any of the 3 timepoints. d) Time to arrest of bleeding following tail tip removal. Results show no 
significant differences between saline and CB at the 2 hour timepoint. Columns represent mean ± 
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4.3.2   Effects of Particulate Administration on Pulmonary Inflammatory Cell Count 
4.3.2.1   Effects of Particulate Instillation on Pulmonary Cell Count and Cell 
Differential 
 
Cytospins of cells taken from BAL fluid show the infiltration of neutrophils 
following instillation of DEP, CB and DQ12 (Figure 4.3). These pictures also show 
DEP and CB particle accumulation in, or on the surface of, macrophages. 
 
Instillation of DEP (P<0.001; Figure 4.4a) or either control particle (CB; P<0.05 or 
DQ12; P<0.05: Figure 4.4b) produced a significant increase, compared with saline-
treated controls, in the total number of cells counted in BAL fluid 6 hours after intra-
tracheal administration. In contrast, there were no increases (compared with control) 
in cell count in BAL samples 2 or 24 hours after administration of DEP. Differential 
analysis indicated that the particle-induced increase in cell numbers 6 hours after 
administration was due to an increase (P<0.001) in the number of neutrophils (Figure 
4.4d), rather than macrophages (P>0.05. Figure 4.4c) or other cell types (data not 
shown). The percentage of pulmonary cells identified as neutrophils rose from 6.2% 
in animals instilled with saline, to 67.5% due to DEP, 6 hours after instillation. 
Intriguingly, the number of neutrophils remained slightly elevated (P<0.05) 24 hours 
after treatment with DEP, despite the total cell count decreasing to levels similar to 
controls. The increased cell count in CB- and quartz-treated rats was also produced 
largely by an increase in the number of neutrophils in each sample (Figure 4.4e). 
Again there were no significant changes in the number of macrophages (Figure 4.4e) 
or other cell types (data not shown) in this experiment. The percentage of pulmonary 
cells identified as neutrophils rose from 6.0% in animals instilled with saline, to 




Chapter 4 - Effects of Diesel Exhaust Particulate on Thrombus Formation In Vivo 
 
 110
Figure 4.3 - Cytospins Showing Pulmonary Inflammatory Cell Infiltration 
Following Particle Instillation. 
Cells recovered from bronchoalveolar lavage samples and stained using haematoxylin and eosin. a) 2 
hour instillation with saline shows macrophages only (large circular cells, single-lobed nucleus. 
Identified by arrow). b) 2 hour instillation with 0.5mg diesel exhaust particulate (DEP) shows mostly 
macrophages with some neutrophil infiltration (smaller cells, multi-lobed nucleus. Identified by 
arrow). DEP uptake by, or adhesion to, macrophages can also be seen. c) 6 hours after instillation with 
saline shows macrophages only. d) 6 hour instillation with 0.5mg DEP shows extensive neutrophil 
infiltration. DEP uptake by macrophages can also be seen. e) 6 hours after instillation with 0.5mg 
carbon black (CB) shows extensive neutrophil infiltration. CB uptake by macrophages can also be 
seen. f) 6 hour instillation with 0.125mg quartz (DQ12) shows extensive neutrophil infiltration. DQ12 
particles are not visible. g) 24 hour instillation with saline shows macrophages only. h) 24 hour 
instillation with 0.5mg DEP shows mostly macrophages with some neutrophil infiltration. DEP uptake 
by macrophages can also been seen. Magnification x400. Pictures taken are of cells at the same 
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Figure 4.4 - Pulmonary Cell Count and Cell Differentials Following Particle 
Instillation In Vivo. 
a) Total cell count of BAL samples 2, 6 and 24 hours after instillation of saline (Blue columns) or 
diesel exhaust particulate (DEP - 0.5mg; Red columns). Results show a significant increase in the 
number of cells counted 6 hours after DEP instillation compared with saline (P<0.001). b) Total cell 
count results show a significant increase in the number of cells counted 6 hours after carbon black 
(CB - 0.5mg; Green columns. P<0.05) or quartz (DQ12 - 0.125mg; Purple columns P<0.05) 
instillation when compared with saline. c) Cell differential analysis shows show no significant 
changes in the number of macrophages recovered from BAL samples 2, 6 and 24 hours after 
instillation of saline or DEP. d) Cell differential shows significant increases in the number of 
neutrophils recovered following instillation of DEP when compared with saline at the 6 hour 
(P<0.001) and 24 hour time-points (P<0.05). e) Cell differential analysis shows significant differences 
in the number of macrophages or other cells between any of the 3 groups. However there was a 
significant increase in the number of neutrophils recovered following both CB (P<0.001) and DQ12 
(P<0.001) instillation when compared with saline. Columns represent mean ± SEM (n=6 for all 
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4.3.2.1   Effects of Particle Tail Vein Injection on Pulmonary Cell Count and Cell 
Differential 
 
Cytospins of cells taken from BAL fluid show no neutrophil infiltration following 
injection of DEP or CB (Figure 4.5). These pictures show no particle accumulation 
in, or on the surface of, macrophages. 
 
The total number of cells collected from BAL fluid of injected mice was markedly 
lower than for instilled mice (∼4-5x106 vs. ∼1-2x107). Tail vein injection of DEP did 
not increase the number of cells in BAL fluid samples at any of the time points (2, 6 
or 24) hours assessed (Figure 4.6a). Similarly, injection of CB did not alter total cell 
number in BAL samples 2 hours following administration (Figure 4.6b). Cell 
differential analysis confirmed that the cells in all BAL samples from all injected rats 
were almost exclusively macrophages (Figures 4.6c & 4.6d).  
 
Chapter 4 - Effects of Diesel Exhaust Particulate on Thrombus Formation In Vivo 
 
 113
Figure 4.5 - Cytospins Showing Pulmonary Inflammatory Cell Populations 
Following Particle Injection. 
Cells recovered from bronchoalveolar lavage samples stained using haematoxylin and eosin. a) 2 
hours after injection with saline. b) 2 hours after injection with 0.5mg/kg DEP c) 6 hours after 
injection with 0.5mg/kg CB. d) 6 hours after injection with saline. e) 6 hours after instillation with 
0.5mg//kg DEP. f) 24 hours after injection with saline. g) 24 hours after instillation with 0.5mg/kg 
DEP. All lavages show only macrophages, no neutrophil infiltration was observed following any of 
the injections and there was no evidence of particulates in the samples. Magnification x400. 
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Figure 4.6 - Pulmonary Cell Count and Cell Differentials Following Particle 
Injection In Vivo. 
a) Cell count following BAL 2, 6 and 24 hours after tail vein injection of saline (Blue columns) and 
diesel exhaust particulate (DEP - 0.5mg/kg: Red columns). b) Cell count following BAL 2 hours after 
tail vein injection of saline and carbon black (CB - 0.5mg/kg: Green columns). c) Cell differential 
shows the number of macrophages recovered following BAL 2, 6 and 24 hours after instillation of 
saline and DEP. e) Cell differential for cells recovered during BAL 2 hours after tail vein injection of 
saline and CB. Results show no significant differences between DEP or CB and saline at any of the 
timepoints tested and no significant neutrophil infiltration was observed under any condition (data not 
































Chapter 4 - Effects of Diesel Exhaust Particulate on Thrombus Formation In Vivo 
 
 115
4.3.3   Effects of Particulate Administration on Pulmonary Cell Viability 
4.3.3.1   Effects of Particulate Instillation on Pulmonary Cytotoxicity and Protein 
Levels 
 
Measurement of total protein in BAL fluid 2, 6 and 24 hours after instillation showed 
similar levels in rats treated with saline or with DEP (Figure 4.7a). Increased protein 
levels were observed 6 hours after instillation when compared to the 2 and 24 hour 
timepoints, however, this increase was observed in both saline and DEP treated 
animals, and is therefore likely to be an artefact of the instillation method. Use of 
control particles (Figure 4.7c) demonstrated that instillation of CB caused a 
significant increase in total protein in BAL fluid (P<0.001, compared with saline-
treated control). In contrast, an apparent increase in total protein in response to DQ12 
did not achieve significance (P>0.05). 
 
Analysis of cell death in BAL fluid demonstrated that cytotoxicity was not increased 
significantly (compared with saline-treated controls) at any of the (2, 6 or 24 hour) 
time-points after instillation of DEP (Figure 4.7b). An apparent increase in cell death 
24 hours after administration did not achieve significance (P>0.05). Similarly, a 
trend towards increased cell death in BAL samples from rats instilled with CB or 
DQ12 (Figure 4.7d) did not achieve significance (both P>0.05). 
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Figure 4.7 - Measurement of Total Protein and Cell Death in Bronchoalveolar 
Lavage Fluid Following Particle Instillation. 
a) Total protein assay of BAL fluid shows no significant differences 2, 6 or 24hrs after instillation of 
saline (Blue columns) or diesel exhaust particulates (DEP - 0.5mg. Red columns). b) Measurement of 
cytotoxicity showed no significant differences between saline- and DEP-treated rats at any of the 3 
timepoints. c) Total protein assay of BAL fluid 6 hours after instillation of saline (Blue columns), 
carbon black (CB - 0.5mg; Green columns) or quartz (DQ12 - 0.125mg: Purple columns). Results 
show a significant increase in total protein in BAL fluid following CB instillation when compared 
with saline (P<0.001). No significant differences were found between saline and DQ12. d) 
Measurement of cytotoxicity showed no significant differences between saline, CB- and DQ12-treated 
groups despite an apparent increase, particularly following DQ12 instillation. Columns represent 












































Chapter 4 - Effects of Diesel Exhaust Particulate on Thrombus Formation In Vivo 
 
 117
4.3.3.2   Effects of Particulate Injection on Pulmonary Cytotoxicity and Protein 
Levels 
 
Measurement of total protein in BAL fluid 2 and 24 hours after tail vein injection of 
saline (Figure 4.8a) demonstrated similar levels to those seen following instillation of 
saline (Figure 4.7a). Interestingly, the increased protein levels observed 6 hours after 
instillation of saline were not seen following injection. Injection of DEP had no 
effect on protein levels in BAL samples at any of the 3 time-points (Figure 4.8a). A 
trend towards increased total protein was observed in BAL fluid 2 hours after tail 
vein injection of CB, however, this did not achieve significance (P=0.086. Figure 
4.8c). 
 
Surprisingly, measurement of cytotoxicity showed a significant increase in 
pulmonary cell death 24 hours following tail vein injection of DEP (P<0.05; Figure 
4.8b), but increases at the 2 and 6 hour timepoints did not reach statistical 
significance. There was no evidence of cell death 2 hours after injection of CB 
(Figure 4.8d).  
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Figure 4.8 - Measurement of Total Protein and Cell Death in Bronchoalveolar 
Lavage Fluid Following Particle Injection. 
a) Total protein assay of BAL fluid 2, 6 and 24hrs after tail vein injection of saline (Blue columns) or 
diesel exhaust particulate (DEP - 0.5mg/kg; Red columns). Injection of DEP did not significantly 
increase total protein levels. b) Measurement of cytotoxicity showed a significant (P<0.05) increase in 
pulmonary cell death in BAL fluid 24hr after exposure to DEP, but not 2 and 6 hours after exposure. 
c) Total protein levels in BAL fluid showed a trend (P<0.1) towards an increase 2 hours after 
instillation of carbon black (CB - 0.5mg/kg: Green columns) but this did not achieve significance. d) 
Cell death was not increased in BAL fluid 2 hrs after tail vein injection of CB. Columns represent 
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4.3.4   Particulate Administration Enhances Platelet Aggregation 
4.3.4.1   Effects of Particulate Instillation on Platelet-Monocyte and Platelet-Platelet 
Aggregation 
 
Using flow cytometry it was shown that platelet-monocyte aggregation was 
significantly increased 6 hours after DEP instillation (P<0.001 compared with saline-
treated controls; Figure 4.9a). In contrast, no increase was seen following instillation 
of CB or DQ12 (Figure 4.9a). Platelet-platelet aggregation was unaltered 6 hours 
after instillation of DEP (Figure 4.9b) but was increased following exposure to CB 
(P<0.05) or DQ12 (P<0.01). 
 
 
4.3.4.2   Effects of Particulate Injection on Platelet-Monocyte and Platelet-Platelet 
Aggregation 
 
Flow cytometry experiments demonstrated a significant increase in platelet-
monocyte aggregation 2 hours after DEP injection (P<0.01 compared with saline-
treated control; Figure 4.10a). A small apparent increase in platelet-monocyte 
activation after injection of CB did not achieve significance (Figure 4.10a). As with 
instillation, injection of DEP had no effect on platelet-platelet aggregation at the 
time-point studied (Figure 4.10b), whereas exposure to the control particle, CB, 
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Figure 4.9 - Effects of Particle Instillation on Platelet-Monocyte and Platelet-
Platelet Aggregation.  
a) Using flow cytometry it was shown that platelet-monocyte aggregation was increased (P<0.001 
compared with saline-treated controls: Blue columns) 6 hours after instillation of diesel exhaust 
particulate (DEP - 0.5mg; Red columns). Instillation of carbon black (CB - 0.5mg; Green columns) or 
quartz (DQ12 - 0.125mg; Purple columns) had no effect. b) In contrast, platelet-platelet aggregation 
was unaffected by instillation of DEP, but increased (compared with saline-treated controls) after 
instillation of CB or DQ12. Results show a significant increase in platelet-platelet aggregates with CB 
(P<0.05) and DQ12 (P<0.01) when compared to saline. There was also a significant difference 
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Figure 4.10 - Effects of Particle Injection on Platelet-Monocyte and Platelet-
Platelet Aggregation. 
a) Using flow cytometry it was shown that platelet-monocyte aggregation was increased (P<0.01 
compared with saline-treated controls: Blue columns) 2 hours after tail vein injection of diesel exhaust 
particulate (DEP - 0.5mg/kg: Red columns). There were no significant differences between carbon 
black (CB - 0.5mg/kg: Green columns) and saline or DEP. b) In contrast, platelet-platelet aggregation 
was increased  (P<0.05 compared with saline-treated controls). There were no significant differences 
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4.3.5   Effects of Particulate Administration on Pulmonary Cytokine Expression 
4.3.5.1   Effects of Particulate Instillation on Markers of Pulmonary Inflammation 
 
Measurement of IL-6 in BAL fluid samples 6 hours after instillation of test solutions 
demonstrated that both DEP (P<0.0001; Figure 4.11a) and CB (P<0.001; Figure 
4.11b) produced a significant increase in the levels of this cytokine when compared 
with saline-treated controls. In contrast, instillation of quartz produced a small 
increase in IL-6 levels in BAL samples that was not significantly different from 
controls (Figure 4.11b). 
 
Levels of TNFα appeared to be elevated (compared to saline-treated controls) 6 
hours after instillation of DEP (Figure 4.11c), CB and DQ12 (Figure 4.11d) but these 
changes were not statistically significant, and were close to the limit of detection for 
the kit (8pg/ml). 
 
CRP levels were unaltered in BAL fluid samples 6 hours after instillation of DEP 
(compared with saline-treated controls; Figure 4.11e). In contrast, pulmonary levels 
of CRP were increased 6 hours following instillation of CB (P<0.05) or DQ12 
(P<0.05 compared with saline-treated controls; Figure 4.11f). 
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Figure 4.11 - Effects of Particle Instillation on Pulmonary Inflammatory 
Factors. 
a) Results of the interleukin 6 (IL-6) ELISA showed a significant increase in pulmonary IL-6 6 hours 
after diesel exhaust particulate (DEP - 0.5mg: Red columns) instillation when compared to saline 
(Blue columns. P=0.013). b) Results of the IL-6 ELISA showed a significant increase in pulmonary 
IL-6 6 hours after carbon black (CB - 0.5mg: Green columns) instillation when compared to saline 
(P<0.001). There was also a significant increase in pulmonary IL-6 following CB when compared to 
quartz (DQ12 - 0.125mg: P<0.05: Purple columns). c) Results of the tumour necrosis factor alpha 
(TNFα) ELISA showed a non-significant increase in pulmonary TNFα 6 hours after DEP instillation 
when compared to saline (P=0.054). d) Results of the TNFα ELISA showed a non-significant increase 
in pulmonary TNFα 6 hours after CB and DQ12 instillation when compared to saline (P>0.05). e) 
Results of the C reactive protein (CRP) ELISA showed no significant increase in pulmonary CRP 
after DEP instillation when compared to saline. f) Results of the CRP ELISA showed a significant 
increase in pulmonary CRP after CB (P<0.05) and DQ12 (P<0.05) instillation when compared to 
saline. Columns represent mean ± SEM (n=6 for all groups). *P<0.05, ***P<0.001. 
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4.3.5.2   Effects of Particulate Injection on Markers of Pulmonary Inflammation 
 
In contrast to samples collected after instillation of saline or test particles (Chapter 
4.3.5.1), IL-6 levels were below the limit of detection (125pg/ml) in BAL samples 
collected 2 hours following injection of test solutions. 
 
Two hours after instillation, levels of TNFα were similar in BAL samples for saline 
treated controls and in rats exposed to DEP (Figure 4.12a) or CB (Figure 4.12b), 
however these results were close to the limit of detection for the kit (8pg/ml). 
 
Measurement of CRP in BAL fluid 2 hours after injection of test samples indicated 
that this marker was unchanged by injection of DEP (Figure 4.12c). A trend (P<0.1) 
towards increased CRP after injection of CB did not achieve significance. (Figure 
4.12d). 
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Figure 4.12 - Effects of Particle Injection on Pulmonary Inflammatory Factors. 
a) Results of the tumour necrosis factor alpha (TNFα) ELISA show no significant increase in 
pulmonary TNFα after diesel exhaust particulate (DEP - 0.5mg/kg: Red columns) tail vein injection 
when compared to saline (Blue columns). b) Results of the TNFα ELISA show no significant increase 
in pulmonary TNFα after carbon black (CB - 0.5mg/kg: Green columns) tail vein injection when 
compared to saline. c) Results of the CRP ELISA show no significant increase in pulmonary CRP 
after DEP instillation when compared to saline. d) Results of the CRP ELISA show no significant 
increase in pulmonary CRP after CB tail vein injection when compared to saline, although there is a 
trend towards increased pulmonary CRP after CB instillation when compared to saline (P=0.1336). 
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4.3.6   Effects of Particulate Administration on Systemic Inflammation 
4.3.6.1   Effects of Particulate Instillation on Markers of Systemic Inflammation 
 
Levels of IL-6 and TNFα in plasma taken 6 hours after instillation of saline, DEP, 
CB or DQ12 were below the limits of detection (125pg/ml and 8pg/ml for IL-6 and 
TNFα, respectively) of the assays used. 
 
In plasma samples taken 6 hours after instillation of test solutions CRP levels were 
unaffected by exposure to DEP (Figure 4.13a). In contrast both controls (Figure 
4.13a), CB and DQ12, induced an increase in circulating CRP levels (P<0.001 when 
compared with saline-treated controls). 
 
 
4.3.6.2   Effects of Particulate Injection on Markers of Systemic Inflammation 
 
As with measurement of IL-6 and TNFα in plasma following instillations, levels of 
these factors were below the limit of detection (IL-6; 125pg/ml, TNFα; 8pg/ml) for 
the relevant ELISAs in plasma samples obtained 2 hours after tail vein injection of 
saline, DEP or CB (data not shown). In contrast, measurement of plasma 
concentrations of CRP ELISA showed that CB, but not DEP, produced a significant 
increase in circulating levels of this protein (Figure 4.13b). 
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Figure 4.13 - Effects of Particle Instillation and Injection on Systemic 
Inflammatory Factors. 
a) Results of the C reactive protein (CRP) ELISA shows a significant increase in levels of CRP in 
plasma collected following instillation of carbon black (CB - 0.5mg: Green columns. P<0.001) and 
quartz (DQ12 - 0.125mg: Purple columns. P<0.001) when compared to saline (Blue columns). There 
was no significant difference between diesel exhaust particulate (DEP - 0.5mg: Red columns) and 
saline, however there were significant increases in plasma CRP following instillation of CB (P<0.001) 
and DQ12 (P<0.001) when compared to DEP. b) Results of the CRP ELISA shows a significant 
increase in levels of CRP in plasma collected following tail vein injection of CB when compared to 
both DEP (P<0.001) and saline (P<0.001). There was no significant difference in CRP levels 
following DEP tail vein injection when compared to saline. Columns represent mean ± SEM (n=6 for 
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4.3.7   Effects of Particulate Administration on the Fibrinolytic System 
4.3.7.1   Effects of Particulate Instillation on the Fibrinolytic System 
 
Analysis of plasma samples obtained 6 hours after instillation indicated that exposure 
to DEP caused a significant reduction in levels of t-PA antigen (P<0.001 compared 
with saline-treated controls; Figure 4.14a). Similar, but smaller, reductions in t-PA 
antigen were also observed 6 hours after instillation of CB (P<0.05) or DQ12 
(P<0.05) (Figure 4.14a). Instillation of each of the three test particulates produced 
small apparent increases in plasma PAI-1 antigen 6 hours after administration but 
these changes did not achieve significance (Figure 4.14b). Calculation of the               
t-PA/PAI-1 ratio (Figure 4.14c) indicated that this was significantly reduced after 
exposure to DEP (P<0.001), CB (P<0.01) or DQ12 (P<0.001) when compared with 
saline-treated controls. 
 
Concentrations of plasma fibrinogen (Figure 4.14d) appeared to be elevated 6 hours 
after instillation of DEP, and reduced after exposure to CB or DQ12. However, none 
of these changes achieved significance. A significant increase in plasma D dimer 
(Figure 4.14e) was observed when DEP was compared to quartz, 6 hours after 
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Figure 4.14 - Effects of Particle Instillation on the Thrombolytic System. 
a) Results of the tissue plasminogen activator (t-PA) ELISA show a significant reduction in plasma     
t-PA antigen 6 hours after instillation of diesel exhaust particulate (DEP - 0.5mg: Red columns: 
P<0.001) when compared to saline (Blue columns). There were also smaller, but significant 
reductions in plasma t-PA antigen following carbon black (CB - 0.5mg: Green columns: P<0.05) and 
quartz (DQ12 - 0.125mg: Purple columns: P<0.05) when compared to saline. b) Results of the 
plasminogen activator inhibitor (PAI-1) ELISA show a general increase in plasma PAI-1 antigen 6 
hours after instillation of DEP, CB and DQ12, however, these results were not significant. c) Results 
of the t-PA/PAI-1 calculation shows significant reductions in the t-PA/PAI-1 ratio 6 hours after DEP 
(P<0.001), CB (P<0.01) and DQ12 (P<0.001) when compared to saline. d) Results of the fibrinogen 
ELISA show a general increase in fibrinogen antigen 6 hours after instillation of DEP, with a general 
decrease observed following instillation of CB and DQ12, however, none of these results are 
significant. e) Results of the D Dimer ELISA show a general increase in D Dimer antigen 6 hours 
after instillation of DEP, however there was only a significant difference between DEP and DQ12 
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4.3.7.2   Effects of Particulate Injection on the Fibrinolytic System 
 
Analysis of plasma 2 hours following injection of test samples indicated a significant 
reduction in t-PA antigen (Figure 4.15a) in response to either DEP or CB (P<0.01 
and P<0.05, respectively, when compared with saline-treated control). Plasma 
concentrations of PAI-1 (Figure 4.15b) antigen were increased 2 hours after tail vein 
injection of CB (P<0.05 when compared with saline-treated controls). A smaller, but 
non-significant, increase was observed following injection of DEP. Calculation of 
the t-PA/PAI-1 ratio (Figure 4.15c) indicated that this was significantly reduced in 
response to both particulate solutions. t-PA and PAI-1 activity ELISAs showed the 
same trends observed with the antigen ELISAs  
 
Plasma levels of fibrinogen antigen (Figure 4.15d) were increased 2 hours after 
injection of DEP (P<0.05 compared with saline-treated controls) whereas injection of 
CB produced a small (non-significant) reduction. Significant increases in D dimer 
antigen (Figure 4.15e) were observed 2 hours after DEP injection when compared 
with saline (P<0.05) and CB (P<0.01). No significant change in D dimer was 
observed between saline and CB. 
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Figure 4.15 - Effects of Particle Injection on the Thrombolytic System. 
a) Results of the tissue plasminogen activator (t-PA) ELISA show a significant reduction in plasma     
t-PA antigen 2 hours after tail vein injection of diesel exhaust particulate (DEP - 0.5mg/kg: Red 
columns: P<0.01) and carbon black (CB - 0.5mg/kg: Green columns: P<0.05) when compared to 
saline (Blue columns). b) Results of the plasminogen activator inhibitor (PAI-1) ELISA show a non-
significant increase in plasma PAI-1 antigen 2 hours after tail vein injection of DEP. There was a 
significant increase in plasma PAI-1 antigen following CB instillation (P<0.05) when compared to 
saline. c) Results of the t-PA/PAI-1 calculation shows significant reductions in the t-PA/PAI-1 ratio 2 
hours after DEP (P<0.01) and CB (P<0.01) when compared to saline. d) Results of the fibrinogen 
ELISA show a significant increase in fibrinogen antigen 2 hours after tail vein injection of DEP 
(P<0.05) when compared to saline. There was also a significant reduction in fibrinogen antigen when 
CB was compared to DEP (P<0.001). e) Results of the D Dimer ELISA show a significant increase in 
D Dimer antigen 2 hours after tail vein injection of DEP when compared to saline (P<0.05) and 
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4.3.8   Staining for Evidence of Particulate Translocation and Deposition 
 
There was no evidence of particle accumulation in H&E stained sections of liver 
(Figure 4.16a) and kidney (Figure 4.16b) taken from rats 6 hours after instillation 
with DEP. In contrast, similar sections from rats 2 hours after injection with DEP 
show detectable particulate deposition in the liver (Figure 4.16d) but not in the 
kidney (Figure 4.16c). Lung sections taken 2 hours after DEP instillation are used as 
positive controls as large DEP aggregates can be clearly distinguished (Figure 
4.16e). DEP can also be easily visualised in the lung 6 hours after instillation (data 
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Figure 4.16 - Staining for Evidence of Particle Translocation and Deposition. 
a) Kidney section showing glomeruli taken 6 hours after diesel exhaust particulate (DEP) instillation. 
b) Liver section taken 6 hours after DEP instillation. c) Kidney section showing glomeruli taken 2 
hours after DEP injection. d) Liver section taken 2 hours after DEP injection. DEP can be visualised 
(arrows). e) Positive control. Lung section taken 2 hours after DEP instillation. DEP aggregates can be 
visualised in some sections (arrows). Pink stain indicates cellular cytoplasm, purple stain indicates cell 




     
 
    
 
a) Kidney - DEP Instillation, 6hrs  b) Liver - DEP Instillation, 6hrs 
c) Kidney - DEP Injection, 2hrs d) Liver - DEP Injection, 2hrs 
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4.4   Discussion 
 
The main hypothesis examined in this chapter was that exposure to diesel exhaust 
particulate (DEP) increases thrombus formation. The experiments described were 
designed to determine whether: 
(1)   this was demonstrable in a rat model of arterial thrombosis,  
(2)   the pro-coagulant effect of DEP required administration via the lungs 
(3)   pulmonary and systemic inflammation contribute to the effect of DEP, and 
(4)  DEP-induced changes in thrombosis were due to alteration in the activity of 
platelets and the endogenous fibrinolytic system. 
 
The data generated confirmed that exposure to DEP, whether via the lungs or by 
direct injection into the bloodstream, increased thrombus formation following 
application of FeCl3 to the carotid artery. This could not be attributed solely to the 
development of inflammation as control particles produced inflammatory changes in 
the lung and the systemic circulation without altering thrombus formation. 
Accelerated thrombus formation in response to DEP was associated with platelet 
activation but not with changes in components of the endogenous fibrinolytic system 
(t-PA, PAI-1) when compared to control particles. Tables 4.1 and 4.2 outline the key 
results found in this chapter. The methods used in this chapter are well established, 
and relevant to the area of study; the ferric chloride method has been used 
successfully to study the effects of various nanoparticles on thrombosis (Kurz et al. 
1990; Radomski et al. 2005; Bihari et al. 2009), as has the tail tip (Elg et al. 1999; 
Tanaka et al. 1998; Sato et al. 1998; Wang & Xu, 2005), flow cytometry to assess 
platelet function (Radomski et al. 2005; Bihari et al. 2009) and ELISA to measure 
pulmonary and systemic inflammation (Ushio et al. 1999; Fahy et al. 1999 
Donaldson et al. 2005; Ahn et al. 2008). The particulates used in this thesis have also 
been used in previous animal studies; DQ12 quartz (Duffin et al. 2001; Duffin et al. 
2007), nano-carbon black (Vincent et al. 2001; Donaldson et al. 2005), and DEP 
from the National Institute of Standards and Technology (NIST 2975. Nemmar et al. 
2007a; Nemmar & Inuwa. 2008a; Nemmar et al. 2010). 
 







Table 4.1 - Results Summary of Particulate Administration on Thrombus Formation, Fibrinolysis and Platelet Function. 
Summary of experiments investigating the effects of particle administration, via intrapulmonary instillation (Ins) and intravenous injection (IV), on thrombus formation 
via ferric chloride (FeCl3) administration, platelet aggregation via flow cytometry, and markers of the fibrinolytic system via ELISA, including tissue plasminogen 
activator (t-PA) antigen, plasminogen activator inhibitor 1 (PAI-1) antigen, t-PA/PAI-1 ratio, fibrinogen antigen and D-dimer antigen. DEP = diesel exhaust 
particulate, CB = carbon black, DQ12 = quartz particulate, N/C = no change from saline control, NS = change from saline control that was not statistically significant 























DEP Ins ↑ 6hrs ↑ 6hrs N/C  ↓ 6hrs ↑ 6hrs (NS) ↓ 6hrs N/C ↑ 6hrs (NS) 
CB Ins N/C N/C ↑ 6hrs ↓ 6hrs ↑ 6hrs (NS) ↓ 6hrs N/C N/C 
DQ12 Ins N/C N/C  ↑ 6hrs ↓ 6hrs ↑ 6hrs (NS) ↓ 6hrs N/C N/C 
DEP IV ↑ 2hrs ↑ 2hrs N/C ↓ 2hrs N/C ↓ 2hrs ↑ 2hrs ↑ 2hrs 
CB IV ↑ 2hrs N/C ↑ 2hrs ↓ 2hrs ↑ 2hrs ↓ 2hrs N/C N/C 
 







Table 4.2 - Results Summary of Particulate Administration on Pulmonary and Systemic Inflammation. 
Summary of experiments investigating the effects of particle administration, via intrapulmonary instillation (Ins) and intravenous injection (IV), on pulmonary and 
systemic inflammation, including total pulmonary cell count and neutrophil count, pulmonary protein levels, lactate dehydrogenase (LDH) assay as a measure of 
pulmonary cytotoxicity, ELISAs for pulmonary levels of the inflammatory markers interleukin-6 (IL-6), tumour necrosis factor alpha (TNFα) and C reactive protein 
(CRP), and ELISA for systemic CRP levels. DEP = diesel exhaust particulate, CB = carbon black, DQ12 = quartz particulate, N/C = no change from saline control, NS 
= change from saline control that was not statistically significant but may produce a physiological result. Timepoint of significant results are indicated after the 
increase (↑) or decrease (↓) from saline control. Results were not achieved for the pulmonary IL-6 antigen ELISA following particle injection, as results were below 
























DEP Ins ↑ 6hrs ↑ 6+24hrs N/C N/C ↑ 6hrs ↑ 6hrs (NS) N/C N/C 
CB Ins ↑ 6hrs ↑ 6hrs ↑ 6hrs N/C ↑ 6hrs ↑ 6hrs (NS) ↑ 6hrs ↑ 6hrs 
DQ12 Ins ↑ 6hrs ↑ 6hrs N/C N/C N/C ↑ 6hrs (NS) ↑ 6hrs ↑ 6hrs 
DEP IV N/C N/C N/C ↑ 24hrs - N/C N/C N/C 
CB IV N/C N/C N/C N/C - N/C ↑ 2hrs ↑ 2hrs (NS) 
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4.4.1   DEP Increases Thrombus Formation in the Rat Carotid Artery 
 
The primary observation of this chapter was that exposure of healthy rats to DEP 
reduced the time to vessel occlusion following treatment with FeCl3. This pro-
thrombotic state was also evident from increases in plasma fibrinogen and d-dimer 
levels and is consistent with increasing published evidence that exposure to DEP 
causes an increase in thrombus formation in experimental animals (much of these 
data coming from Nemmar & colleagues working in Belgium and in the United Arab 
Emirates). The first demonstration that instillation of DEP (5-500μg per animal) 
increased thrombus formation was achieved using hamsters (Nemmar et al. 2002a) 
and has since been confirmed in this species (Nemmar et al. 2003; Nemmar et al. 
2004a), in mice (Cozzi et al. 2007; Nemmar et al. 2009), and in rats (Nemmar et al. 
2007). These results have been obtained using NIST diesel particles (as in the present 
studies), administered in a range of concentrations of DEP either via the lungs (by 
intra-tracheal instillation) or directly into the systemic circulation (by tail vein 
injection). There appear to be no instances in the literature of thrombus formation 
measured in experimental animals after exposure to DEP by inhalation. The 
concentrations of DEP used for the work reported in this chapter are comparable 
with those used previously for instillation and injection in experimental animals. For 
example, instillations were performed using 500μg DEP/rat compared with 5-
500μg/animal for hamsters (Nemmar et al. 2002c; Nemmar et al. 2003b; Nemmar et 
al. 2004a) and 15-30μg/animal for mice (Nemmar et al. 2009b). Similarly, 
intravenous injection was performed using 0.5mg/kg compared with reported doses 
of 0.01-0.5mg/kg (Nemmar et al. 2007; Nemmar & Inuwa. 2008; Nemmar et al. 
2009a; Nemmar et al. 2010) in rats. The timing of the increased thrombotic response 
was also broadly in keeping with previous work: venous and arterial thrombosis were 
increased 6 and 24 hours (but not 1 or 3 hours) after instillation of DEP increased in 
hamsters (Nemmar et al. 2002c) whilst injection of DEP altered platelet number 6 hr 
after administration to rats (Nemmar et al. 2010). On balance, therefore, these data 
suggest that DEP-induced acceleration of thrombus formation is consistent in 
experimental animals and occurs whether the particulate is administered via the 
lungs or directly into the circulation. This pro-thrombotic effect is consistent with 
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clinical studies which indicate that inhalation of DEP alters endogenous fibrinolysis 
(Mills et al. 2005; Mills et al. 2007), and increases platelet monocyte activation and 
ex vivo thrombus formation (Lucking et al. 2008).  
 
Interestingly, enhanced thrombus formation is not a unique property of DEP. Several 
investigations have indicated a similar effect with a number of different types of 
particulate. For instance, increased thrombosis as been reported after instillation of 
silica particles (hamsters; Nemmar et al. 2005, titanium dioxide (TiO2) nanorods 
(rats; Nemmar et al. 2008b), ambient particulate matter (mice; Cozzi et al. 2007), 
carbon nanotubes (mice; Nemmar et al. 2007b) or amine-polystyrene ultrafine 
particles (hamsters; Nemmar et al. 2002a; Nemmar et al. 2002b). As demonstrated in 
this thesis, administration via the lungs is not necessarily required as thrombus 
formation was enhanced following intravenous injection of quantum dots (mouse; 
Geys et al. 2008) whilst addition of TiO2 nanorods to rat blood ex vivo produced a 
dose-dependent increase in platelet aggregation (Nemmar et al. 2008b). It is clear, 
therefore, that ultrafine particles other than DEP are capable of increasing thrombus 
formation. This is consistent with the suggestion in the experiments reported here 
that ‘control’ carbon black particles could also produce small increases in 
thrombogenesis 2 hours after injection. 
 
 
4.4.1.1   DEP Administration Did Not Alter Tail Tip Bleeding Time. 
 
A surprising outcome of these experiments was the failure of the tail tip bleeding 
time technique to detect increased thrombosis in response to DEP administration. 
Measurement of tail tip bleeding time, a method of assessing the coagulation cascade 
and cessation of bleeding, has been previously shown to be platelet dependent 
(Hodivala-Dilke et al. 1999; Nemmar et al. 2009a; Nemmar et al. 2009b). This 
technique has been used successfully to demonstrate alterations in clotting following 
genetic modification of the coagulation cascade (eg. reduced bleeding time in Factor 
IX knockout mice; Metzner et al. 2009) and pharmacological interventions in mice 
and rats (eg. Momi et al. 2001; Kaiser & Markwardt. 1986). More pertinently for this 
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thesis, it has also been used extensively to assess the effects of DEP (Nemmar et al. 
2009b) and other nanoparticles (Nemmar et al. 2007b; Cozzi et al. 2007) on 
thrombosis in both rats and mice. Furthermore, the pilot data reported previously 
(Chapter 3) suggested that tail tip bleeding time was reduced following exposure to 
DEP. 
 
The reasons for this failure of the tail tip transection method can only be speculated 
upon. It is possible that the extended period of anaesthesia in the preliminary 
experiments made changes between the groups more apparent, and, consequently, 
that the use of a shortened period of anaesthesia made the results less significant. 
There is no literature available that currently supports this theory, however, the 
length of anaesthesia is the only experimental detail that was changed between the 
preliminary studies and the experiments described in this chapter. It should be noted, 
however, that previous studies have shown reduced tail tip bleeding time 24 hours 
after instillation or injection of DEP (Nemmar et al. 2007a; Nemmar et al. 2007b). It 
is more likely that the failure of this technique to detect any differences in clotting 
was due to its relatively poor sensitivity. Indeed, it has previously been shown that 
tail tip transection correlates poorly with antithrombotic status in rats (Lavelle & 
Maclomhair. 1998). Fortunately, this technique was only performed as a back-up 
method for analysis of coagulation to provide an alternative in case the main model 
(FeCl3-induced arterial thrombosis) failed to induce consistent thrombus formation.  
 
 
4.4.2   Are the Pro-Thrombotic Effects of DEP Caused by Pulmonary Inflammation? 
 
Several previous investigations have suggested that increased thrombosis following 
exposure to nanoparticles is mediated by the pulmonary inflammation induced by 
these particles. This has been reported with carbon nanotubes (Nemmar et al. 
2007b,), silica particles (Nemmar et al. 2005), and TiO2 (Nemmar et al. 2008b). 
Most relevantly, however, a role for pulmonary inflammation has also been 
suggested following administration of DEP (Nemmar et al. 2003b; Nemmar et al. 
2009b). The investigations described in this chapter controlled for pulmonary 
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inflammation using CB (a nanoparticle that models the carbon core of DEP and may 
be able to translocate from the lung to the systemic circulation) and quartz (DQ12), 
which is known to produce pulmonary inflammation but is considered too large to 
translocate (Clouter et al. 2001; Duffin et al. 2001). Potential contamination with 
bacterial lipopolysaccharide could be excluded since the particulates used have 
previously been assessed (and found to be below the limit of detection; 0.1 EU/mL) 
for endotoxin contamination, by others in my group using the limulus amebocyte 
lysate (LAL) assay (McQueen et al. 2007; Shaw et al. 2010). 
 
The results obtained confirmed that DEP instillation did indeed produce pulmonary 
inflammation that peaked at the same time-point (6 hrs) as accelerated thrombosis. 
However, it was notable that both control particles (CB and DQ12) produced 
comparable pulmonary inflammation without altering thrombus formation. This 
suggests, therefore, that the pro-thrombotic effect of DEP cannot be attributed solely 
to an inflammatory response in the lungs. This is supported by the evidence obtained 
from DEP injections, which accelerated thrombus formation without causing a 
demonstrable pulmonary inflammation. In contrast, and rather unexpectedly, there 
was some evidence that injection of CB caused some pro-inflammatory changes in 
the lung (trend towards increased C-reactive protein concentrations in BAL fluid). 
This has similarities with previous studies reporting that intravenous injection of 
particles can cause both systemic and pulmonary inflammation (Nemmar et al. 
2004b; Nemmar et al. 2007a; Nemmar & Inuwa. 2008a); although in these cases it 




4.4.3   Are the Pro-Thrombotic Effects of DEP Caused by Systemic Inflammation? 
 
Intravenous injection of nanoparticles has previously been shown to cause systemic 
inflammation. DEP administration, for example, has been reported to increase 
circulating levels of IL-6, TNFα and leukotriene B4 in the rat (Nemmar et al. 2009b; 
Nemmar et al. 2010). In the experiments reported here, however, there was very little 
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evidence of systemic inflammation in response to DEP. Plasma levels of IL-6 and 
TNFα remained below the limit of detection, even after administration of DEP or 
CB. Plasma CRP levels were detectable but were unaffected by injection of DEP; 
interestingly, though, injection of the control (CB) particles did cause a non-
significant increase in plasma CRP. This reinforces the conclusion that DEP-
mediated pro-thrombotic changes are not simply secondary to systemic 
inflammation. 
 
In addition to profound pulmonary inflammation, pulmonary instillation of 
nanoparticles has also has also been shown to cause inflammatory changes in the 
systemic circulation (Nemmar et al. 2009b; Cozzi et al. 2007; Nemmar et al. 2004a). 
This is consistent with the demonstration here that instillation of CB or quartz caused 
an increase in plasma levels of CRP. Once again, however, instillation of DEP had 
no observable effect on systemic inflammation. The pro-inflammatory actions 
induced by CB in the lungs and the systemic circulation were interesting. CB is a 
‘clean’ carbon particle (Heinrich et al. 1995) and was initially expected to be less of 
an inflammatory stimulus than DEP. However, recent work in our lab has shown that 
CB produces free radicals, at a level comparable to DEP of the same size (Miller et 
al. 2009). Free radical generation could contribute to the inflammatory response 
following CB instillation. Furthermore, following the start of this work, evidence 
emerged indicating that CB was capable of producing cytotoxic injury, inflammation 
and inhibition of growth in endothelial cells (Yamawaki & Iwai. 2006). Parallel 
studies in my department supported the possibility that CB was more than inert 
particle, showing that it could induce the release of pro-inflammatory cytokines form 




4.4.4   Evidence of Particle Translocation 
 
Administration to the blood ex vivo has indicated that nanoparticles can directly 
activate platelets (Nemmar et al. 2003a; Nemmar et al. 2003b; Lucking et al. 2008), 
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suggesting that pro-thrombotic changes may be the result of particles translocating 
from the lungs to the systemic circulation. Previous studies have suggested that 
nanoparticles, including DEP, are capable of translocation; passing from the alveoli 
into the blood to affect the heart and vasculature directly. Extra-pulmonary 
translocation of radio-labelled ultrafine polystyrene particles has been shown in rats 
by measuring the amount of radioactivity collected in the blood and organs following 
instillation (Chen et al. 2006). This study also showed that pre-treatment with 
lipopolysaccharide induced pulmonary inflammation and markedly increased the rate 
of translocation: suggesting that inhaled ultrafine particles reach the alveoli and 
cause inflammation, which makes the alveoli more permeable and allows particles to 
enter the bloodstream. Similar results have also been shown in healthy human 
volunteers; radiolabelled ultrafine carbon particles (Technegas) could be detected in 
the blood of the volunteers one minute after inhalation (Nemmar et al. 2002). 
However, a subsequent study by my group suggested that extra-pulmonary 
translocation of this particular particle does not occur; the majority of Technegas-
labelled carbon particles remained in the lung 6 hours after inhalation, and when 
signal was detected in the circulation it was attributed to radiolabel that had ‘leeched 
off’ the ultrafine particles before entering the bloodstream (Mills et al. 2006). 
Whether ultrafine diesel particles can pass into the blood still remains unclear.  
Results presented here did not show any evidence of particle translocation; DEP was 
only visible in the livers of rats injected with DEP, no particles were visible in the 
liver or kidneys of rats instilled with DEP. It is possible that particles could 
accumulate over time at the site of thrombus formation with repeated exposures, 
producing direct effects on thrombus formation. However, there is no evidence to 
support that hypothesis in this thesis as particles were not found in the vasculature 
and, indeed, detection of particle translocation was not a primary aim for the 
experiments described. It is possible that particles translocating into the vasculature 
are so small that they might not be detected using standard histological methods. It is 
also possible that particles in the lungs activate inflammatory cells, which increase 
thrombosis after translocation into the circulation (Shaw et al. 2010). Although this 
may be partly responsible for the effects observed with DEP, it is unlikely that this is 
the only explanation given the pro-inflammatory effects of CB and DQ12 (which did 
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not alter time to occlusion). An alternative possibility is that metals and organic 
compounds found on the surface of DEP become separated from the particles in the 
lungs and translocate into the bloodstream, causing the effects on the fibrinolytic 
system. This could explain the different effects of DEP, CB and quartz. 
 
 
4.4.5   How does DEP Exposure Increase Thrombus Formation? 
 
The most likely mechanisms to explain the pro-thrombotic response to DEP 
administration involve changes in platelet function and in the endogenous 
fibrinolytic system.  
 
 
4.4.5.1   Exposure to DEP Causes Platelet Activation 
 
Several previous investigations have suggested that the pro-thrombotic response to 
DEP is the result of platelet activation (Nemmar et al. 2002a; Nemmar et al. 2003a; 
Nemmar et al. 2003b; Nemmar et al. 2004a; Nemmar et al. 2005; Nemmar et al. 
2010). Instillation of non-diesel particulates increased platelet activation (Nemmar et 
al. 2003a) and platelet-granulocyte aggregation in experimental animals (Bihari et al. 
2009). Platelet activation has been observed ex vivo in response to DEP exposure in 
previous experimental animal studies (Nemmar et al. 2002c; Nemmar et al. 2004a; 
Nemmar et al. 2008b). Results described in this chapter indicate that platelet 
activation, assessed by measuring platelet-monocyte aggregation, was increased 
following either instillation or injection of DEP. This is consistent with results 
obtained in a previous clinical study into the effects of DEP (Lucking et al. 2008), 
and suggests a pathway through which DEP can increase thrombus formation. It was 
noted that platelet-platelet aggregation was not increased in animals with enhanced 
thrombosis, indicating that this measure is a poor predictor of thrombosis in rats in 
vivo, although there is no literature currently available to support or explain this 
theory. 
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4.4.5.2   Particle Administration Alters Function of the Endogenous Fibrinolytic 
System 
 
Clinical investigations performed by researchers in my group have shown that 
inhalation of DEP impairs the endogenous fibrinolytic system (reducing endothelial 
t-PA release) in healthy volunteers (Mills et al. 2005) and in men with stable 
coronary heart disease (Mills et al. 2007). These effects occurred over a time-course 
(2-6 hours) consistent with the pro-thrombotic effects seen in the pre-clinical 
investigations described in this chapter. On the basis of these observations, it was 
necessary to determine whether altered endogenous fibrinolysis could be implicated 
in the increased thrombotic response to FeCl3. Consistent with the clinical studies, 
DEP administration (whether by instillation or injection) did impair function of 
endogenous fibrinolysis, with reduced plasma t-PA levels and increased PAI-1. The 
effects of DEP on the fibrinolytic system have not previously been fully examined 
using animal models: one report of a DEP-induced inhibition of PAI-1 expression 
(Furuyama et al. 2006) contrasts with the results described here, although ambient 
particulate matter increased plasma levels of PAI-1 in mice (Cozzi et al. 2007). It is 
apparent, however, that the pro-thrombotic effects of DEP cannot be attributed solely 
to altered fibrinolysis as both control particles (CB, whether injected or instilled; and 
DQ12) produced a similar impairment in fibrinolytic function. This suggests that, at 
best, altered endogenous fibrinolysis is just one component of DEP-mediated 
acceleration of thrombosis, and acts via a mechanism common to other particulates. 
 
 
4.4.5.3   Potential Mechanisms of Pro-Thrombotic Effects of DEP 
 
The investigations described in this chapter were not designed to identify definitively 
which pathways are involved in mediating the pro-thrombotic effects of DEP. As 
discussed (above), previous investigations have suggested that DEP-mediated 
thrombotic changes are secondary to inflammation. Indeed it has been shown that the 
presence of DEP in the lungs leads to the formation of peroxynitrite, which leads to 
pulmonary inflammation (Ito et al. 2000). This would be consistent with the 
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suggestion that instilled silica particles enhance thrombus formation (Nemmar et al. 
2004) by stimulating the release of neutrophil elastase into the systemic circulation 
and, thus, causing platelet activation (Nemmar et al. 2005). Support for this 
mechanism is provided by the demonstration that inhibition of oxidative stress in the 
mouse lung reduced pulmonary inflammation and reversed the shortening in tail 
bleeding time caused by DEP instillation (Nemmar et al., 2009, Toxicology). 
Similarly, inhibition of pulmonary inflammation (using the glucocorticoid 
dexamethasone or sodium cromoglycate) abolished the pro-thrombotic effects of 
DEP instillation in hamsters, apparently by preventing degranulation and release of 
histamine by mast cells (Nemmar et al., 2004, Circulation). The same researchers, 
however, also demonstrated that an H1 antagonist which abolished DEP-induced 
neutrophils influx in the hamster lung did not alter thrombus formation or platelet 
function.  
 
The studies described in this chapter used control particles to demonstrate that 
increased thrombosis in response to DEP is not dependent on either pulmonary or 
systemic inflammation. This is consistent with evidence that particles, including 
DEP, can directly increase platelet activation and aggregation (Nemmar et al. 2003a; 
Nemmar et al. 2003b; Nemmar et al. 2010). Thus, the role of inflammation in 
mediating the pro-thrombotic effects of DEP remains unproven. Indeed, the 
suggestion that control particles produce milder pro-thrombotic effects and alter the 
endogenous fibrinolytic system suggest a number of factors contribute to DEP-
induced thrombogenicity. Furthermore, it seems likely that some of these effects will 
be attributable to the nanoparticulate nature of the DEP, and some to specific 
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4.4.6   Conclusions 
 
The main conclusions drawn from the work described in this chapter are that 
exposure to DEP increases thrombus formation in vivo, and that this effect is 
independent of inflammation. The use of control particles demonstrated clearly that 
animals with pulmonary and systemic inflammation in excess of that produced by 
DEP did not exhibit accelerated thrombosis. The issue of particle translocation 
remains unproven. Injection of DEP confirmed their ability to alter thrombogenesis 
by direct interaction with the cardiovascular system. Furthermore, the time taken for 
changes in thrombus formation to occur (2 hrs for injection; 6 hours for instillation) 
would be consistent with particles translocating from the lungs. There was no direct 
evidence, however, of such translocation and it seems unlikely that a sufficient 
number of instilled particles would gain access to the bloodstream to account for this 
effect. The pro-thrombotic effect of DEP was most clearly attributable to platelet 
activation. However, there was some evidence control particles could induce a 
modest increase in thrombus formation, suggesting that the pro-thrombotic action of 
DEP may be due to a combination of effects general to particles (induction of 
inflammatory response, alteration of endogenous fibrinolysis) with those specific to 
DEP (platelet activation). The characteristics of DEP that make them more pro-
thrombotic than the control particles (nano-carbon black; quartz) used in this 
investigation remain to be identified. One of the more likely explanations is that 
metals and organic compounds associated with the surface of DEP account for their 
ability to increase thrombosis. This would need to be confirmed in future studies; 
possibly by administration of the soluble and organic fractions (and the residual 
carbon particle) obtained by ‘washing’ DEP (Arimoto et al. 2007). Further studies 
could also include measurement of blood pressure, heart rate and systemic vascular 
resistance following exposure of animals to DEP. The results described in this 
chapter provide thorough evidence that DEP can increase thrombus formation via 
alteration of platelet function independent of systemic or pulmonary inflammation. 
Further work is now necessary to understand if some of the same processes that have 
been observed in these animal studies also occur in cultured human endothelial cells.
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5.1   Introduction 
 
The demonstration that direct injection of diesel exhaust particulate (DEP) induces 
an acute (2 hours after administration) acceleration in thrombus formation (Chapter 
4) is consistent with the hypothesis that particles can interact directly with the 
cardiovascular system. This indicates that DEP translocating from the lungs may 
directly alter coagulation pathways. The mechanisms through which DEP achieve 
this have not, however, been identified, although there is increasing evidence that 
they can interact directly with the blood to cause platelet activation (Nemmar et al. 
2003b; Nemmar et al. 2010). It is also possible that DEP can interact directly with 
the arterial wall to alter function of the endogenous fibrinolytic system in vascular 
endothelial cells. Certainly there is some evidence that organic extracts from DEP 
reduce PAI-1 expression in rat coronary microcirculation endothelial cells, as a result 
of increased oxidative stress (Furuyama et al. 2006). In addition, the carbon core 
itself may alter fibrinolytic function as exposure of HUVECs to PM10 reduced 
expression of t-PA mRNA and protein levels in culture medium (Gilmour et al. 
2005). This would certainly be consistent with the demonstration (Chapter 4) that 
intravenous injection of carbon black (CB) produces a change in endogenous 
fibrinolytic factors similar to that produced by DEP. In order to assess whether DEP 
can directly alter the fibrinolytic pathway in endothelial cells, the work described in 
this chapter details the impact of DEP suspensions of markers of fibrinolysis (tissue 
plasminogen activator  (t-PA) and plasminogen activator inhibitor (PAI-1)) in human 
endothelial cell cultures. 
 
Before cell culture experiments could begin, it was necessary to develop a suitable 
dispersant which could be used to ensure optimal exposure of endothelial cells to 
DEP. A dispersant was required which would: 
1) keep DEP in suspension for prolonged periods of time. 
2) suspend DEP in required concentrations. 
3) hold DEP in nanoparticulate form without the formation of aggregates. 
4) be non-toxic to human endothelial cells in culture. 
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Previous studies in this field have attempted to solve the dispersant problem by using 
the detergent Tween (Sagai et al. 1993; Ichinose et al. 1995; Matsuo et al. 2003). 
Detergents certainly provide a dispersant capable of preventing particles from 
forming aggregates and from falling out of suspension. However, detergents are also 
likely to interfere with cultured cells through disruption of cell membranes (Culvenor 
et al. 1982). Surprisingly, none of the groups that used Tween as a dispersant report 
its effects on cell viability. Indeed, although Matsuo et al. (2003) reported that DEP 
in a Tween suspension induced death of cultured human bronchial epithelial cells, 
Tween was not suspected of contributing to cytotoxicity. In other studies, detergents 
have been avoided with dispersion of DEP achieved by sonication in an appropriate 
cell culture medium (Hashimoto et al. 2000; Alfaro-Moreno et al. 2007). These 
investigations, however, rarely document the resultant particulate size or stability of 
suspensions produced in this manner. Finally, another study assessed the effects of 
DEP on cell cultures with no explanation of the methods used to generate particulate 
suspensions (Takizawa et al. 2000). Given this apparent lack of research into the 
dispersants previously used, it was felt that thorough method development was 
required to allow selection of the optimum dispersant for use with cell cultures. 
 
It has been suggested that organic extracts of DEP can alter fibrinolytic function in 
endothelial cells (Furuyama et al. 2006), possibly by induction of oxidative stress. 
(Hirano et al. 2003). Few studies, however, have assessed the effects of DEP on this 
process. Furuyama and colleagues (Furuyama et al. 2006) showed that organic 
extracts of DEP reduced cellular excretion of PAI-1 (although with no demonstrable 
effect on PAI-1 protein within the cells) but did not alter secretion of t-PA 
(Furuyama et al. 2006). This pattern differs from the increase in circulating PAI-1 
and decrease in circulating t-PA observed in the in vivo response to DEP reported in 
this thesis (Chapter 4). These differences are possibly explained by the fact that the 
earlier study (Furuyama et al., 2006) used organic extracts of diesel, rather than 
DEP. In addition, previous work performed in Edinburgh (Gilmour et al. 2005) 
indicated that CB particles can also reduce t-PA expression and secretion in 
HUVECs. These results are consistent with the suggestion that different components 
of the particulate contribute to the effects of DEP. 
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5.1.1   Hypothesis 
 
The work described in this chapter addressed the hypothesis that exposure to diesel 
exhaust particulate (DEP) would cause a direct inhibition of the endogenous 
fibrinolytic system in cultured human umbilical vein endothelial cells (HUVECs). 
 
 
5.1.2   Aims  
 
The specific aims of the work described in this chapter were: 
i. to develop a dispersant for DEP that was not toxic when applied to HUVECs 
in culture. 
ii. to determine whether DEP in solution retained the characteristics of 
nanoparticulates. 
iii. to determine whether exposure to DEP in solution inhibited the endogenous 
fibrinolytic system in cultured HUVECs. 
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5.2   Methods 
5.2.1   Preparation of DEP Suspensions. 
 
Diesel exhaust particulate (DEP), collected from industrial forklift engine exhausts 
(SRM 2975), was obtained from the National Institute of Standards and Technology 
(NIST, Gaithersburg, MD, USA). For the purposes of method development, a 
number of different dispersants were screened in single experiments to assess their 
suitability for use with cultured cells. Assessment of the suitability of these 
dispersants was based on their ability to maintain suitable suspensions of DEP in a 
non-cytotoxic mix. On the basis of this screening, more detailed assessments were 
made of the sample concentrations and particulate size in suspension in selected 




5.2.2   Dispersant Development 
5.2.2.1   Water 
 
Water was used as a control for testing DEP dispersion. DEP suspensions (1mg/ml) 
were prepared in deionised water (dH2O), probe sonicated (Status Homogenisers. 
Philip Harris Scientific; US70, Lichfield, UK) at 70% power for 5 minutes to ensure 
dispersion, and centrifuged at 500g for 1 hour in order to remove large DEP 
aggregates, leaving only nanoparticles in suspension. 
 
 
5.2.2.2   Tween 20 
 
Tween 20 was also used as a control for testing DEP dispersion. Tween 20 is a 
detergent, and should, therefore, provide good DEP dispersion without the formation 
of aggregates. It was not intended for use in cell culture experiments, as it has been 
previously shown to be cytotoxic (Han et al. 2008) and could, therefore, affect the 
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results of experiments designed to investigate the effects of DEP on cell viability. 
Tween 20 was made up at concentrations of 0.01 and 1% in dH2O. This dispersant 
was then used to make 1mg/ml DEP suspensions, using the method described above 
(Chapter 5.2.2.1). These suspensions were used only as controls to assess particle 




5.2.2.3   Cell Culture Medium With or Without Serum and BSA 
 
EGM-2 cell culture growth medium (GM; Lonza Walkersville; Maryland, USA) and 
EGM-2 medium without added foetal bovine serum (serum-free medium - SFM) 
both with and without bovine serum albumen (BSA, 1mg/ml - 50μg/ml; Sigma 
Aldrich; Munich, Germany) were tested as dispersants. BSA is a large protein used 
to simulate blood composition and which has been used in previous cell culture 
experiments to stabilise experimental suspensions (Shires et al. 1989; Fischer et al. 




5.2.2.4   Synthetic Surfactant 
 
Serum-free EGM-2 culture medium with 100μg/ml dipalmitoyl phosphatidylcholine 
(DPPC. Sigma Aldrich; Munich, Germany), with and without 250μg/ml BSA (Sigma 
Aldrich; Munich, Germany) was also tested as a dispersant. The DPPC used is a 
synthetic version of the principal surfactant in the human lung (Fisher & Dodia. 
1997). This solution was heated to 60°C for 10 min and sonicated using a probe 
sonicator for 30 min (85% power, 5 cycles) in order to fully disperse DPPC. This 
dispersant was used to make DEP suspensions (1mg/ml), as described (Chapter 
5.2.2.1). Collaboration with another lab in the department subsequently suggested 
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that DPPC has cytotoxic effects on some cell types (C. Poland, Centre for 
Inflammation Research. Unpublished data). 
 
 
5.2.2.5   Phosphate Buffered Saline With or Without BSA 
 
Phosphate buffered saline (PBS), and PBS + 0.5mg/ml BSA (Sigma Aldrich; 
Munich, Germany), were also tested as dispersants. These experiment were 
conduced after preliminary assessment of dispersants, which found that a 0.5mg/ml 
BSA solution was most effective for dispersal of 1mg/ml DEP. DEP suspensions 
(1mg/ml) were prepared using this dispersant as described (Chapter 5.2.2.1). 
 
 
5.2.3   Analysis of DEP Suspensions 
 
Following preparation of DEP suspensions, the top 80% of the supernatant was 
aspirated off and used in measurements of absorbance (as a measure of DEP 
concentration), and mean particle diameter. 
 
 
5.2.3.1   Absorbance Spectra Measuring DEP Concentration in Suspension 
 
DEP suspensions (1mg/ml) were diluted to a 1/50 concentration with dH2O and 
analysed by spectrophotometer (SmartSpec 3000. Bio-Rad; Hertfordshire, UK) 
measuring absorbance at 500nm, to give a comparative estimation of the amount of 
diesel in suspension. 
 
 
5.2.3.2   Analysis of Particle Size in Suspension 
 
Following spectrophotometric analysis, the 1/50 dilutions of the diesel suspensions 
were assessed using a particle size analyser (90 Plus particle size analyser. 
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Brookhaven Instruments Corporation; NY, USA), which uses laser scatter to 
calculate mean particle diameter. 
 
 
5.2.3.3   Confirmation of DEP Concentration in Suspensions 
 
The concentration of DEP in individual suspensions was also assessed by spinning 
aliquots (1ml) in a heated vacuum centrifuge overnight, along with 1ml samples of 
SFM + 0.5mg/ml BSA. The dry weights of the SFM + BSA samples were subtracted 
from the dry weights of the DEP suspensions to give the mass of DEP/ml. This was 
then used to calculate DEP concentrations in all future experiments. 
 
 
5.2.4   Endothelial Cell Culture 
 
Human umbilical vein endothelial cells (HUVECs - Promocell; Heidelberg, 
Germany) were cultured at 37°C in 75cm3 flasks using endothelial cell culture 
growth medium (EGM-2 BulletKit - basal medium containing human epidermal 
growth factor, hydrocortisone, gentamicin, ampheroteracin B, foetal bovine serum, 
vascular endothelial growth factor, human fibroblast growth factor B, insulin-like 
growth factor 1, ascorbic acid and heparin - Lonza Walkersville; Maryland, USA). 
When cells had grown to confluence they were passaged by first removing the 
culture medium and then washing the cells twice with 3ml HEPES-buffered saline 
solution (Reagent Pack Subculture Kit - Lonza Walkersville; Maryland, USA). Cells 
were then incubated with 3ml trypsin/EDTA solution (Reagent Pack Subculture Kit - 
Lonza Walkersville; Maryland, USA) at 37°C for 5 minutes, and the sides of the 
flask were gently tapped to lift cells from the culture surface. Trypsin neutralising 
solution (5ml; Reagent Pack Subculture Kit - Lonza Walkersville; Maryland, USA) 
was then added to the cells to prevent lysis. The cell suspension was split equally 
between four new flasks, 15ml culture medium was added and the flasks were 
incubated at 37°C. Cells up to passage 6 (P6) were used for further experiments. For 
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endothelial cell exposures EGM-2 medium without added foetal bovine serum 
(serum-free medium - SFM) + 0.5mg/ml BSA was used to disperse DEP. 
 
 
5.2.5   Assessment of Cell Death. 
5.2.5.1   Trypan Blue Exclusion 
 
HUVECS (200,000 cells/well in 2ml GM) were plated onto 6 well plates and 
incubated (2 hours, 37°C) to allow adhesion to the well surface. DEP suspensions 
were then added to the wells to give final DEP concentrations of 20 and 60μg/ml. 
Control wells contained dispersant in GM without DEP. Cells were incubated in the 
presence of DEP suspensions for 2, 6, 16 and 24 hours under standard culture 
conditions. After the appropriate exposure time, HUVECs were photographed and 
assessed for viability using Trypan Blue exclusion (Cook and Michell, 1989). 
Briefly, the HUVECs were washed and trypsinised and an aliquot (10μl) of the cell 
suspension was mixed with 90μl trypan blue. Live cells actively exclude the stain 
and appear white when examined microscopically. Dead cells cannot exclude the 
stain and, therefore, appear dark blue. Cells were counted using a haemocytometer; 
the number of dead cells was expressed as a percentage of total cells counted. 
 
 
5.2.5.2   Lactate Dehydrogenase Assay 
 
HUVECs (50,000 cells/well in 100μl GM) were seeded onto 96 well plates and 
incubated (2 hours, 37°C) to allow adhesion to the well surface. The cell culture 
medium was then removed and replaced with 100μl DEP suspension in the 
appropriate dispersant diluted in SFM to give final concentrations of 10, 20, 40, 60 
and 80μg/ml. Control wells received 100μl SFM alone. Cells were left to incubate 
for 2, 6, 16 and 24 hours under standard culture conditions. Positive controls were 
generated by adding hydrogen peroxide (final concentrations 1μM - 1mM) or Tween 
20 (final concentrations 0.1% - 50%) to induce cell death. LDH release was 
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determined in a colorimetric assay by measuring absorbance at 490nm (cytotoxicity 
detection, LDH assay kit; Roche Diagnostics). Cytotoxicity was calculated as a 
percentage of maximum and spontaneous LDH release, as determined by high and 
low control wells. Background absorbance was taken into account by measuring the 




5.2.6   Assessment of DEP on the Release of Fibrinolytic Factors from HUVECs 
5.2.6.1   Assessment of DEP on Basal Release of Fibrinolytic Factors 
 
The impact of exposure to DEP on the activity of components of the endogenous 
fibrinolytic system was assessed using the dispersant/DEP combination selected 
from pilot investigations on cell viability. Briefly, HUVECs were cultured in GM 
and then exposed to DEP dispersed in SFM containing 0.5mg/ml BSA (made up to a 
final volume of 15ml with SFM; final DEP concentrations were 10, 20, 50, 100 and 
150mg/ml) for 2, 6, 16 and 24 hours, in order to assess the effects of DEP on 
constitutive release of fibrinolytic factors. 
 
 
5.2.6.2   Assessment of DEP on Stimulated Release of Fibrinolytic Factors 
 
Double exposure experiments were designed to test the effects of DEP on stimulated 
release of fibrinolytic factors. Cells were first incubated with either 100μg/ml DEP 
(prepared in SFM containing 0.5mg/ml BSA, added to 15ml SFM), or serum free 
medium alone, for 16 hours. Cells were then washed and exposed to a range of 
thrombin concentrations (0.1, 0.5 and 1U/ml in SFM with SFM used as a second 
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5.2.6.3   Collection and Storage of Endothelial Cell Samples Following DEP 
Exposure 
 
At the end of both experiments, aliquots of medium (1ml) were taken and stored at        
-70°C for later analysis of tissue plasminogen activator (t-PA) and plasminogen 
activator inhibitor (PAI-1) levels. RNA from these cells was also extracted and 




5.2.7   Reverse Transcriptase Polymerase Chain Reaction Analysis of HUVECs 
 
Reverse transcriptase polymerase chain reaction (RT-PCR) was used (see Chapter 
2.7.4.1) to assess the phenotype of HUVECs in culture. 
 
 
5.2.7.1   RNA Extraction 
 
Cultured cells were trypsinised, centrifuged (1000rpm, 5min) and the supernatant 
removed and discarded. RNA extraction was achieved using the TRIzol extraction 
method (Chapter 2.7.3.1). Following the extraction process, samples were vortexed 
and centrifuged (7,500g, 5 min, 4°C), the supernatant discarded and the RNA pellets 
allowed to air dry (room temperature, 5 min). Pellets were then re-suspended in 
autoclaved 0.1% diethylpyrocarbonate (DEPC)-treated water (50μl) by incubating at 
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5.2.7.2   RNA Integrity 
 
RNA concentration was determined using a GeneQuant spectrophotometer reading at 
320nm. The integrity of the extracted RNA was verified by denaturing agarose gel 
electrophoresis (Chapter 2.7.3.1). RNA was then visualised on a UV trans-
illuminator at 254nm and photographed using a Mitsubishi P93 video printer. 
 
 
5.2.7.2   Reverse Transcription 
 
Reverse transcription of extracted RNA was performed using a Promega A3500 RT 
system. RNA (1μg/ml) was added to the Promega Mastermix (containing 10x Buffer, 
MgCl2, Oligonucleotides, dNTPs and RNase inhibitor at a ratio of 2:4:1:2:1). 
Reverse transcriptase enzyme was added and samples were incubated at 42°C for 30 
min, 99°C for 5 min and 4°C for 10 min in an Eppendorf 5331 thermal cycler. At this 
time two negative controls were added, one containing no reverse transcriptase 
enzyme, and a second containing no RNA.  
 
 
5.2.7.4   Polymerase Chain Reaction for Tie2 
 
RT-PCR was conducted to show RNA expression in HUVECs up to P6. Primers for 
Tie2, an endothelial cell specific tyrosine kinase receptor for angiopoietin (Davis et 
al. 1996), were designed using Gene Jockey software to show that HUVECs retained 
characteristics of endothelial cells up to P6 (Partanen et al. 1992). Primer sequences 
are shown in Table 5.1. Following reverse transcription, PCR was performed using a 
Promega M5661 Taq Bead Hot Start Polymerase kit. cDNA samples were added to 
the Promega Mastermix (containing 10x Buffer, MgCl2, dNTPs, forward primer, 
reverse primer and nuclease free H2O at a ratio of 5:3:1:2:2:32). Samples were run in 
an Eppendorf 5331 thermal cycler at 95°C for 45 secs, then 35 cycles of 90°C for 45 
secs, 60°C for 30 secs, 72°C for 90 secs, then finally 72°C for 5 min and 4°C for 10 
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min. Samples were run on a 1.2% agarose gel along with a 100 bp DNA ladder 




5.2.7.5   Polymerase Chain Reaction for t-PA and PAI-1 
 
RNA was extracted from cultured HUVECs exposed to DEP in the experiments 
described previously, and RT-PCR was performed for t-PA, PAI-1 and the 
housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH), as 
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Table 5.1 - Reverse Transcription Polymerase Chain Reaction Primers.  
RT-PCR primer sequences and band sizes for endothelial tyrosine kinase receptor for angiopoietin 
(Tie2), tissue plasminogen activator (t-PA), plasminogen activator inhibitor (PAI-1) and 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH). 
 
 Forward Primer  Reverse Primer  Band Size 
Tie2 TCA CTC CAG TAT 
CAG CTC AAG GG 
CAG CTG GTT CTT 
CCC TCA CGT T 
300bp 
t-PA ATC TTT GCC AAG 
CAC AGG AGG TCG 
CTT CAG CCG CTC 
CGA ATA GAA AGG 
410bp 
PAI-1 AGC ACG GTC AAG 
CAA GTG GAC T 
GGC AGT TCC AGG 
ATG TCG TAG TAA 
325bp 
GAPDH CCA CCC ATG GCA 
AAT TCC ATG GCA 
TCT AGA CGG CAG 






Table 5.2 - Real Time Polymerase Chain Reaction Primers. 
Real-time PCR primer sequences for tissue plasminogen activator (t-PA), plasminogen activator 
inhibitor (PAI-1), glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and β-Actin. 
 
 
 Forward Primer  Reverse Primer  
t-PA CGG GTG GAA TAT TGC 
TGC T 
CTT GGC TGG CTG CAA 
CTT 
PAI-1 CTC CTG GTT CTG CCC 
AAG T 
CAG GTT CTC TAG GGG 
CTT CC 
GAPDH GCT AGG GAC GGC CTG 
AAG 
GCC CAA TAC GCC AAA 
TCC 
β Actin CCA ACC GCG AGA AGA 
TGA 
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5.2.8   Quantitative Real-Time Polymerase Chain Reaction  
 
RNA was extracted from HUVECs exposed to DEP as described (Chapter 2.7.4.1), 
reverse transcribed to cDNA and stored at -70°C until real-time PCR was performed. 
Real time primers (shown in Table 5.2, Invitrogen) were diluted to 100μM using TE 
(Tris EDTA buffer solution; Fluka BioChemika, Switzerland). Fluorescent probes 
were added to each set of forward and reverse primers to produce a Mastermix (0.1μl 
each) along with 5μl Roche probe master, 2.75μl RNase free distilled water (Both 
from LightCycler 480 probes master kit; Roche, Burgess Hill, UK) and 2μl of cDNA 
(previously diluted 1 in 8 using RNase free water). Samples were analysed using a 
Roche LightCycler 480 and corresponding software, and analysed by comparing the 
unknown samples to serial 1:2 dilutions for each set of primers. 
 
 
5.2.9   Analysis of the Impact of DEP on t-PA and PAI-1 Release by HUVECs 
 
Supernatants sampled from cell culture experiments (see above) were assessed for     
t-PA antigen and activity using a t-PA Combi Actibind ELISA kit (Technoclone Ltd. 
Surrey, UK), and PAI-1 activity using a Technozym PAI-1 Actibind ELISA kit 
(Technoclone Ltd. Surrey, UK). Full experimental design and kit details can be 
found in Chapter 2.7.2. 
 
 
5.2.10   Statistics 
 
Data are expressed as mean + SEM. Results were analysed using GraphPad Prism 
software. Comparison of 2 groups was performed using an unpaired two-tailed t-test. 
Comparison of 2 groups for 2 experimental conditions was achieved using a two-way 
ANOVA with a Bonferroni post-test. Significance was assumed when P<0.05. 
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5.3   Results 
5.3.1   Effects of Dispersants on Particle Suspension and Mean Particle Diameter 
5.3.1.1   Initial Dispersant Development 
 
A range of dispersants was prepared (as described in Chapter 5.2.1) and used to 
suspend DEP at 1mg/ml. The original dispersants included dH2O, Tween 20 (0.1 and 
1% in dH2O), serum-free EGM-2 culture medium (SFM) containing a range of BSA 
concentrations (50μg/ml - 1mg/ml), SFM containing 100μg/ml DPPC and SFM 
containing 100μg/ml DPPC and 250μg/ml BSA. The absorbance spectra of 1:10 
dilutions of the DEP suspensions showed that Tween 20 provided the highest 
retention of DEP in suspension. Good suspension was also achieved using BSA in 
medium as the dispersant, especially at 0.5mg/ml (Figure 5.1a). Measurement of 
particle diameter showed that culture medium containing BSA maintained low mean 
particle diameter; again, particularly at 0.5mg/ml (Figure 5.1b). 
 
 
5.3.1.2   Assessment of Growth Medium and Bovine Serum Albumen as Dispersants 
 
Absorbance spectra of 1 in 10 dilutions of 1mg/ml DEP suspended in a range of 
dispersants including phosphate buffered saline (PBS), SFM and full EGM-2 growth 
medium (GM) both with and without BSA (0.5mg/ml). The results of this assay 
showed that BSA improved particle suspension when added to PBS or SFM. GM 
provided good suspension both with and without BSA (Figure 5.2a). Mean particle 
diameter analysis was carried out on the suspensions that retained DEP to a 
measurable level in the previous experiment (Figure 5.2b). Results show that SFM + 
BSA, GM and GM + BSA all retained particles with a low mean diameter (<50nm). 
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Figure 5.1 - Dispersion and Mean Particle Diameter of DEP in a Range of 
Dispersants. 
The suitability of different dispersants for DEP was assessed by measuring absorbance, to estimate 
diesel exhaust particulates (DEP) concentration, and by measuring particle size to determine whether 
particle aggregation was occurring in suspensions. DEP suspensions (1mg/ml) were prepared in a 
range of dispersants; all BSA and DPPC dispersants were originally made up in serum-free EGM-2, 
Tween 20 was made up to the correct concentrations in dH2O and used along with dH2O as controls. 
All suspensions were then diluted 1:10 using serum free EGM-2 for analysis, following centrifugation 
at 500g for 1 hour. a) Most dispersants, with the exception of medium containing the lowest 
concentrations (50-100μg/ ml) of BSA, allowed production of stable, concentrated suspensions of 
DEP. b) Most dispersants (once again, excepting the lowest concentrations of BSA) produced 
suspensions of DEP with mean particle diameters below 200nm. Results were not statistically 
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Figure 5.2 - Comparison of the Influence of Growth Factors and Bovine Serum 
Albumen on Suspension of DEP in EGM-2. 
The effect of growth factors and bovine serum albumen (BSA) on formation of suspensions of DEP in 
EGM-2 was assessed by measuring absorbance (to estimate the concentration of DEP) and mean 
particulate size (to assess particle aggregation). DEP suspensions (1mg/ml) in the relevant dispersant 
were diluted 1:10 using serum free EGM-2, following centrifugation at 500g for 1 hour.                       
a) Measurement of absorbance indicated that phosphate buffered saline (PBS) and serum free EGM-2 
(SFM) failed to hold DEP in suspension. Addition of bovine serum albumen (BSA) or foetal bovine 
serum to EGM-2 (GM) maintained DEP in suspension to a similar degree. Distilled water and 1% 
Tween 20 were used as controls. b) Mean particle diameter remained below 200nm for all dispersants 
but was dramatically reduced (to ~25nm) by the addition of BSA to PBS or of growth factors (GM) to 
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5.3.2   Investigation into the Cytotoxic Effects of Dispersants 
5.3.2.1   Cytotoxic Effects of Tween 20 
 
Preliminary investigations were carried out to examine the cytotoxic effects of a 2 
hour exposure to Tween 20 (0.1, 0.5, 1 and 1.5% in serum free medium) on 
HUVECs using trypan blue exclusion. Over the range examined, the number of live 
endothelial cells decreased with increasing Tween 20 concentrations (data not 
shown). However no dead endothelial cells were observed at any of these 
concentrations (data not shown). The absence of dead cells could be due to the 
detergent effects of Tween 20; upon microscopic examination of the HUVECs tested 
the cells were found to be rounder and less adherent to the cell culture plate.  
 
 
5.3.2.2   Cytotoxic Effects of Synthetic Surfactants 
 
Preliminary investigations were carried out to examine the cytotoxic effects of a 24 
hour exposure to DPPC (100μg/ml) and DPPC (100μg/ml) + BSA (250μg/ml). 
Results suggested that there was some reduction in the number of live cells and an 
increase in the number of dead cells following exposure to these dispersants (data not 
shown). These changes were subtle, and no statistical analysis was possible due to 
the low group number (n=1). However, results from other in the group (Centre for 
Inflammation Research, University of Edinburgh) also suggested that DPPC was 




5.3.3   Confirmation of the Ability of the Selected Dispersant to Maintain DEP in 
Suspension Without Particle Aggregation 
 
Suspensions of DEP (1mg/ml) were prepared using EGM-2 GM or SFM containing 
BSA (0.5mg/ml). Suspensions were then diluted using SFM to a range of 
concentrations likely to be used in cell culture experiments. Absorbance spectra of 
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these suspensions confirmed a linear relationship between sample absorbance and 
concentration (Figure 5.3a). Absorbance spectra were similar whether suspensions 
were made using SFM or GM. Measurement of mean particle diameter showed that, 
over the concentration range examined, both SFM and GM kept DEP particle size 
below 200nm (Figure 5.3b). These results indicate that either dispersant is suitable 
for preparing suspensions of DEP for use with cultured cells. SFM containing BSA 
was chosen as the dispersant for subsequent experiments as it provided good particle 
dispersion in the absence of serum and, therefore, could be used without stimulating 
endothelial cell proliferation. The amount of DEP in suspensions made using the 
SFM/BSA combination was confirmed by oven drying 1mg/ml samples. This 
showed that ~0.652mg/ml DEP was left in a stable suspension following 
centrifugation (n=6. data not shown). This value was used in all subsequent 
experiments to calculate DEP concentrations before application to HUVECs. 
 
 
5.3.4   Effects of DEP on Endothelial Cell Viability 
5.3.4.1   Trypan Blue Exclusion Assay for Cell Death 
 
Trypan blue exclusion showed a trend towards reduced cell viability dependent on 
incubation time and DEP concentration (Figure 5.4). Statistical analysis was not 
possible on these results due to the low group number (n=3). This experiment was 




5.3.4.2   Lactate Dehydrogenase Assay for Cell Death 
 
Measurement of LDH demonstrated that incubation with DEP (Figure 5.5c) had little 
or no effect on HUVEC viability, when compared with positive controls such as 
Tween 20 (0.1, 1, 5 or 10%; Figure 5.5b) and hydrogen peroxide (1, 10, 100, 500 or 
1000μM; Figure 5.5a). 
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Figure 5.3 - Characteristics of DEP Suspensions Prepared Using EGM-2 
Containing Growth Factors of Bovine Serum Albumin. 
Suspensions of DEP (10-100μg/ml) prepared in serum free EGM-2 medium containing bovine serum 
albumen (BSA) or foetal calf serum (GM) were compared for particulate concentration and size. 
Suspensions were prepared (1mg/ml) in EGM-2 GM (blue), or serum-free EGM-2 medium containing 
0.5mg/ml BSA (red), and diluted in serum-free EGM-2 to give a range of experimental 
concentrations. a) Absorbance spectra demonstrate a linear relationship between absorbance and 
concentration of DEP suspensions. Results were identical in suspensions generated using SFM/BSA 
and GM. b) Mean particle diameters remained below 200nm for all concentrations and were similar 
whether suspensions were prepared in GM (blue) or in SFM/BSA (red). Data points represent mean ± 
SEM. Statistical analysis was not performed because of low group numbers (n=4).  
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Figure 5.4 - Influence of DEP on Endothelial Cell Viability - Trypan Blue 
Exclusion Assays. 
Trypan blue exclusion assays for cell death following exposure of HUVECs to a) 20 and b) 60μg/ml 
DEP for 2, 6, 16 and 24 hours. Results suggest a time- and concentration-dependent decrease in cell 






















a) 20μg/ ml DEP 
b) 60μg/ ml DEP 
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Figure 5.5 - DEP Suspensions do not Reduce EC Viability - LDH Assay. 
a) HUVEC exposure to H2O2 (1, 10, 100, 500 or 1000μM, 24 hours) produced extensive, 
concentration -dependent cell death (n=1). b) HUVEC exposure to Tween 20 (0.1, 1, 5 or 10%, 24 
hours) produced almost total cell death at all concentrations (n=1). c) HUVEC exposure to DEP (10, 
20, 40, 60 or 80μg/ml) for 2 (red), 6 (blue), 16 (green) and 24 (purple) hours produced no increases in 
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5.3.5   The Influence of DEP Suspensions on the Endogenous Fibrinolytic System in 
Cultured Endothelial Cells 
5.3.5.1   Expression of Tie-2 in HUVECs: Reverse Transcription Polymerase Chain 
Reaction 
 
RNA was extracted from 2 samples of HUVECs and RT PCR performed using 
primers for the endothelial cell marker Tie2 (Primer sequence shown in Table 5.1). 
Bands 300bp in size were detected in HUVECs at P6, suggesting conserved 
expression of Tie2 (Figure 5.6). No bands were visible in the two negative controls; 
the first of which did not contain the reverse transcriptase enzyme necessary for RT 
PCR (-RT), and the second of which contained RNase free water instead of sample 
RNA (H2O). This experiment suggests that HUVECs up to P6 retain characteristics 
of endothelial cells and can be used for subsequent experiments. 
 
 
5.3.5.2   Reverse Transcription Polymerase Chain Reaction for t-PA and PAI-1. 
 
RT PCR was performed in preliminary experiments exposing HUVECs to DEP 
concentrations up to 80μg/ml over 2 to 24 hours. RT PCR for PAI-1 showed bands 
(325bp) in all samples, but there appeared to be no significant change in band density 
over the exposure range. An apparent increase in band brightness towards the centre 
of the gel was probably a photographic artefact (Figure 5.7). RT PCR was also 
conducted for t-PA following the same exposures. However, no bands were detected 
for any of the exposures, even though 2 different primer sets were tested (results not 
shown). This could indicate that the primers did not function correctly, or that RT-
PCR is not a sensitive enough technique to pick up basal levels of t-PA. It was, 
therefore, decided that real-time PCR would be used to study the direct effects of 
DEP on HUVECs.  
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Figure 5.6 - RT PCR showing Tie2 expression in P6 HUVECs. 
RT PCR gel showing 300bp bands in two separate samples (samples 1 and 2) of passage 6 (P6) 
HUVECs, indicating the presence of the endothelial cell marker Tie2. Bands were not present in either 
of the negative control wells; -RT contained no reverse transcriptase enzyme necessary for PCR, H2O 
contained RNase free water instead of sample RNA. HUVEC, Human umbilical vein endothelial 
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Figure 5.7 - Effects of HUVEC Exposure to DEP on PAI-1 Expression: 
Analysed by RT PCR. 
Reverse transcriptase polymerase chain reaction (RT-PCR) gel showing bands for plasminogen 
activator inhibitor (PAI-1) at 325bp in human umbilical vein endothelial cells (HUVECs). Diesel 
exhaust particulate (DEP) concentration and incubation time are shown above each band. Results 
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5.3.6   Effects of DEP Exposure on Basal Expression of Fibrinolytic Factors in 
Human Endothelial Cells. 
 
Quantitative real-time PCR analysis of HUVECs following exposure to DEP 
indicates a concentration-dependent, time-dependent decrease in t-PA expression 
(Figure 5.8c). In contrast, there appeared to be a concentration-dependent, time-
dependent increase in PAI-1 expression following exposure to DEP (Figure 5.8d). 
After 2 and 6 hour DEP incubations PAI-1 expression in cells exposed to 150μg/ml 
DEP was approximately 3 times higher than basal levels. However, this effect was 
less apparent when incubations were extended to 16 and 24 hours. Data were 
quantified with reference to internal controls, GAPDH and β-Actin, which did not 
vary in response to incubation time or exposure to DEP. Statistical analysis of these 
data was not performed due to small (n=3) group numbers. 
 
Key observations were investigated by increasing group sizes for two of the DEP 
exposures to allow statistical analysis; 6 and 24 hour exposures to 150μg/ml DEP 
were compared with control exposures for the same time periods. In both cases it 
was confirmed that exposure to DEP reduced t-PA expression (Figure 5.9a) but 
increased expression of PAI-1 (Figure 5.9b). 
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Figure 5.8 - Effects of DEP Exposure on Basal Expression of Fibrinolytic 
Factors in Human Endothelial Cells. 
Expression of tissue plasminogen activator (t-PA) and plasminogen activator inhibitor in endothelial 
cells (HUVECs) after exposure to diesel exhaust particulate (DEP; 10-150μg/ml) for up to 24 hours. 
Expression of positive controls, GAPDH (a) and β-actin (b) were unaffected following exposure to 
DEP. In contrast, exposure to DEP produced a time-dependent, concentration-dependent decrease in t-
PA expression (c) but a time-dependent, concentration-dependent increase in PAI-1 expression (d). 
Interestingly, this increase in PAI-1 expression was blunted after longer (16, 24 hour) exposures. 
Symbols represent mean ± SEM (n=3) after incubation for 2 (red), 6 (blue), 16 (green) or 24 (purple) 
hours. Expression of t-PA and PAI-1 was calculated by comparison with positive controls (GAPDH 
and β-actin) expression. Statistical comparisons were not made due to small group size.  
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Figure 5.9 - Effects of DEP Exposure on Basal Expression of Fibrinolytic 
Factors in Human Endothelial Cells - Final Analysis. 
In order to confirm that exposure to diesel exhaust particulate (DEP) reduced expression of t-PA but 
increased expression of PAI-1 in HUVECs, selected experiments were repeated to allow statistical 
analysis of results. This confirmed that exposure to DEP (150μg/ml; red columns) for 6 or 24 hours 
significantly reduced t-PA expression (a) but increased PAI-1 expression (b) compared with controls 
(blue columns). As indicated in preliminary experiments, the increase in PAI-1 expression was larger 
after 6 hours incubation, than after exposure to DEP for 24 hours. Columns represent mean ± SEM 
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5.3.7   DEP-induced Stimulation of the Fibrinolytic System in HUVECs 
5.3.7.1   Thrombin-mediated t-PA release from HUVECs - Pilot Investigation 
 
In order to assess the ability of thrombin to stimulate t-PA release HUVECs were 
exposed to thrombin (0.1-1.0 U/ml) fro 6 or 24 hours and t-PA antigen measured in 
the supernatants by ELISA (t-PA Combi Actibind ELISA kit; Technoclone GmbH, 
Vienna, Austria). Evidence of t-PA release was observed in unstimulated HUVECs 
after 24 hours (but not after 6 hours) in culture (Figure 5.10). Thrombin had no effect 
at 6 hours but produced a concentration-dependent release of t-PA after 24 hours 
stimulation. Statistical analysis of these data was not performed due to the low group 
number (n=3). However, on the basis of this preliminary data 24 hour exposure to 
thrombin was selected for subsequent experiments. 
 
 
5.3.7.2   Effects of exposure to DEP on t-PA and PAI-1 Expression in HUVECs 
 
Quantitative real-time PCR showed that exposure of HUVECs to thrombin caused an 
increase in the expression of both t-PA (Figure 5.11c) and PAI-1 (Figure 5.11d). 
These increases were attenuated by pre-exposure to DEP (16 hours, 100μg/ml). In 
contrast, expression of controls (GAPDH and β-actin) was unaffected by incubation 
with thrombin (Figures 5.11a and 5.11b). Statistical analysis of these data was not 
performed due to small group sizes (n=3). In order to enable statistical comparison, 
selected conditions (16 hour exposure to 100μg/ml DEP followed by 24 hour 
incubation with serum free medium or 0.1-1.0U/ml thrombin) were repeated to 
increase group sizes. This confirmed that pre-incubation with DEP significantly 
reduced the expression of both t-PA (Figure 5.12a) and PAI-1 (Figure 5.14b) both in 
unstimulated cells and following stimulation with thrombin. 
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Figure 5.10 - Thrombin-Mediated Stimulation of t-PA Release from HUVECs. 
HUVECS were exposed to thrombin (0,1-1.0U/ml), or vehicle, for 6 (light-grey columns) or 24 (dark-
grey columns) hours and t-PA antigen concentration was measured in the supernatant using a 
commercially available ELISA.  In vehicle-treated cells, t-PA was virtually undetectable after 6 hours’ 
incubation but had increased approximately 10 fold after 24 hours. Similarly, thrombin did not 
increase t-PA secretion after 6 hours but induced a concentration-dependent in t-PA antigen after 24 
hours exposure. Columns represent mean ± SEM (n=3). Data were not analysed statistically due to 
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Figure 5.11 - Pre-Incubation with DEP Inhibits Thrombin-Induced Expression 
of Fibrinolytic Factors in HUVECs. 
Human umbilical vein endothelial cells (HUVECs) were exposed to diesel exhaust particulate (DEP; 
100μg/ml, 16 hours. Blue line) or saline (16 hours. Red line). Cells were then washed and stimulated 
with thrombin (0.1-1.0U/ml, 24 hours) These treatments had no effect on expression of GAPDH (a) or 
β-actin (b). Incubation with thrombin produced an apparent increase in expression of tissue-
plasminogen activator (t-PA; c) and plasminogen activator inhibitor (PAI-1: d). Furthermore, 
thrombin produced a concentration-dependent increase in expression of both fibrinolytic factors, 
which was dramatically attenuated by pre-incubation with DEP. Symbols represent mean ± SEM 
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Figure 5.12 - Effects of DEP Exposure on Stimulated Expression of Fibrinolytic 
Factors in Human Endothelial Cells. 
In order to confirm the effects on expression of fibrinolytic factors of pre-incubation with diesel 
exhaust particulate (DEP; 100μg/ml, 16 hours. blue columns) in un-stimulated (red columns) human 
umbilical vein endothelial cells (HUVECs) and in cells stimulated with thrombin (1.0U/ml 24 hours), 
selected experiments were repeated to allow statistical analysis. This confirmed that pre-exposure to 
DEP significantly reduced expression of both tissue plasminogen activator (t-PA) and plasminogen 
activator inhibitor (PAI-1) in un-stimulated  (0.0U/ml thrombin) and in stimulated (1.0U/ml thrombin) 
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5.3.8   Effects of DEP Exposure on Basal and Stimulated Secretion of Fibrinolytic 
Factors by HUVECs 
5.3.8.1   The Effects of DEP on Basal and Stimulated t-PA Activity and Antigen 
Expression 
 
The combined t-PA activity and antigen ELISA failed to produce reliable results for 
the t-PA activity study (not shown). In vehicle-treated cells t-PA antigen levels 
increased in a time dependent manner in HUVEC supernatants (Figure 5.13a; n=3). 
At all time-points (2-24 hours), incubation with DEP (10-150μg/ml) produced a 
concentration-dependent inhibition of t-PA antigen levels. In order to enable 
statistical analysis, group numbers were increased for selected conditions (150mg/ml 
DEP; 6 hours and 24 hours; Figure 5.13b). This confirmed that DEP did significantly 
reduce constitutive t-PA antigen levels in HUVEC supernatant. 
 
t-PA antigen levels were considerably lower in HUVECs pre-treated with DEP 
(150mg/ ml, 16 hours) followed by incubation (24 hr) in serum free medium than in 
those pre-incubated with vehicle (Figure 5.13c). Stimulation with thrombin (0.1-
1.0U/ml, 24 hours) produced a small increase in t-PA antigen levels in HUVEC 
supernatants, with the lowest concentration of thrombin producing almost the 
maximal response (Figure 5.13c; n=3). Levels of t-PA antigen were dramatically 
reduced after exposure to DEP, although this appeared to be due to a reduction in 
basal levels, rather than to an impairment of the thrombin-stimulated release of t-PA. 
Increasing the group size to allow statistical analysis (Figure 5.13d; n=6) confirmed 
that t-PA levels were lower reduced by pre-exposure to DEP in un-stimulated cells 
and in those stimulated with thrombin (0.5U/ml; 24 hours).  
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Figure 5.13 - The Effects of DEP on Basal and Stimulated t-PA Secretion from 
HUVECs. 
The effects of prolonged culture and exposure to diesel exhaust particulate (DEP) and thrombin on 
release of tissue plasminogen activator (t-PA) from human umbilical vein endothelial cells were 
assessed by antigen levels in cell supernatants. (a) t-PA antigen increased in cells exposed to vehicle 
(0 DEP) in a time-dependent manner. Exposure to DEP (10-150μg/ ml) produced a concentration-
dependent suppression in t-PA antigen levels at all time-points (2hr, red; 6 hr, blue, 16 hr, green; 24 
hr, purple; n=3). (b) Increasing group sizes (n=6) confirmed that DEP (150μg/ ml, blue columns)-
induced inhibition of t-PA antigen levels was statistically significant, compared with vehicle (serum-
free medium)-treated controls (red columns) after 24 hours in culture. (c) Thrombin (0.1-1.0U/ml) 
produced a small increase in t-PA antigen levels (n=3). These were reduced in HUVECs pre-
incubated with 100μg/ml, DEP (red) although this appeared to be due to a reduction in basal levels 
rather than inhibition of thrombin-stimulated release. (d) Increasing group sizes confirmed that t-PA 
antigen levels were lower in supernatants from both un-stimulated and thrombin-treated HUVECs 
after pre-incubation with DEP. Symbols and columns represent mean ± SEM. Statistical comparisons 
were made using Student’s unpaired t-test **P<0.01, ***P<0.001. 
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5.3.8.2   The Effects of DEP on Basal and Stimulated PAI-1 Activity 
 
PAI-1 activity in the supernatant of HUVECs cultured (2-24 hours) in the absence of 
DEP showed an apparent increase over the first 6 hours, but then remained stable up 
to 24 hours (Figure 5.14a). Exposure to DEP (10-150μg/ ml) produced an apparent 
concentration-dependent reduction in PAI-1 activity at 6, 16 and 24 hour (but not the 
2 hr) time-points (n=3). However, increasing group sizes (n=6) for selected 
conditions (150μg/ ml DEP) indicated that levels of PAI-1 activity were similar in 
DEP- and vehicle-treated HUVECs after incubation for 6 and 24 hours (Figure 
5.14b). 
 
Prolonged (16 hr) incubation of HUVECs with DEP (100μg/ ml) followed by 
exposure to serum free medium (24 hr; vehicle control) did not dramatically alter 
PAI-1 activity in cell supernatants (Figure 5.14c; n=3). However, stimulation with 
thrombin (0.1-0.5μg/ ml; 24 hours) produced an apparent concentration-dependent 
increase in PAI-1 activity that was abolished by pre-incubation with DEP. Increasing 
selected group sizes (n=6) confirmed that pre-exposure to DEP attenuated PAI-1 
activity in supernatant from thrombin (0.5U/ml; 24 hrs)-stimulated HUVECs but not 
in vehicle-treated controls (Figure 5.14d). 
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Figure 5.14 - The Effects of DEP on Basal and Stimulated PAI-1 Activity. 
The effects of prolonged culture and exposure to diesel exhaust particulate (DEP) and thrombin on 
activity of plasminogen activator inhibitor (PAI-1) released from human umbilical vein endothelial 
cells were assessed enzyme linked immunosorbant assay (ELISA). (a) PAI-1 activity increased over 
the first 6 hours in cells exposed to vehicle (0 DEP) but then remained stable. Exposure to DEP (10-
150μg/ ml) produced a concentration-dependent suppression in t-PA antigen levels at all time-points 
(6 hr, blue, 16 hr, green; 24 hr, purple) except 2hr (red). n=3. (b) Increasing group sizes (n=6) showed 
that exposure to DEP (150μg/ ml, blue columns) reduced PAI-1 activity compared with vehicle 
(serum-free medium)-treated controls (red columns) after 6 and 24 hours in culture. (c) Thrombin 
(0.1-1.0U/ml) increased PAI-1 activity levels (n=3) but this effect was virtually abolished in HUVECs 
pre-incubated with 100μg/ml, DEP (red). (d) Increasing group sizes (n=6) confirmed that PAI-1 
activity was lower in supernatants from thrombin (0.5U/ml)-treated (but not from un-stimulated) 
HUVECs after pre-incubation with DEP. Symbols and columns represent mean ± SEM. Statistical 
comparisons were made using Student’s unpaired t-test **P<0.01, ***P<0.001. 
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5.4   Discussion 
 
The main hypothesis investigated in this chapter was that direct exposure of 
endothelial cells to DEP would induce changes in the activity of the endogenous 
fibrinolytic system. Exposure to suspensions of DEP reduced constitutive expression 
and antigenic levels of t-PA whilst increasing expression but reducing activity of   
PAI-1 in unstimulated HUVECs. Stimulation of HUVECs with thrombin caused a 
concentration-dependent increase in t-PA and PAI-1 expression mirrored by an 
increase in t-PA antigen and PAI-1 activity. Exposure to DEP prior to stimulation 
with thrombin reduced expression of both t-PA and PAI-1 and inhibited the elevation 
of t-PA antigen and PAI-1 activity. 
 
 
5.4.1   Use of HUVECs to Test the Direct Effects of DEP on the Vascular 
Endothelium 
 
Cell culture has clear advantages for assessing the direct effects of DEP on the 
vascular endothelium as it allows controlled exposures under well-defined 
conditions. Consequently, this approach has been used to assess the effects of various 
atmospheric pollutants on isolated cell populations, including endothelial cells 
(Terada et al. 1999; Bai et al. 2001; Hirano et al. 2003; Sumanasekera et al. 2007; 
Andersson et al. 2009; Xu et al. 2009; Shaw et al. 2010), epithelial cells (Terada et 
al. 1999; Matsuo et al. 2003) and leukocytes (Hirota et al. 2008; Shaw et al. 2010). It 
is possible to generate primary endothelial cell cultures from rats but for these 
studies it was decided to use an established source of human endothelial cells, as 
these would be more readily applicable (than rat cells) to the clinical situation. 
Cultured HUVECs de-differentiate after repeated passaging and lose characteristics 
of quiescent endothelial cells (Partanen et al. 1992). For this reason all HUVECs 
were used up to passage 6.  RT-PCR confirmed that passage 6 HUVECs still 
expressed the endothelial cell marker Tie-2. 
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5.4.2   Development of a Suitable Dispersant for Suspension of DEP 
 
Surprisingly few investigations have exposed cultured cells to suspensions of DEP 
(Furuyama et al. 2006) and those studies that are available have used a variety of 
solutions to suspend DEP (Sagai et al. 1993; Ichinose et al. 1995; Hashimoto et al. 
2000; Matsuo et al. 2003; Alfaro-Moreno et al. 2006). The choice of suspending 
medium was important as a vehicle was needed that would not compromise cell 
viability, would enable generation of a range of DEP concentrations, would keep the 
particles in suspension and would prevent excessive clumping of the nanoparticles. 
Preliminary investigations demonstrated that serum free EGM-2 was not suitable as a 
dispersant as DEP did not remain in suspension and measurement of particle 
diameter suggested clumping. Some studies reporting the effects of DEP on cultured 
cells do not report how dispersion was achieved (Takizawa et al. 2000), while others 
simply used cell culture medium (Hashimoto et al. 2000; Alfaro-Moreno et al. 2007) 
without reporting the resulting particle size or suspension stability. One group used 
the detergent Tween 80 (0.0025%) to disperse DEP for cell culture experiments 
(Matsuo et al. 2003), without apparent consideration to the effects of the detergent 
on cell viability. Addition of Tween 20 to EGM produced stable suspensions with 
particle size in the required range (<200nm). However, pilot data also suggested that 
Tween 20, even at concentrations of 0.01% in EGM-2, caused significant endothelial 
cell death (LDH Assay).  This was considered most likely due to the ability of 
detergents to disrupt cell membranes (Culvenor et al. 1982). Given the pilot data 
showing that Tween 20 was toxic to HUVECs, attempts were made to find an 
alternative dispersant for DEP for use in subsequent experiments. 
 
Since DEP entering the lungs will encounter pulmonary surfactant, it was proposed 
that modelling this environment might provide a method for maintaining particulates 
in suspension. This possibility was assessed using a synthetic form of DPPC (a 
phospholipid that is the strongest surfactant in the lungs; Fisher & Dodia. 1997). Use 
of this compound was intended simply to improve dispersion of DEP, not to model 
the intra-pulmonary environment. Initial results were encouraging, as addition of 
DPPC to EGM-2 helped keep the particulates in suspension and appeared to prevent 
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clumping. However trials with DPPC were discontinued as others in the group 
produced evidence to suggest that DPPC was toxic to cultured cells (Dr Craig 
Poland, Centre for Inflammation Research, University of Edinburgh). This is, 
perhaps unsurprising, since surfactants (including DPPC) have been shown 
previously to cause cell lysis (Findlay et al. 1995).  
 
Pilot investigations indicated that stable DEP suspensions were formed in ‘growth 
medium’ (EGM-2 containing growth factors and foetal calf serum). However, this 
medium was not suitable for the experiments planned as it stimulates HUVEC 
proliferation. Healthy ECs in vivo are generally quiescent (Zhang et al. 1999) and, 
therefore, a non-proliferative equivalent to growth medium was required. This would 
also make any exposure results easier to interpret, as cell proliferation would not 
occur in any exposures. Therefore mRNA expression and protein levels were always 
calculated from the same number of endothelial cells. To this end, BSA was added to 
serum free EGM-2, as it is a large protein used to simulate blood composition, and 
has been used in previous cell culture experiments to stabilise experimental 
suspensions (Shires et al. 1989; Fischer et al. 1995). Early investigation found that 
BSA provided optimal DEP dispersal when it was used at half the concentration of 
DEP in serum free cell culture medium; a high proportion of DEP was retained in a 
stable suspension (0.652mg/ml from an original 1mg/ml stock, after sonication and 
centrifugation) with a low mean particle diameter (<50nm). Consequently, EGM-2 
containing 0.5mg/ml BSA was chosen as the dispersant for DEP for use in cell 
culture experiments. Having identified a suitable dispersant it was then possible to 
expose HUVECs to DEP suspensions and assess whether this treatment altered the 
activity of the endogenous fibrinolytic system in these cells. 
 
 
5.4.3   Does DEP alter activity of the Endogenous Fibrinolytic System in HUVECs? 
 
Few previous studies have reported the effects of exposing endothelial cells to 
pollutant particulates on the fibrinolytic system. It is apparent, however, that DEP 
can influence endothelial cell function as much research has been conducted into the 
Chapter 5 - The Influence of Diesel Exhaust Particulates on the Thrombolytic System in Cultured 
Human Umbilical Vein Endothelial Cells 
 187
effects of DEP on oxidative stress and DNA damage (reviewed by Risom et al. 
2005). Using suspensions prepared in EGM-2 plus BSA, HUVECs were exposed to 
DEP over a range of concentrations (0-150μg/ml) and timepoints (2, 6, 16 and 24 
hours) in order to assess its effects on the basal release of fibrinolytic factors. 
Analysis of the cells using real time PCR showed a decrease in t-PA expression, but 
an increase in PAI-1 expression, which were both time and concentration dependent. 
Measurement of antigen levels in the culture medium indicated that t-PA 
accumulated over time but this was completely abolished in the presence of DEP. 
PAI-1 activity also increased in medium over time (although this peaked earlier than 
t-PA antigen; at 6, rather than 24, hours) and was also inhibited in the presence of 
DEP. This suppression of PAI-1 is consistent with the effects previously reported 
with organic extracts of DEP and ultrafine particles (Furuyama et al. 2006), although 
Furuyama et al. (2006) found no effect of these compounds on t-PA production. 
Interestingly, though, exposure to carbon black (CB) has been shown to inhibit both 
t-PA expression and protein production in cultured HUVECs (Gilmour et al. 2005). 
It is also notable, however, that the measurements of mRNA are not consistent with 
measurements obtained by ELISA. Most striking is the increased PAI-1 expression 
in response to DEP in the cells but reduced PAI-1 activity in the medium. Since DEP 
was present in the medium for the course of this experiment, it is possible that t-PA 
and PAI-1 released into the medium were bound by the DEP. If this is the case, the 
measurements obtained by ELISA must be viewed with caution. However, the ability 
of DEP to bind these proteins, or inhibit their activity, would be interesting as this 
may contribute to the effects of nanoparticulates in vivo. 
 
The second series of experiments was designed to investigate the effects of DEP on 
stimulated release of fibrinolytic factors. To this end, HUVECs were pre-incubated 
with DEP (or serum free medium alone), followed by stimulation with thrombin 
(Hanss & Collen. 1987). One bonus of this study design is that DEP is absent from 
the culture medium during stimulation with thrombin, removing the possibility that 
fibrinolytic factors may be absorbed by suspended particulate. Thrombin was chosen 
to stimulate fibrinolytic factor production as it has been shown previously to increase 
the expression and release of t-PA and PAI-1 from bovine (Fukushima et al. 1989) 
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and human endothelial cells (Gelehrter et al. 1986), including HUVECs (Hanss & 
Collen. 1987; Seljeflot et al. 1995). These experiments showed that pre-incubation 
with DEP caused significant reductions in thrombin-stimulated t-PA and PAI-1 
expression and release. In these experiments the results of the ELISAs mirrored the 
PCR results. Since the DEP in these experiments was washed from the cells before 
adding thrombin, this supports the proposal that the presence of DEP in the cell 
culture medium may have affected the results of the original experiment studying 
basal expression. No previous studies investigating the effects of particles on 
stimulated release of fibrinolytic factors are available in the literature. Preliminary 
investigations demonstrated that, after 6 hours in culture, significant concentrations 
of t-PA could not be detected in medium from unstimulated HUVECs and exposure 
to thrombin had no effect. In contrast, after 24 hours in culture, t-PA was detectable 
in the medium and exposure to thrombin produced an apparent concentration-
dependent increase in t-PA concentrations. Using these exposure conditions, 
quantitative real time PCR confirmed that pre-exposure to DEP reduced expression 
of t-PA in unstimulated cells. Consequently, t-PA expression was lower in thrombin-
stimulated cells and the thrombin-induced increase in expression appeared blunted. 
Measurements of t-PA in the culture medium were broadly consistent with these 
results. Pre-incubation with DEP reduced t-PA concentration in culture medium, but 
did not block the thrombin-stimulated release of t-PA. One possible interpretation of 
these results was that the pre-incubation with DEP reduced the cells’ ability to 
produce or release t-PA; even though the DEP suspension was washed from the cells 
prior to incubation with thrombin, DEP was observed adhered to the cell surface, 
which remained in place throughout the thrombin incubations. It is possible that the 
adhered DEP reduced the cells’ ability to react to the thrombin signal, resulting in 
reduced t-PA mRNA expression and antigen levels. It is also possible that this 
mechanism was at work in cells exposed to only SFM for the second exposure; 
reducing resting t-PA mRNA expression and antigen levels. 
 
Measurements of the effects of DEP on thrombin-induced PAI-1 activity produced 
conflicting data. In contrast with the original experiments (measuring basal PAI-1), 
pre-incubation with DEP produced a small, but significant, reduction in PAI-1 
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expression. This contrasts with the apparent increase observed in the previous 
investigations. As with t-PA, exposure to thrombin produced a concentration-
dependent increase in PAI-1 expression in cells and activity in the medium; both 
these increases were completely abolished in cells previously exposed to DEP. As 
with the previous experiments, investigating the effects of DEP on thrombin 
stimulated t-PA mRNA expression and antigen levels, it is possible that DEP 
adhered to the cell surface reduced the cells ability to react to the thrombin signal in 
order to produce and release PAI-1. 
 
The DEP-induced changes in t-PA and PAI-1 indicate that direct exposure of 
endothelial cells to DEP can produce alterations in the endogenous fibrinolytic 
system both under basal conditions and following stimulation. The reduced 
expression and release of t-PA is consistent with measurements of plasma t-PA 
following intravenous injection of DEP (Chapter 4) and also with the previous 
demonstration that inhalation of DEP alters endogenous fibrinolysis in humans 
(Mills et al. 2005). Interestingly, this clinical study suggested that exposure to DEP 
did not alter basal circulating levels of t-PA or PAI-1, but did attenuate bradykinin-
induced release of t-PA 6 hours (but not 2hrs) after inhalation. The timing of these 
changes suggests the involvement of an inducible pathway or changes in protein 
synthesis. The reduced t-PA generation in response to DEP is similar to changes 
reported in cigarette smokers (Newby et al. 1999) and linked to atherothrombosis 
(Newby et al. 2001). Human exposure to DEP has not always produced 
demonstrable changes in fibrinolytic factors; however, two previous studies indicate 
no change in a variety of coagulation factors, including t-PA and PAI-1 (Carlsten et 
al. 2007; Baccarelli et al. 2007). Combination of these in vivo and clinical studies 
with the data reported in this chapter could indicate a direct effect of DEP on the 
endothelial-fibrinolytic system. It was notable, however, that injection of CB 
(Chapter 4) produced a similar reduction in t-PA in vivo. This suggests that 
interaction with endothelial cells is a property common to nanoparticulates and is 
consistent with previous demonstrations that CB can influence endothelial cell 
function (Gilmour et al. 2005; Yamawaki & Iwai. 2006; Shaw et al. 2010). This 
interpretation might be an over simplification, however, as instillation of particulates 
Chapter 5 - The Influence of Diesel Exhaust Particulates on the Thrombolytic System in Cultured 
Human Umbilical Vein Endothelial Cells 
 190
(DEP, CB and quartz) also reduced t-PA in the plasma (Chapter 4). It is conceivable 
that translocation of particles, and thus direct interaction with the endothelium, could 
be occurring with DEP and CB (although it seems unlikely that this could produce a 
sufficiently high concentration of particles in the blood). Quartz, by contrast, is too 
large to translocate and, thus, the alterations in t-PA activity are more likely 
secondary to the inflammatory response to particle administration. Chronic 
inflammation has been associated with impairment of the endogenous fibrinolytic 
system in vivo (Speidl et al. 2005; Agirbasli et al 2006; Matejovic et al. 2007), while 
the antioxidant ascorbic acid has been shown to restore the fibrinolytic function of 
chronic smokers by reducing systemic inflammation (Kaehler et al. 2008). 
Inflammatory stimuli, such as endotoxin, have also been shown to reduce fibrinolytic 
activity both in animal models (Krishnamurti et al. 1991) and in cultured endothelial 
cells (Colucci et al. 1985; Schleef & Loskutoff. 1988; al-Azhary et al. 1994). This 
mechanism is likely to occur in animals exposed to quartz, and to a lesser extent CB 
and DEP, and may be partly responsible for the changes in expression of fibrinolytic 
factors observed with all 3 particles. 
 
The effects of DEP on PAI-1 in HUVECs were less consistent and do not fit so 
readily with the in vivo data. Initial demonstrations of increased PAI-1 expression in 
response to DEP (in unstimulated cells) were consistent with a small increase in 
circulating PAI-1 following injection or instillation of particulates in vivo (Chapter 
4). This was not supported, however, by subsequent investigations in which pre-
exposure to DEP reduced both unstimulated and basal expression and activity of 
PAI-1. These differences are difficult to explain and must be attributed to variations 
in study design. What they do indicate, however, is that direct exposure to DEP can 
alter PAI-1 expression in HUVECs, even if the nature of this alteration remains 
unclear. As with the t-PA, changes in PAI-1 in vivo were common to all particulates 
and independent of exposure route. This suggests, therefore, that alteration of PAI-1 
may be a feature of nanoparticulates in general (rather than an exclusive property of 
DEP) and may also be influenced by inflammatory responses in vivo. 
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The results of these cell culture experiments support the hypothesis that DEP can 
directly alter the endogenous fibrinolytic system in endothelial cells. Thus, if DEP 
can translocate from the lung to the systemic circulation, it is possible that their 
actions on the endothelium could contribute to increased thrombus formation. The 
evidence for particle translocation, however, remains very sparse and was not 
assessed directly in the work described in this thesis. It should be noted that all of 
these proof-of-concept experiments used high concentrations of DEP and it seems 
unlikely that sufficient particles could move from the lungs to alter endothelial cell 
function; at least in acute investigations. Chronic exposure to DEP could conceivably 
result in particle translocation and accumulation at vulnerable sites in the vasculature 
but this remains to be shown. The mechanisms through which DEP interact with 
HUVECs were not investigated in these experiments but there is considerable 
evidence to suggest that the toxicity (Donaldson et al. 2003) and pro-inflammatory 
capabilities (Baeza-Squiban et al. 1999; Nel et al. 2001) of these particles is 
mediated by oxidative stress. It is also possible that DEP enter endothelial cells via 
scavenger pathways (Apopa et al. 2009). Recent work by my group has shown, using 
electron microscopy, that DEP accumulate within cultured endothelial cells 
following exposures similar to those described in this chapter (Shaw et al. 2010). If 
this process also occurs in vivo it may provide further insight into the mechanism(s) 
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6.1   Summary 
 
The main hypothesis addressed in this thesis is that exposure to air pollution, 
specifically diesel exhaust particulate (DEP) pollution, increases thrombogenicity 
through alterations in the endogenous thrombolytic system. There is some limited 
evidence from clinical and pre-clinical studies to support this hypothesis, and also that 
nanoparticles in general increase thrombosis and that particulate pollution alters 
function of the cardiovascular system (Nemmar et al. 2003c; Nemmar et al. 2004a; 
Mills et al. 2005; Nemmar et al. 2005; Radomski et al. 2005; Mills et al. 2007; 
Tornqvist et al. 2007; Geys et al. 2008; Lucking et al. 2008; Nemmar et al. 2009). To 
address this hypothesis, it was first necessary to develop a usable experimental model 
of arterial thrombosis in vivo and then to use this model to investigate the effects of 
DEP on thrombus formation and breakdown. With this model, and the use of control 
particulates, it was possible to address the importance of systemic and pulmonary 
inflammation in the modulation of thrombogenesis, by comparing the effects of 
intravenous and intratracheal administration of particles. This design also provided 
indirect evidence of the potential role of particle translocation in mediating the 
response to DEP. Having demonstrated accelerated thrombus formation in response to 
DEP administration in vivo, the second aim was to determine the impact of direct 
exposure of vascular cells to DEP on the endogenous thrombolytic system, by 
detailed mechanistic examination of cultured endothelial cells exposed to DEP in 
vitro. 
 
The key results of these studies were that DEP administration, via either instillation or 
injection, caused an increase in the rate of thrombus formation, which was not 
dependent on pulmonary or systemic inflammation. This action appeared to be 
mediated through increases in platelet-monocyte aggregation. Changes in the 
endogenous fibrinolytic system (reduced tissue plasminogen activator (t-PA) and a 
tendency to increased plasminogen activator inhibitor (PAI-1)) were detected but 
were also produced by control particles (which did not alter thrombus formation). In 
vitro investigations confirmed that DEP could alter endogenous fibrinolytic function 
by direct interaction with endothelial cells. 
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6.2   Main Conclusions 
 
Several methods were considered for assessing the effects of particulates on clotting 
and thrombus formation. In initial investigations, measurement of tail tip bleeding 
time was used to examine blood clotting; with a significant reduction in clotting time 
observed after intravenous injection of DEP. However, extension of this method 
beyond the pilot investigations did not replicate these initial results. The only 
difference between these experiments was the length of time the animals were 
exposed to anaesthesia; in pilot experiments the animals were sedated for the entire 2 
hour exposure period, whereas in the subsequent experiments the animals were 
allowed to regain consciousness after exposure until the required timepoint for 
assessment of clotting. This suggests that the length of anaesthesia had an effect on 
bleeding time in rats, although there appears to be no data available in the literature 
assessing the effect of extended on anaesthesia on clotting activity. It is also possible 
that the extended period of anaesthesia in preliminary investigations caused a stress 
response in the experimental animals, leading to increased coagulability, although this 
cannot be substantiated. 
 
Initial work developing the Folts model of arterial thrombosis proved to be 
problematic. This model did not reliably cause thrombus formation in experimental 
animals, and when thrombus formation did occur it was very difficult to embolise; a 
key step in the quantification of coagulation in this model. Communication with other 
groups who had previously used this method indicated that poor reliability of 
thrombus formation and embolisation was a recurrent issue. Therefore, it was decided 
that an alternative approach should be attempted. The model of ferric chloride 
(FeCl3)-induced carotid artery thrombosis proved to be a reliable alternative; 
consistently generating clot formation in a reproducible time frame. In this model loss 
of blood flow is measured during thrombus formation at a site of iron-induced injury. 
Following pilot experiments to establish reproducibility, this model was used to assess 
the effects of DEP on thrombus formation and inflammation 2, 6 and 24 hours after 
intratracheal instillation or intravenous injection. These experiments were expanded 
by the use of control particles; the effects of carbon black (CB) and quartz (DQ12) 
were examined 6 hours after intratracheal instillation and the effects of CB were 
Chapter 6 - Discussion 
 
 194
examined 2 hours after intravenous injection. CB is a carbon particle of comparable 
size to DEP, without the volatile groups, metals and organic compounds associated 
with the surface of DEP. DQ12 is a large non-carbon particle, which induces 
pulmonary inflammation without the possibility of translocation into the circulation. 
Both CB and DQ12 were used as controls in instillation experiments. In contrast, CB 
alone was used as a control for intravenous administration of DEP, as DQ12 is too 
large to translocate from the lungs, and was used specifically to investigate the effects 
of pulmonary inflammation on thrombus formation. These experiments showed that 
DEP caused a significant reduction in time to thrombus formation, results that were 
supported by the demonstration of increased plasma levels of fibrinogen and D-Dimer 
in DEP-treated animals. Lesser reductions in time to thrombus formation were 
observed with control particles, with statistical significance only observed 2 hours 
after CB injection. The combination of these results shows that DEP has greater 
effects on increasing thrombus formation than CB, a clean carbon nanoparticle. This 
suggests that the volatile groups, metals and organic compounds associated with the 
DEP surface may play a role in enhancing the effects of the carbon core in terms of 
thrombus formation. Some compounds associated with the DEP surface, such as 
hydrocarbons, have been linked to the pulmonary inflammatory actions of DEP (Fahy 
et al. 2009; Holder et al. 2007), and possibly cardiovascular actions, including 
oxidative stress (Hirano et al. 2003). However, this is the first time that clear evidence 
has been provided for the direct role of DEP surface constituents on thrombus 
formation. 
 
The ability of DEP and control particles to induce pulmonary and systemic 
inflammation were assessed by measuring their effects on levels of established 
markers of inflammation; namely, a range of cytokines, including interleukin 6 (IL-6), 
tumour necrosis factor alpha (TNFα) and C reactive protein (CRP). These cytokines 
have been used previously as markers of pulmonary and systemic inflammation 
(Donaldson et al. 2001; Saber et al. 2006; Sunil et al. 2009; Nemmar et al. 2010; 
Mills et al., 2005). These experiments showed that the control particles, CB and 
DQ12, caused a higher degree of both pulmonary and systemic inflammation than 
DEP. This was not initially expected; the concentration of DQ12 was chosen 
specifically to elicit the same inflammatory response as the chosen DEP 
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concentration. At the start of these investigations it had been anticipated that CB 
would essentially be an inert particle with few physiological effects. This proved not 
to be the case, however, as (similarly to DQ12) the level of pulmonary inflammation 
caused by CB was far in excess of that produced by DEP. This indication that CB is 
an active particle is consistent with results reported by other groups (Yamawaki & 
Iwai. 2006) and has been has been confirmed by recent experiments in our 
laboratories (Miller et al. 2009; Shaw et al. 2010), which have shown that CB 
produces higher levels of free radicals than DEP and are able to stimulate cytokine 
production from cultured endothelial and inflammatory cells. Comparison of 
measurements of inflammation and arterial thrombus formation indicated that 
inflammation cannot be the only factor in determining thrombogenicity. For example, 
exposure to DEP clearly increased thrombus formation but had relatively small effects 
on systemic and pulmonary inflammation. In contrast, CB and DQ12 caused 
considerable pro-inflammatory changes but had relatively modest (if any) effects on 
thrombogenesis. 
 
In order to further understand the mechanisms through which DEP accelerated 
thrombus formation, a series of assays were performed to assess the effects of 
nanoparticles on platelet function and the fibrinolytic system. DEP injection and 
instillation caused increases in platelet-monocyte aggregation, consistent with 
previous demonstrations that that platelet activation is involved with the increase in 
thrombogenicity (Lucking et al., 2008; Nemmar et al., 2003). DEP also reduced 
protein levels of t-PA, while control particles appeared to have more of an impact on 
increasing PAI-1 protein levels. Regardless, when the t-PA/PAI-1 ratio was 
examined, all three particles produced a similar reduction when compared with saline 
controls. It is clear that DEP has an impact on t-PA and PAI-1 expression, but these 
effects alone do not explain the differences in thrombus formation observed between 
DEP and the control particles. An outline of the fibrinolytic system is given, and the 
changes in this system caused by particle exposure outlined, in Figure 6.1. 
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Figure 6.1 - Changes in the Fibrinolytic System Caused by Particulate Exposure. 
a) Outline of the fibrinolytic system. Thrombus formation in the vessel is generated by platelet 
activation and aggregation at the site of endothelial denudation, which is stabilised via the conversion 
of fibrinogen to fibrin. Endothelial cells release tissue plasminogen activator (t-PA) in response to 
thrombus formation, which converts inactive plasminogen to active plasmin, which then dissolves the 
thrombus by breaking down fibrin into fibrin degradation products and D dimer. The actions of t-PA 
are controlled by plasminogen activator inhibitor (PAI-1), which regulates fibrinolytic activity. b) 
Table outlining the effects of diesel exhaust particulates (DEP), and control particles carbon black (CB) 
and quartz (DQ12), on components of the fibrinolytic system. ↑ = increased expression, ↓ = decreased 























 t-PA PAI-1 t-PA/PAI-1 Fibrinogen D Dimer 
DEP ↓ ↑ ↓ ↑ ↑ 
CB/DQ12 ↓ ↑ ↓ N/C N/C 
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In vitro investigations were performed to determine whether the ability of DEP to 
alter endogenous fibrinolysis, as demonstrated in clinical studies (Mills et al. 2005, 
Mills et al. 2007), could be attributed to direct interaction with the vascular 
endothelium. Much of the initial in vitro work involved development of a suitable 
dispersant for DEP for use in cell culture experiments. This is an issue that appeared 
not to have been addressed previously in studies investigating the effects of DEP in 
cell culture. Assessment of the effects of a range of DEP dispersants on particle size 
and suspension stability found that EGM-2 culture medium containing 0.5mg/ml 
bovine serum album (BSA) was the best dispersant to use in cell culture. Using this 
dispersant, human endothelial cells were exposed to suspensions of DEP to examine 
its effects on the basal and stimulated release of t-PA and PAI-1. The results of the 
experiments on basal release were consistent with the in vivo experiments examining 
the effects of particulate exposure on t-PA and PAI-1; t-PA mRNA transcripts and 
antigen levels were reduced with increasing DEP exposure, while PAI-1 mRNA 
transcripts and antigen levels increased. This observation confirms the results of the in 
vivo studies, but also shows that the effects of DEP on components of the fibrinolytic 
system are both concentration- and time-dependent. Stimulated t-PA and PAI-1 
release was examined by exposing endothelial cells to thrombin after incubation of 
the cells with DEP. This provided an in vitro approximation of the processes that 
accompany thrombus formation in vivo, in which an acute release of t-PA is necessary 
for thrombus breakdown. This exposure reduced expression and secretion of both 
factors following DEP treatment. The mechanism(s) responsible for this action of 
DEP was not investigated, although previous investigations implicate a role for 
oxidative stress. DEP particles were observed to adhere to the endothelial cell surface 
in culture and it is possible that this may have interfered with the interaction of 
thrombin with the endothelial cell surface. It seems unlikely that a similar mechanism 
would be significant in humans exposed, as there is no evidence that sufficient 
concentrations of DEP translocate from the lungs to the systemic circulation. 
 
In conclusion, the work presented in this thesis examines the effect of DEP exposure 
on thrombogenicity, pulmonary and systemic inflammation, platelet function and the 
fibrinolytic system. The results obtained with DEP have been compared with control 
particles, in order to clarify the mechanisms of the effects observed. Similarly, two 
different methods of administration were used to determine whether pulmonary 
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inflammation was necessary to induce the pro-thrombotic effects of DEP. 
Administration of DEP via the tail vein demonstrated that direct interaction of these 
particles with the cardiovascular system could alter thrombus formation. Despite this, 
the contribution of particle translocation to accelerated thrombosis following 
instillation induced was not examined and remains unresolved. No data were 
generated to support a role for particle translocation into the systemic circulation after 
instillation. It is more likely that the inflammatory effects of the three particles 
investigated have some downstream effects on fibrinolysis, but this does not explain 
the additional effects of DEP, which caused least inflammation but most pro-
thrombotic effects. Comparing the effects of DEP to CB, it seems likely that the 
volatiles, metals and organic compounds associated with the DEP surface cause 
further changes to platelet function and the fibrinolytic system, possibly by 
dissociating from the particle surface in the lungs and translocating into the 
bloodstream alone.  
 
 
6.3   Implications 
6.3.1   Atmospheric pollution 
 
The demonstration that exposure to DEP accelerates thrombosis is consistent with 
observations made in clinical studies (Mills et al. 2005; Mills et al. 2007; Lucking et 
al. 2008). These results are, therefore, applicable to man and may help to influence 
current health policies and advice designed to inform people about, and protect them 
from, dangerous exposures to atmospheric pollution. This may be especially 
important to those at risk of myocardial infarction. The current level of concern about 
the health implications of atmospheric pollution is emphasised by the recent 
publication of a report by the Environmental Audit Committee (UK Parliament 
investigation) and coverage of the issue by the National media (including the BBC). 
 
The most obvious advice suggested by the results of this work would be to avoid 
sources of significant particulate pollution, particularly emissions from road traffic. 
However, whilst logical, this advice may simply not be practical, or even possible, for 
many people to follow in today’s society. An alternative approach to reducing 
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exposure to DEP is through the development of vehicles designed to run using 
hydrocarbon-free fuels, such as electricity and hydrogen fuel cells, as found in the 
new Honda FCX Clarity (currently under consumer testing in America). It could be 
argued that provision of greater resources to develop this type of technology would 
have clear health-care benefits. Similar arguments would support the further 
development of bio-fuels and filters designed to reduce particulate emissions from 
current engine exhausts. Worldwide adoption of vehicular modifications such as these 
could have a dramatic effect on reducing morbidity and mortality due to 
cardiovascular events in the developed world, especially in densely populated areas.  
 
In addition to traffic-derived particulate emissions, other sources of particulate 
pollution, such as wood smoke and coal-fuelled power plants should also be 
considered. Coal fly-ash from power plants acutely increases pulmonary and systemic 
inflammation in rats (Smith et al. 2006) whilst similar effects of wood smoke have 
been identified in fire fighters (Swiston et al. 2008). These sources of particulate 
pollution have not, however, been linked with cardiovascular and thrombotic 
complications, supporting the contention that it is nanoparticulates (particularly those 
such as DEP with combustion-derived compounds on their surface), that have the 
most dramatic influence on the cardiovascular system. 
 
This work also suggests possible new treatment advice for patients presenting with 
myocardial infarction. Thrombolysis (using streptokinase, urokinase or t-PA) is 
currently the standard pharmacological approach to restoring vessel patency following 
myocardial infarction or stroke (Shaughnessy & Scow. 1996; Rentrop et al. 1979). 
However, strict guidelines must be adhered to before treating a patient with t-PA, as 
bleeding complications can occur. For myocardial infarction, physical intervention, 
such as angioplasty (Fung et al. 1986), is used to restore patency in individuals for 
whom thrombolytic therapy is contraindicated. Anti-platelet regimens (such as daily 
administration of aspirin) can also be used as these improve survival and also enhance 
the effect of thrombolytic therapy. The data described in this thesis, combined with 
results of clinical investigations (Mills et al. 2005; Mills et al. 2007; Lucking et al. 
2008) suggest that prophylactic anti-platelet therapy (for example with aspirin) may 
be beneficial in individuals with a high risk of myocardial infarction who are 
regularly exposed to high levels of air pollution (such as road traffic exhaust). The 
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benefit of this approach would, obviously, have to be balanced against potential side 
effects (such as the development of stomach ulcers). Further clinical studies would be 
required to confirm the benefit of this approach in at-risk patients. 
 
 
6.3.2   Engineered and Medical Nanoparticles 
 
The work described in this thesis may also have relevance beyond the issue of 
atmospheric pollution. A clear example of this is in its application to understanding 
the potential cardiovascular risk of nanoparticle use in clinical practice. Several 
different types of nanoparticulate (such as quantum dots and ultrasmall paramagnetic 
iron oxides (USPIOs)) have potential clinical applications; for example for the 
identification and targeting of cancer cells and for imaging arterial inflammation/ 
lesion development. Quantum dots, nanoparticle crystal semiconductors that emit 
visible light upon excitation, can be bio-engineered to specifically target cellular 
markers of disease. Their use is currently being researched to aid identification of 
pancreatic cancer cells (by conjugation with specific antibodies such as anti-claudin 4 
and anti-prostate stem cell antigen (Yong et al. 2009)), and breast cancer cells (by 
conjugation with human epidermal growth factor receptor 2 (Chen et al. 2009)). Since 
quantum dots are much more efficient than traditional organic dyes (they emit a 
brighter signal and are much more stable (Walling et al. 2009)), their use promises to 
greatly improve our understanding of the mechanisms underlying disease 
pathogenesis. Current use has been largely limited to in vitro testing, but initial 
attempts have been made to target tumour cells in vivo using animal models (Ballou et 
al. 2004). Adverse effects identified using in vitro techniques may limit the potential 
of quantum dots. For example, exposure of quantum dots to ultraviolet light caused 
the release of (highly toxic) cadmium (Lee et al. 2009), although this seems more 
likely to produce a waste disposal problem than to happen in vivo. Previous work in 
mice has also shown that quantum dots remain in the body for up to 4 months (Ballou 
et al. 2004), indicating a need for long-term studies to ensure that these nanoparticles 
do not cause vascular injury and inflammation for a significant period of time after 
administration. This could be important since several different types of nanoparticle 
(including polystyrene and carbon nanotubes) have detrimental effects on the 
cardiovascular system; for example, carbon nanotubes accelerate the progression of 
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atherosclerosis in ApoE knockout mice (Li et al. 2007). Given the results reported in 
this thesis, it must also be considered possible that quantum dots may influence 
thrombosis. Indeed, one study has shown that high doses of quantum dots cause 
pulmonary vascular thrombosis, possibly by stimulating the coagulation cascade via 
contact activation (Geys et al. 2008). Similar concerns could be raised for the use of 
USPIOs, which have potential clinical application for enhancement of molecular 
resonance imaging of sites of vascular inflammation/lesion formation (Tang et al. 
2009). Much more work is required to ensure that nanoparticles such as quantum dots 
and USPIOs do not have the same effects on the thrombolytic system as the DEP 
described in this thesis. 
 
Another use for engineered nanoparticles is in water purification, with nanoparticulate 
gold and palladium added to drinking water in order to degrade biological and 
chemical toxins (Heck et al. 2009). Previous work, including data presented in this 
thesis, shows that the issue of nanoparticle translocation has not been successfully 
resolved. Although the lungs and the gastrointestinal tract are anatomically very 
different, it is not inconceivable that a proportion of nanoparticles could enter the 
blood stream via absorption through the gut and cause changes in the cardiovascular 
system. Gold nanoparticles are also being developed to target cancer cells, allowing 
them to be destroyed using a laser, or preventing them from multiplying in areas that 
cannot be targeted by laser (Kang et al. 2010). Again, as with the previous examples, 
this appears to be an exciting area of research, which has the potential to save many 
lives. There is no direct evidence linking nanoparticulate gold to cardiovascular 
disease, and gold is a very inert particle. However, once again the long-term impact of 
these nanoparticles appears not to have been taken fully into consideration. Further 
work must be conducted before these treatments are routinely used, in order to fully 
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6.4   Future Work 
 
This work described in this thesis has provided insights into the mechanisms 
contributing to the reported increase in cardiovascular events following acute 
exposure to atmospheric pollution. Despite this, many questions concerning the 
relationship between atmospheric particulate pollution and atherothrombosis remain. 
 
The studies described were designed specifically to investigate the causes of increased 
cardiovascular events in response to recent exposure to environmental pollution 
(Peters et al. 2004). They were not, however, designed to address the cardiovascular 
implications of chronic exposure to elevated levels of DEP. There is increasing 
evidence that chronic exposure to atmospheric pollutants, and particularly to vehicle 
exhaust emissions, has detrimental effects on the cardiovascular system (for example, 
see Sun et al. 2005). Furthermore, it seems logical that exposure to atmospheric 
pollution may have similarities to the effects of cigarette smoking, which has well-
described cardiovascular consequences (Davies et al. 1997; Chen et al. 1995) 
including impairment of endogenous fibrinolysis (Newby et al. 1999). If this is true, it 
is also possible that individuals exposed to atmospheric pollution may exhibit an 
equivalent of the ‘smokers’ paradox’; that is they may be more likely to develop 
occlusive thrombotic disease but also may be more responsive to thrombolytic 
therapy (Purcell et al. 1999; Newby & Boon. 1999). These possibilities emphasise the 
importance of investigating the effects of chronic exposure to DEP on thrombogenesis 
and the endogenous fibrinolytic system in vivo. This could be achieved by repeated 
instillations or injections of DEP at relevant concentrations over a period of weeks or 
months. Administration of DEP by inhalation would be desirable in such 
investigations but would have to be performed carefully to ensure the specified dose 
of DEP reached the lungs (the complex structure of the rodent nasal passage, and the 
fact that particles often stick to the coat, may dramatically reduce the pulmonary 
exposure to atmospheric pollutants). 
 
It would also be interesting to assess the impact of DEP administration on 
thrombogenesis in animals with pre-existing cardiovascular disease. The effects of 
acute exposure to atmospheric pollution on cardiovascular events are likely to occur 
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in individuals with pre-existing atherosclerotic disease. Therefore, it would be logical 
to apply the FeCl3 model of arterial thrombosis to animals with pre-existing 
atherosclerotic lesions and/or endothelial cell dysfunction. 
 
Further experiments could also be performed in an effort to identify more clearly the 
component(s) of the DEP responsible for the observed changes in thrombogenesis and 
the endogenous fibrinolytic system. ‘Washing’ DEP with dichloromethane allows 
removal of organic compounds from the surface of the particles (Takano et al. 2007). 
The organic compounds and washed DEP could then be tested separately, via 
instillation and injection using the in vivo model described in this thesis, to determine 
which component(s) contribute to alterations in clotting activity. This approach is 
currently being used by my group to determine which components of DEP contribute 
to particulate-mediated alterations in arterial function in vitro (Miller et al. 2009). 
 
Finally, further study is required for complete clarification of the mechanism 
responsible for DEP-induced acceleration of thrombus formation. While differences 
in expression and activity of enzymes within the thrombolytic system were 
demonstrated, further investigations could be performed to clarify the role of 
particular components of the endogenous fibrinolytic system in. The use of transgenic 
animals, such as the PAI-1 deficient transgenic mouse (Liu et al. 2009), could help to 
further dissect the role of the fibrinolytic system following exposure to DEP. Early 
work described in this thesis found that applying arterial thrombosis models to mice 
was extremely problematic. However, other groups have reported positive results 
when using thrombosis models, including the FeCl3 (Farrehi et al. 1998), Rose Bengal 
(Eitzman et al. 2000) and Folts (Sturgeon et al. 2006) models in mice. Also, using 
these models in combination with pharmacological treatments (for example aspirin to 
reduce platelet activation) would help to improve our understanding of the 
mechanisms at work, and may advance development of practical treatments to prevent 




Chapter 6 - Discussion 
 
 204
6.5   Concluding Remarks 
 
The work described in this thesis addressed the hypothesis that acute exposure to DEP 
accelerates thrombosis by direct modulation of the endogenous fibrinolytic system. 
Optimisation of an in vivo model of thrombosis enabled the demonstration that DEP 
did indeed increase thrombus formation, without the need for systemic or pulmonary 
inflammation. Changes contributing to this effect included increased platelet 
activation and alterations in the endogenous fibrinolytic system. In vitro 
investigations suggested that the latter could have been caused by direct interaction of 
DEP with the endothelium. Possible future investigations could address the effect of 
chronic exposure to DEP on disease free animals, on animals with pre-existing 
cardiovascular disease and on animals with relevant genetic modification. In addition, 
pharmacological interventions could be applied to animals following (chronic or 
acute) exposures to both further understand the mechanism responsible for accelerated 
thrombosis and to identify potential remedies for DEP-induced acceleration of 
thrombosis. The work could also be extended to clinical trials to examine whether the 
same mechanisms are at work in humans. Expanding the work in this thesis, as 
suggested, may promote further testing of the thrombogenic potential of other 
nanoparticles (such as quantum dots and nanoparticulate gold) and may help inform 
healthcare policy regarding nanoparticulate exposure. Overall, this study has provided 
more evidence that exposure to DEP promotes thrombus formation, and has identified 
key components of the thrombotic and fibrinolytic systems that are responsible for 
these effects. The results presented in this thesis suggest that reducing, or removing, 
particulate pollution may significantly reduce cardiovascular morbidity and mortality. 
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